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Summary 
Background: The human relationship with cats and dogs has been suggested to be of potential 
concern to public health because of the possible role of pets as reservoir of antibiotic resistant 
microorganisms. Here I suggest the “One Health” interdisciplinary approach to be helpful towards 
the understanding of the role of pets in antibiotic resistance spreading, considering also the socio-
emotional context of the human-pet relationship. 
Methods: I investigated the presence of multi-drug resistant (MDR) staphylococci in cats, dogs and 
people in the nursing homes and in the community of four Swiss Cantons (Berne, Ticino, Vaud and 
Zurich). The study received ethical clearance from the responsible Cantonal Ethical Committees 
and authorization for animal experimentation from the Cantonal and Federal Veterinary Offices. 
Between March 2008 and December 2009 I collected nasal swabs from 978 people and nasal and 
ear swabs from 256 dogs and 277 cats and checked them for the presence of staphylococci. Isolated 
bacteria were identified and their phenotypic antibiotic resistance profile evaluated. Questionnaires 
on demographic information, health status and human–pet contact were completed by each 
participant and for each animal investigated.  
Results: Rapid and reliable identification of staphylococci by matrix assisted laser desorption 
ionisation – time of flight mass spectrometry (MALDI-TOF MS) was a pre-requisite to understand 
the distribution of Staphylococcus spp. in people and pets, also to differentiate among 
phylogenetically close related species such as S. delphini, S. intermedius, and S. pseudintermedius. 
The analysis of the staphylococcal population composition of healthy cats and dogs revealed that 
S. pseudintermedius was present in 27 % (70/256) of healthy dogs and 3 % (8/277) of healthy cats, 
whereas S. felis was isolated only from cats and represented 31 % of their coagulase-negative 
staphylococcal isolates. About 17 % (92/533) of pets carried MDR Staphylococcus spp. strains. 
Previous hospitalisation (stay in a veterinary clinic during at least one night) was identified as a risk 
factor for the carriage of these strains in nostril and ear of cats and dogs. However, although a 
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relevant proportion of pets and nursing home residents was found to be carrier of MDR 
staphylococci, the residents had no increased risk of being carriers of these strains when living in 
homes with pets or having contact with these animals at least once a week. Findings suggested 
limited strain transmission between pets and humans. I could show strong physical closeness of pets 
with their owners in households and the high emotional importance of this relationship, but I did not 
observe any evident impact of pets on carriage of MDR staphylococci in their owners.  
At the end of my study I also analysed the clinical implications of methicillin-resistant 
S. pseudintermedius (MRSP) infections using as an example the isolation of this microorganism 
from a pyoderma lesion in a dog that underwent various antibiotic treatments before the correct 
diagnosis was made and an appropriate antibiotic treatment was administered.  
Discussion and conclusions: MDR staphylococci were recovered in relevant proportions from 
healthy pets and people. I could document the potential for exchange of strains due to close physical 
contact between their hosts. My results, however, indicated negligible rates of MDR staphylococcal 
transmission between human and pets.  
In evaluating the role of pets as reservoir of antibiotic resistant staphylococci, the network of 
contacts and their physical intensity, together with information on multi-drug resistance carriage in 
humans and pets should be considered for a correct estimation of the transmission and distribution 
of antibiotic resistant strains among different hosts. 
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Riassunto 
Contesto dello studio: Recentemente è stato suggerito che il contatto delle persone con i cani e i 
gatti possa costituire un potenziale problema per la salute pubblica in seguito al possibile ruolo 
degli animali domestici come serbatoi di microorganismi resistenti agli antibiotici. In questo lavoro 
propongo che l’approccio interdisciplinare “One Health (una sola salute)” potrebbe essere uno 
strumento utile per comprendere il ruolo degli animali domestici nella diffusione della resistenza 
antibiotica, considerando anche il ruolo socio-emozionale della relazione uomo-animale domestico. 
Metodi: Ho studiato la diffusione di stafilococchi multi resistenti agli antibiotici (MDR) in gatti, 
cani e persone negli istituti di lunga degenza e nella comunità di quattro cantoni svizzeri (Berna, 
Ticino, Vaud e Zurigo). Lo studio ha ricevuto un’autorizzazione alla sua realizzazione da parte dei 
comitati etici dei cantoni interessati e un’autorizzazione per la sperimentazione sugli animali da 
parte degli uffici veterinari cantonali e federale. Tra marzo 2008 e dicembre 2009 ho eseguito degli 
strisci al naso di 978 persone e al naso e orecchio di 256 cani e 277 gatti per rilevare la presenza di 
stafilococchi. I batteri isolati sono stati identificati ed è stato valutato il loro profilo di resistenza 
fenotipica agli antibiotici. Dei questionari sulla demografia, lo stato di salute e il contatto uomo-
animale domestico sono stati completati da ogni partecipante e per ogni animale investigato. 
Risultati: Un’identificazione rapida e affidabile degli stafilococchi tramite spettrometria di massa 
(MALDI-TOF MS) è stata un prerequisito per la comprensione della distribuzione di 
Staphylococcus spp. nelle persone e negli animali domestici, anche per distinguere specie 
filogeneticamente molto vicine quali S. delphini, S. intermedius, e S. pseudintermedius. L’analisi 
della composizione della popolazione di stafilococchi isolati da gatti e cani sani ha rivelato che 
S. pseudintermedius era presente nel 27 % (70/256) dei cani e 3 % (8/277) dei gatti, mentre S. felis è 
stato isolato unicamente dai gatti e rappresentava il 31 % di tutti gli stafilococchi coagulasi-negativa 
isolati. Circa il 17 % (92/533) degli animali era portatore di almeno un ceppo di 
Staphylococcus spp. MDR. Un’ospedalizzazione precedente (soggiorno di almeno una notte in una 
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clinica veterinaria) è stata identificata come fattore di rischio per la presenza di questi 
microorganismi nel naso e nelle orecchie dei cani e dei gatti. Nonostante una proporzione 
relativamente alta di animali e residenti di istituti di lunga degenza fosse portatrice di stafilococchi 
MDR, i residenti degli istituti dove gli animali erano presenti o con un contatto con questi animali 
almeno una volta la settimana non avevano un rischio accresciuto di essere portatori. I risultati 
indicano quindi una trasmissione limitata di ceppi tra uomo e animale. Ho potuto osservare una 
vicinanza fisica intensa degli animali con i loro proprietari all’interno delle economie domestiche e 
verificare la forte importanza emotiva di questa relazione, ma non ho osservato nessun impatto 
evidente degli animali sulla presenza di stafilococchi MDR nei loro proprietari. 
In conclusione del mio lavoro ho pure analizzato le implicazioni cliniche delle infezioni da 
S. pseudintermedius resistente alla meticillina (MRSP) prendendo spunto da un microorganismo 
isolato da una lesione del pioderma in un cane che aveva ricevuto diversi trattamenti antibiotici 
prima che una diagnosi corretta fosse eseguita e fosse somministrato un appropriato trattamento 
antibiotico. 
Discussione e conclusioni: Ho potuto isolare degli stafilococchi MDR in proporzioni relativamente 
alte da animali domestici sani e da persone. Ho pure potuto documentare un potenziale per uno 
scambio di ceppi in seguito ad un contatto fisico stretto tra i loro ospiti. I nostri risultati indicano 
però che la probabilità di una trasmissione di stafilococchi MDR è trascurabile.  
Nel valutare il ruolo degli animali domestici come serbatoio di stafilococchi, la rete di contatti e la 
loro intensità fisica, così come le informazioni sulla presenza di multiresistenze nelle persone e 
negli animali domestici dovrebbero essere considerati per ottenere una stima corretta della 
probabilità di propagazione dei ceppi resistenti agli antibiotici nei vari ospiti. 
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Résumé 
Contexte de l’étude: Dans les dernières années il a été proposé que le contact des gens avec des 
chats et des chiens puisse entraîner un problème de santé publique à cause du rôle potentiel des 
animaux domestiques en tant que réservoir de microorganismes résistants aux antibiotiques. Dans 
ce travail je propose que l’approche interdisciplinaire “One Health (une seule santé)” pourrait être 
un moyen utile pour comprendre le rôle des animaux domestiques dans la diffusion de la résistance 
antibiotique, en considérant aussi le contexte socio-émotionnel de la relation homme-animal 
domestique. 
Méthodes: J’ai étudié la présence de staphylocoques multirésistants aux antibiotiques (MDR) chez 
les chats, les chiens et les personnes dans des établissements médico-sociaux (EMS) et dans la 
communauté de quatre Cantons Suisses (Berne, Tessin, Vaud et Zürich). L’étude a reçu 
l’autorisation à son déroulement de la part des Comités d’étique cantonaux concernés et une 
autorisation pour l’expérimentation sur les animaux de la part des Offices vétérinaires cantonaux et 
fédéral. Entre mars 2008 et décembre 2009 j’ai effectué des frottis au nez de 978 personnes et au 
nez et à l’oreille de 256 chiens et 277 chats pour rechercher la présence de staphylocoques. Les 
bactéries isolées ont été identifiées et leur profil de résistance phénotypique aux antibiotiques a été 
évalué. Des questionnaires sur la démographie, l’état de santé et le contact homme-animal 
domestique ont été remplis par chaque participant et pour chaque animal investigué.  
Résultats: Une identification rapide et fiable des staphylocoques à l’aide de la spectrométrie de 
masse en désorption laser assisté par matrice (MALDI-TOF MS) a été une condition préalable pour 
la compréhension de la distribution de Staphylococcus spp. chez les personnes et les animaux 
domestiques; elle a aussi aidé à identifier fiablement des espèces phylogénetiquement très proches 
comme S. delphini, S. intermedius et S. pseudintermedius. L’analyse de la composition de la 
population de staphylocoques de chats et chiens sains a relevé que S. pseudintermedius était présent 
chez 27 % (70/256) des chiens et 3 % (8/277) des chats, tandis que S. felis a été isolé uniquement 
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depuis les chats et il représentait 31 % de tous les isolats de staphylocoques coagulase-négatives. 
Environ 17 % (92/533) des animaux était porteur au moins d’une souche de Staphylococcus spp. 
MDR. Une hospitalisation préalable (séjours dans une clinique vétérinaire au moins pendant une 
nuit) a été identifiée comme facteur de risque pour le portage de ces souches dans le nez et l’oreille 
des chats et chiens. Tout de même, malgré la proportion assez haute d’animaux et de résidents 
d’EMS qui étaient porteurs de staphylocoques MDR, les résidents n’avaient pas un risque accru 
d’être porteurs de ces souches lorsqu’ils vivaient dans des EMS où les animaux étaient présents ou 
lorsqu’ils avaient un contact avec ces animaux au moins une fois par semaine. Les résultats 
indiquent donc une transmission limitée de souches entre homme et animal. J’ai pu observer une 
proximité physique intense des animaux avec leurs maîtres à l’intérieur des ménages familiers et 
une forte importance émotionnelle de cette relation, mais je n’ai remarqué aucun impact évident des 
animaux sur le portage de staphylocoques MDR chez leurs maîtres.  
A la fin de mon travail j’ai aussi analysé les implications cliniques des infections par 
S. pseudintermedius résistant à la méticilline (MRSP) en utilisant comme exemple une isolation de 
ce microorganisme depuis une lésion du pyoderme chez un chien qui avait reçu plusieurs 
traitements antibiotiques avant qu’une diagnostique correcte soit faite et un traitement antibiotique 
efficace ait été donné. 
Discussion et conclusions: Des staphylocoques MDR ont été isolés en proportion remarquable 
depuis des animaux et des personnes saines. Nous avons documenté le potentiel qui existe quant à 
l’échange de souches dû au contact physique étroit entre les différents hôtes. Cependant nos 
résultats indiquent une proportion négligeable d’échange de staphylocoques résistants aux 
antibiotiques entre animaux et humains. 
Dans l’évaluation du rôle des animaux domestiques en tant que réservoir de staphylocoques 
résistant aux antibiotiques, le réseau de contacts et leur intensité physique, ainsi que l’information 
quant au portage de multirésistance aux antibiotiques chez les humains et les animaux domestiques 
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devraient être considérés à fin d’avoir une estimation correcte de la probabilité de propagation de 
souches résistantes aux antibiotiques parmi les différents hôtes. 
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Zusammenfassung 
Hintergrund: In den letzten Jahren hat man den Kontakt zwischen Menschen und Katzen sowie 
zwischen Menschen und Hunden zunehmend als potentiell besorgniserregend für die öffentliche 
Gesundheit eingestuft, vor allem wegen der möglichen Rolle von Haustieren als Reservoir 
antibiotikaresistenter Mikroorganismen. In meiner Arbeit schlage ich, den "One Health (eine 
einzige Gesundheit)" interdisziplinären Ansatz, der auch die sozialen und emotionalen Aspekte der 
Mensch-Tier Beziehung berücksichtigt, als ein mögliches Werkzeug vor, um die Rolle der Tiere bei 
der Verbreitung der Antibiotikaresistenz zu verstehen. 
Methoden: Ich studierte die Prävalenz multiresistenter (MDR) Staphylococcus-Stämme bei 
gesunden Menschen, Katzen und Hunden in der Gemeinschaft und in ausgewählten Alters- und 
Pflegeheimen von vier Schweizer Kantonen (Bern, Tessin, Waadt und Zürich). Das Projekt wurde 
jeweils von den zuständigen Ethischen Komitees sowie durch die Veterinärämter der Kantone und 
das Bundesamt für Veterinärwesen (BVET) bewilligt. Von März 2008 bis Dezember 2009 
sammelte ich Nasentupfer von 978 Personen und Nasen- und ein Ohrtupfer von 256 Hunden und 
277 Katzen und prüfte sie auf das Vorhandensein von Staphylokokken. Die isolierten Bakterien 
wurden molekularbiologisch bestimmt und ihre phänotypische Resistenz gegen Antibiotikas 
ausgewertet. Von jedem Teilnehmer und für jedes Tier wurden demographische Daten, 
Gesundheitszustand und Angaben über Mensch-Tier Kontakt gesammelt und ausgewertet. 
Ergebnis: „Matrix assisted Laser Desorption Ionisation - time of flight“ Massenspektrometrie 
(MALDI-TOF-MS) wurde zur genauen und schnellen Bestimmung von phylogenetisch 
nahverwandten Arten wie S. delphini, S. intermedius und S. pseudintermedius angewandt. 
S. pseudintermedius wurde aus 27 % (70/256) der Hunde und 3 % (8/277) der Katzen isoliert; 
S. felis dagegen wurde nur von Katzen isoliert und stellte insgesamt 31 % der Koagulase-negativen 
isolierten Staphylokokken dar. Über 17 % (92/533) der Haustiere beherbergten MDR 
Staphylococcus-Stämme. Ein Aufenthalt in einer Tierklinik während mindestens einer Nacht des 
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vorhergehenden Jahres vor Studienanfang stellte einen Risikofaktor für die Anwesenheit von MDR-
Staphylokokken in der Nase und im Ohr von Katzen und Hunden dar. Meine Studie lässt einerseits 
eine potentielle Übertragung von MDR-Staphylokokken zwischen Haustieren und Menschen 
vermuten. Andererseits habe ich aber keine klare Rolle der Haustiere für die Übertragung von 
MDR-Staphylokokken auf ihre Besitzer zeigen können, obwohl ich während der ganzen Studie 
einen ausgeprägten, körperlichen Kontakt zwischen Haustieren und ihren Besitzern und die daraus 
entstehende emotionale Bedeutung dieser Beziehung beobachtet hatte.  
Am Schluss meiner Arbeit bespreche ich auch die klinische Bedeutung von Methicillin-resistenten 
S. pseudintermedius (MRSP)-Infektionen: als Beispiel dient die unwirksame Behandlung mit 
verschiedenen Antibiotika eines aus einer Pyodermie isolierten MRSP, bevor die richtige Diagnose 
gestellt und die entsprechende antibiotische Behandlung verschrieben worden war. 
Diskussion und Schlussfolgerungen: Multiresistente Staphylokokken wurden in relativ hohen 
Mengen in gesunden Haustieren und Menschen nachgewiesen. Daraus könnte man sich eine 
potentielle Übertragung dieser Mikroorganismen durch den körperlichen Kontakt zwischen den 
Wirten vorstellen. Die Ergebnisse meiner Studie zeigen jedoch, dass die Wahrscheinlichkeit einer 
Übertragung von MDR-Staphylokokken zwischen Menschen und Haustieren vernachlässigbar klein 
ist. 
Künftig sollten auch das Netzwerk von Kontakten und ihre körperliche Intensität in die Bewertung 
der Rolle der Haustiere als Reservoir antibiotikaresistenter Staphylokokken einbezogen werden. 
Zusammen mit Informationen über die Anwesenheit von MDR-Staphylokokken bei Menschen und 
Haustieren sollten sie zu einer korrekten Schätzung der Verbreitung antibiotikaresistenter Stämme 
in verschiedenen Wirten führen. 
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1. Introduction 
1.1. The “One Health” approach 
Reports on the occurrence of probable exchange of antibiotic resistant microorganisms between 
human and pets have raised concerns about the role of pets as reservoir of multi-drug resistant 
(MDR) bacteria. Pets are increasingly used to assist therapy in nursing homes and the interaction 
between cats, dogs and their owners in the household has become very close. Thus, public health 
would benefit by investigating this issue with a “One Health” approach. “One Health” is a 
conceptual thinking that promote interdisciplinary cooperation between human and animal health 
(1).  
My thesis aims to look at the carriage of MDR staphylococci from a perspective that embraces both 
human and veterinary medicine. The presence of antibiotic resistant staphylococci is, in fact, of 
concern for both disciplines and both can therefore benefit from common investigations in this 
field. Studies on the interactions between people and animals need to take into account the socio-
cultural components and the context in which the study is carried out (2). This is why, in my work, I 
have examined also these aspects which are of primary importance in the relationship between pets 
and humans. 
 
1.2. Socio-cultural and psychological context 
In my work I mainly concentrated on the microbiological and epidemiological aspects of the 
human-pet relationship. However, although psychological analysis was definitely not the focus of 
my thesis, I believe it is important to investigate the role of pets as potential reservoir of MDR for 
humans by evaluating it also in a broader context, which considers also the psychological aspects of 
their interaction.  
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1.2.1. Challenges of the modern society 
In the last decades social factors, such as the high divorce rate, the number of people living alone, 
the increased number of widowed elderly, the stress associated with urbanisation and geographic 
mobility, have fostered the appearance of several psychological disorders such as depression and 
loneliness (3). The World Health Organisation (WHO) defines mental health as “a state of well-
being in which each individual realizes his or her own potential, can cope with the normal stresses 
of life, can work productively and fruitfully and is able to make a contribution to her or his 
community” (4). Depression is an important handicap for mental health: according to the WHO, it 
affects about 121 million people worldwide. Future projections show that by 2020 depression will 
concern all class of ages and will reach the 2nd place of the ranking of Disability Adjusted Life 
Years (DALYs), after the cardio-vascular diseases (5). Loneliness is not as well defined as 
depression, but both mental states are interleaved forms of sadness or unhappiness, with loneliness 
being a subtype of depression characterised by a deficiency in the interpersonal relationships (3). 
Improvements in the medical field, with development and availability of new technologies, have 
changed the demographic picture of the society, raising life expectancy and thus the proportion of 
older people. In Switzerland in 2008 the rate of 65 years old or older people was 21.2 %  and this 
rate is expected to reach 33.3 % by 2050 (6). As a consequence of changes in the family structure, 
older people in need of care or no longer self-sufficient often do not live at home with their 
relatives. Since increased age was shown to be related to the occurrence and degree of 
multimorbidity, elderly people often spend a substantial part of their time in nursing homes where 
health care is provided (7). 
 
1.2.2. Evolution of the human-pet relationship 
The relationship between humans and pets has its origins in the ancient times when wolfs have been 
progressively domesticated and wild cats captured by early humans (8, 9). This interaction 
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successively evolved and reached an equilibrium that can be described as a social mutualism (10). 
Today this symbiotic relationship provides an atmosphere in which the two partners have an 
emotional interaction without any threatening at the physiological level (11). In the last decades the 
relationship between pets and their owners has become closer: cats and dogs are members of the 
family network, even representing sometimes the only daily life companion for people living 
marginally to society. Pets can help people in developing healthful components, providing 
companionship and pleasurable activity, facilitating exercise, play and happiness, being something 
to care for and a source of consistency, allowing feeling of security, being a comfort to touch and 
pleasurable to watch (12). It has been shown that people interacting with animals may benefit from 
improved physical health and psychological and social well-being (13). Actively looking after pets 
might also be an incentive to keep a moderate level of physical activity, thus reducing the risk of 
being overweight (14). At present pets have an important role of companionship in our society as 
they have never had previously in human history. 
 
1.2.3. Pet-assisted therapy 
Pets are increasingly used in the therapy of chronically diseased or elderly patients. These animals 
are extensively trained and have a clear therapeutic goal (15, 16). Studies conducted on hospitalised 
patients and elderly people residing in institutional settings reported a general health benefit from 
pet-assisted therapy, including reduced feeling of anxiety, loneliness and isolation (17, 18). Benefits 
of such approach apply also to children care, showing that, in acute care paediatric setting, children 
who underwent pet-assisted therapy experienced a significant reduction in pain level compared to 
children not having this kind of treatment (19). 
Despite the psychological and social benefits shown to arise from pet-assisted therapy, there is a 
debate on the zoonotic potential of human-pet contact, which is at the basis of this therapeutic 
approach (20, 21). Indeed, pets might act as source of diseases (20). To date, no regulations on pet-
Chapter 1 – Introduction - 4 - 
Epidemiology of multi-drug resistant staphylococci in cats, dogs and people in Switzerland 
therapy animals and their handling in healthcare settings were available. Thus, Enoch et al., while 
documenting the carriage of methicillin-resistant Staphylococcus aureus (MRSA) in a pet-therapy 
dog, suggested guidelines in an attempt to prevent potential spread of nosocomial infections, such 
as MRSA, from dogs employed in healthcare-associated settings (22). 
 
1.3. Microbiological context 
1.3.1. Contact with pets and risk of pathogen transmission 
Zoonoses refer to “any disease or infection that is naturally transmissible from vertebrate animals to 
humans” (23). They may originate from bacteria, fungi, virus or parasites that can be transmitted by 
physical contact, faecally–orally, or through vectors (24). Scratches and bites from cats and dogs 
can lead to infections (25, 26). Guay (20) reviewed a panel of zoonoses that might be expected in 
long-tern care setting in association with pet-assisted therapy, providing examples of medically 
important infectious diseases acquired from cats and dogs, such as dermatophytosis, bartonellosis 
and toxoplasmosis.  
Pets have been suggested to be reservoirs for antimicrobial-resistant bacteria (27-29). Companion 
animals represent indeed potential sources of spread of antimicrobial resistance, owing to the 
extensive use of antimicrobial agents in veterinary practices dealing with small animals (30, 31) and 
close contact with humans. The transmission of antibiotic resistant microorganisms between pets 
and humans in different settings (e.g. veterinary clinics and household) was recently documented 
(32-36). 
 
1.3.2. Antibiotic use and antibiotic resistance 
In 2002 the worldwide use of antibiotics was estimated to be around 100,000-200,000 tonnes per 
year (37). Large differences in antibiotic consumption were observed across countries (38). In 
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Switzerland the outpatient antibiotic consumption in human medicine was shown to be determined 
by socioeconomic factors (e.g. pro capita income, antibiotic price, density of medical practices, 
demographic, cultural and educational parameters) (39).  
Since the discovery and the use of the first antimicrobial drugs in the 1930s and 1940s, bacteria 
showed the capacity to resist to antibiotics by developing different strategies (40-42). Three 
mechanisms of resistance toward antimicrobial agents are known: (i) enzymatic inactivation of the 
antibiotic; (ii) decreased intracellular accumulation of the antibiotic; and (iii) alteration or protection 
of the cellular target (43). The presence of resistance genes located in genetic elements (e.g. 
plasmids, transposons, chromosomal cassettes) greatly enhances their mobility and ability to spread 
from one bacterial strain to the other. Horizontal gene transfer, by exchange and acquisition of new 
genetic material by transduction, transformation or conjugation, is the primary mechanism by which 
microorganisms acquire antibiotic resistance (44). 
Antibiotic resistance is commonly associated to fitness costs. Microorganisms must pay an 
evolutionary cost for their resistances that results in a loss of fitness (45) and can be measured at 
biological level (e.g. reduced growth, physiological weakness) (46). We are concerned with this 
evolutionary issue when thinking at the strategies for control of spread of antibiotic resistance. It 
has been suggested that a reduction in antibiotic use would benefit the susceptible bacteria strains 
that are fit under low antibiotic pressure and would thus be able to outcompete resistant strains over 
time (47, 48). However, reversibility is function of the time required to reduce the abundance of 
resistant bacteria and this is inversely related to the fitness cost of resistance (49, 50). Therefore, if 
the fitness cost associated to a given antibiotic resistance is low, the reversibility process might be 
so slow that, in most cases, it is unlikely to be of practical importance (46). 
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1.3.3. Antibiotic resistance in Staphylococcus spp. 
Bacteria of the genus Staphylococcus are grouped in coagulase-positive (CPS) and coagulase-
negative (CNS) species. They are common members of the normal cutaneous and mucosal bacterial 
community of humans and animals, but they may also cause significant and widespread bacterial 
infections in their hosts (51-62). Staphylococci have developed resistance to a wide range of 
antibiotics and the reduced treatment options in case of infections caused by MDR staphylococci is 
a critical issue and a challenge for clinicians and veterinarians (63-66).  
Among the antibiotic resistance mechanisms found in staphylococci, methicillin resistance is of 
concern because of the synthesis of the low-affinity penicillin-binding protein PBP2’ (PBP2a), 
encoded by the mecA gene, which confers resistance to all beta-lactams (67). The PBP2a has a 
decreased affinity for beta-lactams due to the modification of its active site, preventing beta-lactams 
and their derivates from inhibiting the final stages of peptidoglycan biosynthesis (68). The mecA 
gene is located in a mobile genetic element called staphylococcal cassette chromosome (SCCmec). 
The SCCmec can harbour antibiotic resistance genes others than the mecA, but also virulence 
determinants. There is evidence of horizontal gene transfer of SCCmec between different 
staphylococcal species (69). SCCmec have been classified and characterised according to their 
putative cassette chromosome recombinase gene (ccr) and their overall genetic composition (70). 
Six different types of SCCmec, (SCCmec I-VI), have been described; their discrimination, coupled 
with other typing methods, e.g. pulsed field gel electrophoresis (PFGE), allowed identifying 
genetically related staphylococcal isolates and thus confirmed also their epidemiological 
relationship (71, 72). 
 
1.4. Clinical and epidemiological context  
Species of Staphylococcus are opportunistic pathogens that can be found both as commensal 
microorganisms and as causative infectious agents of skin and soft tissues. As a general rule, CPS 
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species (Staphylococcus aureus, S. intermedius, S. schleiferi subsp. coagulans, S. hyicus, S. lutrae, 
S. delphini and S. pseudintermedius) are more virulent pathogens than CNS species (e.g. 
S. epidermidis, S. hominis, S. felis, S. pettenkoferi,…), the latter having more subtle clinical 
manifestations, with a subacute or even chronic clinical course lacking immediate signs of infection 
(73, 74). MDR staphylococci, both CPS and CNS, have become widespread in hospitals around the 
world, and currently methicillin-resistant strains represent the most common causes of bacterial 
nosocomial infections (75). Prevalence of community-associated MRSA (CA-MRSA) is increasing 
worldwide (76) with up to 63% of CA-MRSA that were isolated from cases of community skin and 
soft-tissue infections due to S. aureus (77); and methicillin resistance is of concern also in 
veterinary setting (78, 79). 
 
1.4.1. Staphylococci in humans 
In humans, CPS bacteria are of major interest because they include S. aureus, which is present in 
the anterior nares of about 25-30 % healthy people (80). This microbe has developed resistance to a 
wide range of antibiotics: in fact, methicillin-resistant S. aureus (MRSA) represents a considerable 
challenge of treatment for human clinicians (80, 81). MRSA strains can be classified into two 
groups: hospital acquired MRSA (HA-MRSA), and community acquired MRSA (CA-MRSA). The 
majority of CA-MRSA strains are characterized by the presence of Panton-Valentine leukocidin 
(PVL) toxin, (82, 83). HA-MRSA and CA-MRSA are further differentiated by their antimicrobial 
resistance patterns. MDR MRSA isolates are usually considered HA-MRSA, whereas CA-MRSA 
are resistant only to beta-lactams and macrolides (84). In Swiss nursing homes the prevalence of 
MRSA carriage in old patients can reach 5 % (85, 86); in 1995 up to 20 % of all S. aureus isolated 
in Swiss hospitals were MRSA (87). Meanwhile, outbreaks of CA-MRSA infections are becoming 
an important public health problem worldwide as a consequence of the unique combinations of 
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virulence factors and resistance traits of these strains that have been associated with high morbidity 
and mortality in the community (88). 
S. aureus is the most investigated CPS, being documented and recognized as pathogenic agent, but 
in the literature cases of infection caused by CPS other than this species were occasionally reported. 
S. schleiferi subsp. coagulans (89, 90) and recently also S. pseudintermedius infections were 
identified in humans (54, 57, 58). We can find also reports of infections due to S. intermedius (91-
93), but these are probably misidentified S. pseudintermedius. S. pseudintermedius was described 
for the first time in 2005 and it is indistinguishable from S. intermedius by phenotypic analyses; in 
addition, the discrimination power of 16S in these closely related staphylococcal species is 
questionable (94-96). To my knowledge, there are no reports on human infections caused by the 
CPS species S. hyicus, S. lutrae or S. delphini. 
CNS have also emerged as a considerable cause of nosocomial infections, with about 80-90 % of 
human isolated strains producing an inducible beta-lactamase (97). Patients with CNS infections are 
usually immunocompromised, with indwelling or implanted foreign bodies (e.g. catheters) (98). 
Even if clinical manifestations of CNS are subtle when compared to CPS (73, 74), the important 
role of these pathogens and their increasing incidence has been recognized (98-101). For example 
CNS have been documented as infectious agents in neutropenic patients (102), accounting for about 
one quarter of all bloodstream infections (103). Moreover, several studies showed clonal intra- and 
inter-hospital spread of S. epidermidis strains, suggesting that similar infection control measures 
may be necessary for MDR CNS isolates as for MRSA (98, 104-107). Accurate identification of 
CNS is necessary to provide a better understanding of the pathogenic potential of the various 
species (108, 109). Since the SCCmec in CNS are identical to those found in MRSA strains, and 
evidence of horizontal gene transfer of SCCmec between CNS and S. aureus has been reported, 
methicillin-resistant CNS might indeed act as reservoirs for methicillin resistance in S. aureus (69). 
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Risk factors associated with carriage and infections by MRSA were extensively investigated in last 
years. Colonisation by MRSA was associated with a 4-fold increase in the risk of infections caused 
by this microorganism (OR = 4.08, 95 % confidence interval (CI): 2.10-7.44) (110). Factors 
reported to increase the risk of colonisation or infection by MRSA include age above 60 years, 
hospitalisation in the previous year, antibiotic use in the previous 3 months, presence of wounds and 
recent skin infection, urinary catheter, diabetes mellitus, and peripheral vascular disease (111-114). 
Risk factors for the emergence and spread of CNS clones in hospitals include duration of hospital 
stay (especially in intensive care units), duration of antibiotic treatment, antibiotic pressure in the 
environment, and hygienic standards (115). Additionally, intravascular catheters, low gestational 
age, and long hospital stays have been described as important risk factors for the development of 
putative CNS infections in neonatal intensive care (116). 
 
1.4.2. Staphylococci in cats and dogs 
The most frequently isolated CPS species from dog clinical samples is S. pseudintermedius (117). 
This microorganism can show resistance to methicillin (118-121) and can also harbour the gene of a 
presumptive PVL analogue (lukS-I) (122, 123). This species, together with S. intermedius and 
S. delphini, belongs to the so called “Staphylococcus intermedius Group” (SIG) (124). The three 
species are indistinguishable by biochemical and morphological characters; only recently the 
epidemiological relevance of S. pseudintermedius became evident, when new molecular 
identification methods (e.g. partial sequence of hsp60 and sodA genes, multiplex-PCR) were 
developed (34, 94, 125). We lack therefore indications on the epidemiology of this species before 
2005. From a phylogenetic point of view, however, S. pseudintermedius is not a new emerging 
species among dogs, but rather a misidentified biotype of S. intermedius (126). Additionally, SIG 
strains share many phenotypic characteristics with S. aureus, further complicating their 
identification (127, 128). In the last 5 years methicillin-resistant S. pseudintermedius (MRSP) 
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carriage or infections were increasingly reported in veterinary settings both in cats and dogs (59, 60, 
119, 129, 130). Other CPS species found in these pets include S. schleiferi subsp. coagulans (131-
133) and S. aureus (22, 134, 135). 
CNS are also part of the normal bacterial community of skin and mucosae of pets, but developed 
resistance mechanisms to various antibiotics as well (136, 137). Nevertheless, their pathogenic 
potential and the capacity to transfer resistance genes to the CPS species are still under-investigated. 
Previous studies mainly focused on CPS with very little investigation on CNS (138). However, 
S. felis, a CNS species, was recognized as a possible feline urinary tract pathogen (53). 
Only recently risk factors associated with the carriage of MRSA in cats and dogs were investigated 
in veterinary practices and referral hospitals (139, 140). Antimicrobial drugs (β-lactams or 
fluoroquinolones), number of antimicrobial treatments, number of days admitted to veterinary 
clinics, intravenous catheterisation and surgical implants were found to be associated with the 
carriage of MRSA in cats and dogs, thus suggesting similarities with the risk factors described for 
humans (139, 140). Unifactorial contingency tables were used to explore possible risk factors 
associated to the carriage of MRSP, showing prior hospitalisation and/or antibiotic therapy to be 
potential associated factors (141).  
 
1.4.3. Potential exchange of staphylococci between humans and pets 
Specific categories of people working with animals (e.g. pig farmers) are at risk of colonisation or 
infection by animal related methicillin-resistant staphylococcal strains (142-145). Cases of carriage 
or infection by S. pseudinteremedius in humans after contact with pets have been reported (57, 146). 
In the last decade the carriage of S. aureus in pets, with strain types typically found in humans, was 
also documented (22, 32, 146). Hanselman et al. described a high prevalence of S. aureus in dogs 
and S. pseudinteremedius in pet owners thus suggesting that transmission of CPS may occur 
between humans and companion animals residing within the same household (146). 
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2. Aim and specific objectives of the thesis 
Aim of this thesis is to gain insight in the microbiological and epidemiological relationship between 
humans and pets with regards to carriage of staphylococci. This will eventually allow better 
understanding of the potential role of cats and dogs as reservoirs of antibiotic resistant 
microorganisms. 
 
Specific objectives of the thesis are: 
1. To determine the prevalence of Staphylococcus spp. in cats, dogs and people in nursing 
homes of different Swiss regions;  
2. To identify the isolated staphylococci at the species level and to assess their antimicrobial 
resistance pattern; 
3. To assess whether people exposed to pets are at higher risk of carrying MDR staphylococci 
compared to people without close contact with pets; 
4. To genotype the isolates to investigate the existence of epidemiological relationships 
between animal and human strains. 
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3. Overview of the manuscripts 
Manuscripts issued from my PhD work are the result of different collaborations that allowed 
investigating microbiological and epidemiological aspects of MDR staphylococci. The work 
includes different approaches to the problem statement: challenges in the identification and 
discrimination of species belonging to the Staphylococcus intermedius Group (RESEARCH 
PAPER 1), investigation on the distribution of MDR Staphylococcus spp. in pets and associated 
risk factors (RESEARCH PAPER 2), examination of MDR staphylococcal carriage in nursing 
homes residents in relation to the contact with pets (RESEARCH PAPER 3), assessment of 
physical closeness of pets with people in the household, emotional importance of this relationship 
and its implications for the carriage of staphylococci in pet owners (WORKING PAPER 1), 
clinical challenges related to the antibiotic treatment of methicillin-resistant S. pseudintermedius 
(MRSP) infections (RESEARCH PAPER 4). 
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Identification of Staphylococcus intermedius Group by MALDI-TOF MS 
 
Paola Decristophoris a, b, c, 1,*, Amy Fasola d, 1, Cinzia Benagli a, Mauro Tonolla a, e, Orlando Petrini a 
a  Cantonal Institute of Microbiology, 6500 Bellinzona, Switzerland 
b Epidemiology and Public Health, Swiss Tropical and Public Health Institute, 4002 Basel, 
Switzerland 
c  Faculty of Science, University of Basel, 4003 Basel, Switzerland 
d  School of Pharmaceutical Sciences, University of Geneva, 1211 Geneva, Switzerland 
e Microbial Ecology, Microbiology Unit, Plant Biology, University of Geneva, 1211 Geneva, 
Switzerland 
1 Both authors contributed equally to this work 
* Corresponding author. Tel.: +41 91 814 60 37; fax: +41 91 814 60 19. 
E-mail address: paola.decristophoris@ti.ch 
 
Abbreviations: SIG: Staphylococcus intermedius Group; MALDI-TOF MS: Matrix Assisted Laser 
Desorption Ionization - Time Of Flight Mass Spectrometry; SARAMISTM: Spectral Archive And 
Microbial Identification System 
hsp60 sequence data are accessible under the numbers FR731134 - FR731159 
 
This article has been published in: Systematic and Applied Microbiology, 34 (2011) 45-51 
Chapter 4 – Research paper 1 - 32 - 
Epidemiology of multi-drug resistant staphylococci in cats, dogs and people in Switzerland 
Abstract 
The Staphylococcus intermedius Group includes S. intermedius, S. pseudintermedius and 
S. delphini, coagulase-positive bacteria commonly isolated from animals. The identification of 
organisms belonging to this group is presently carried out using molecular methods. This study 
assessed the suitability of MALDI-TOF MS for their identification. 69 strains of different biological 
and geographic origins, identified by partial hsp60 gene sequencing as S. intermedius (n = 15), 
S. pseudintermedius (n = 32) and S. delphini (n = 22), were analyzed by MALDI-TOF MS. The 
estimated sensitivity, specificity and efficiency were calculated. In addition we computed the 
agreement between the outcome of MALDI-TOF MS identification and partial hsp60 gene 
sequencing. The sensitivity of MALDI-TOF MS was higher for S. intermedius [0.95 (95% CI: 0.68-
0.99)], than for S. pseudintermedius [0.78 (95% CI: 0.60-0.90)] and S. delphini [0.64 (95% CI: 
0.41-0.83)], whereas the specificity was 1 for S. intermedius and S. delphini and 0.97 (95% CI: 
0.86-0.99) for S. pseudintermedius. The Cohen’s kappa coefficient indicated almost perfect 
agreement between MALDI-TOF MS and hsp60 gene sequencing for the identification of 
S. intermedius [0.96 (95% CI: 0.87-1.04)], and substantial agreement for S. delphini and S. 
pseudintermedius [0.70 (95% CI: 0.52-0.89) and 0.76 (95% CI: 0.62-0.92), respectively]. The 
overall efficiency of the proteomic identification ranged between 0.88 (95% CI: 0.78-0.95) for 
S. pseudintermedius and S. delphini and 0.99 (95% CI: 0.92-0.99) for S. intermedius. MALDI-TOF 
MS is thus a valuable and reliable tool for the rapid and accurate identification of bacteria belonging 
to the Staphylococcus intermedius Group. 
 
KEY WORDS: MALDI-TOF MS; hsp60; Veterinary medicine; Identification; Sequencing; 
Taxonomy 
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Introduction 
The Staphylococcus intermedius Group (SIG) includes S. intermedius, S. pseudintermedius and 
S. delphini. The denomination SIG was first used because the three species were indistinguishable 
by biochemical and morphological characters (1, 2). SIG are the most common coagulase-positive 
staphylococci (CPS) isolated from animals, in which they may act as opportunistic pathogens and 
cause a variety of infections such as otitis externa, pyoderma, abscesses, reproductive tract 
infections, mastitis, and wound infections (3). The identification of bacteria belonging to SIG is 
problematic. Phenotypic identification is unreliable, no commercial kits are available, and 
molecular identification is so far the only reliable tool (4). SIG strains share many phenotypic 
characteristics with S. aureus and this further complicates their identification (5). 
S. pseudintermedius, and not S. intermedius as previously thought, is the most common CPS species 
isolated from cats and dogs (6). Therefore, from a phylogenetic point of view, S. pseudintermedius 
is not a new emerging species among dogs, but rather a misidentified biotype of S. intermedius (7). 
In veterinary medicine, failure in treatments against staphylococcal infections might stem from 
inadequate species identification as for example in the case of methicillin-resistant CPS isolates, for 
which the MIC breakpoints of oxacillin differ with species (8, 9). Thus, a reliable and accurate 
method allowing a fast identification of staphylococci belonging to SIG is needed. 
Many methods used to identify CPS were developed before the description of S. pseudintermedius 
in 2005 (10). Recently, Sasaki et al. (4), provided a first reliable molecular phylogenetic analysis 
and species identification based on partial hsp60 gene sequences. Other genes already shown to be 
useful for the identification of staphylococcal species, e.g. the partial rpoB gene (11), might also be 
used for the identification of SIG species, but their adequacy in identifying SIG species has not yet 
been proven.  
In the last decade matrix assisted laser desorption ionisation-time of flight mass spectrometry 
(MALDI-TOF MS) has been increasingly used for the identification of microorganisms because of 
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its ease of use, the extremely small amount of sample needed and the possibility of simultaneous 
detection of analytes without previous isolation of bacterial strains (12). MALDI-TOF MS was 
shown to be highly accurate for bacterial classification and identification even in samples with low 
abundances and mixed flora (13). The technique produces a fingerprint spectrum of peptides and 
proteins of the analyzed microorganisms that allows an accurate identification of the bacterial 
species. In contrast to molecular biology, MALDI-TOF MS is a taxonomic tool with no direct 
phylogenetic component, being at least partly independent of the genomic features of the analyzed 
bacteria (14). This technique was already successfully applied to the identification of different 
staphylococcal isolates, both CPS and coagulase-negative species (CNS) (15, 16). 
Our study aimed to assess the suitability of MALDI-TOF MS for the identification of members of 
the SIG complex. We calculated the estimated sensitivity, specificity and efficiency as well as the 
percentage of agreement in the identification of MALDI-TOF MS as compared to the sequencing of 
partial hsp60 gene for the identification of strains belonging to the species S. intermedius, 




We analyzed 69 strains belonging to the Staphylococcus intermedius Group (SIG) and identified 
them by sequencing of the partial hsp60 gene as S. intermedius (n = 15), S. pseudintermedius 
(n = 32) and S. delphini (n = 22). The strains had different biological and geographic origins (Table 
1). We included one reference strain and one type strain (T) each for S. intermedius (LMG19136, 
LMG13351- T) and S. pseudintermedius (LMG22221, LMG22219- T) from BCCM/LMG and the 
type strain for S. delphini (CCUG 30107- T) from the CCUG, Sweden. The BCCM/LMG reference 
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strain LMG19136 was identified as S. pseudintermedius by hsp60 gene sequencing. All strains were 
stored in 7% skimmed milk at -80°C. 
 
DNA extraction and genetic analysis 
Pure cultures were grown on blood agar at 37°C for 24h and genomic DNA was extracted using the 
InstaGeneTM kit (Bio-Rad, Cat. No. 732-6030) according to the manufacturer’s instructions. Genetic 
analyses were performed using the partial heat shock protein (hsp60) gene sequences. The PCR 
mixture consisted of 20 µl of InstaGene DNA extract, 25 µl Taq PCR Master-Mix (Cat. No. 
201445), 2 µl filtered (0.2 µm) and sterilized H2O, 1.5 µl of a 10 µM primer forward and 1.5 µl of a 
10 µM primer reverse solution. The positive control consisted of 20 µl of DNA extracted from the 
MRSA strain ATCC43300.  
The primers for the amplification of the partial hsp60 gene sequence were Staph H279 (nucleotide 
sequence 5’-GAATTCGAIIIIGCIGGIGA(TC)GGIACIACIAC-3’) and Staph H280 (nucleotide 
sequence 5’-CGCGGGATCC(TC)(TG)I(TC)(TG)ITCICC(AG)AAICCIGGIGC(TC)TT -3’), which 
allowed the amplification of a 600bp DNA fragment (17, 18). The PCR thermal cycling conditions 
were 3 min at 95°C for 1 cycle, followed by 40 cycles of 1 min at 94°C, 2 min at 37°C, and 5 min at 
72°C. The last cycle was performed at 72°C and lasted 10 min (18). DNA amplified fragments were 
stained on 0.8% agar gel with GelRed (Biotium, Cat. No. 41003). DNA purification was performed 
using NucleoSpin (Cat. No. 740609.250) according to the instructions for direct purification of 
PCR products. We quantified the amplified and purified DNA fragments before the sequencing 
reaction using the software NANO DROP ND-1000. 
Sequencing reactions were carried out using Big Dye Terminator v1.1 Cycle Sequencing Kit 
(Applied Biosystems) with a 15 µl total volume composed of 3 µl Big Dye Terminator, 1.5 µl Big 
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Dye buffer, 2.4 µl primer 1 µM, 7.1 µl H2O and 1 µl DNA (~20 ng/µl) sample. Primers for the 
sequencing of the partial hsp60 gene were the same as those used for the PCR reaction (18). The 
thermal cycling conditions were 1 min at 96°C for 1 cycle, followed by 25 cycles of 10 sec at 96°C, 
5 sec at 50°C, and 4 min at 60°C. Sequence reactions were purified on a 0.025 µm membrane filter 
in a Tris-EDTA buffer solution pH 8 before sequencing with HiDi™ Formamide (Applied 




Pure cultures were grown on blood agar at 37°C for 24h. All samples were processed with a 
MALDI-TOF MS Axima Confidence™ spectrometer (Shimadzu-Biotech Corp., Kyoto, Japan) in 
positive linear mode (m/z = 2,000-20,000). A small amount of a colony of each pure culture was 
transferred to a FlexiMass™ target well using a disposable loop, overlaid with 0.5 µl of 2,5-
dihydroxybenzoic acid matrix solution (DHB; 10 mg/ml in acetonitrile / 0.1 % trifluoroacetic acid 
1:1) and air-dehydrated within 1-2 min at 24-27 °C. 
The reference strain Escherichia coli K12 (GM48 genotype) was used as a standard for calibration 
and as reference measurement for quality control. Sample information such as medium and grown 
conditions was imported into the software Shimadzu Biotech Launchpad™, v.2.8 (Shimadzu-
Biotech Corp., Kyoto, Japan). Protein mass profiles were obtained with detection in the linear 
positive mode at a laser frequency of 50 Hz and within a mass range from 2,000-20,000 Da. 
Acceleration voltage was 20 kV, and the extraction delay time was 200 ns. A minimum of 20 laser 
shots per sample was used to generate each ion spectrum. For each bacterial sample, 50 protein 
mass fingerprints were averaged and processed. Spectra were analyzed using SARAMIS™ 
(Spectral Archive And Microbial Identification System, AnagnosTec GmbH) at default settings. We 
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created the reference spectra (SuperSpectra) on the basis of the most discriminating peaks for a 
given species and for each species we selected an amount of mass to charge ratios (m/z) that were 
genus specific, i.e. they were present in all SIG strains. Species specific peaks had to be present 
only in a given species. Mass to charge ratios that were species specific were given a larger 
relevance, as described in the SARAMIS™ user manual. Dendrograms were based on the peak 
patterns of all analyzed strains submitted to single-link clustering analysis using SARAMIS™ 
(0.08% error, range from m/z 2,000 to 20,000). 
 
Data analysis 
Genetic data were analyzed using the software ABI PrismTM 310 Collection Genetic Analyser 
(Applied Biosystems). Multiple alignments were performed using the BioNumerics software v.6.01 
(Applied Maths). The modular microorganism identification system AnagnosTec 
AXIMA@SARAMIS was used to archive and evaluate MALDI-TOF MS data. SARAMIS™ was 
also used to construct dendrograms to show relationships among the strains. 
We calculated the estimated sensitivity and specificity and the 95% confidence intervals (CI) 
compared to a constructed perfect standard (19), corresponding to the identification by partial hsp60 
gene sequences. We calculated the estimated sensitivity and specificity separately for the three 
species S. intermedius, S. pseudintermedius and S. delphini, defining a positive identification by 
MALDI-TOF MS when the identification confidence was ≥ 90%. The Cohen’s kappa coefficient 
was also computed (20). 
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Table 1. Description of the investigated strains, name (T: type strain), source, biological origin, geographic 
origin (B: Belgium, CH: Switzerland, CZ: Czech Republic, DK: Denmark, F: France, I: Italy, J: Japan, PL: 
Poland, S: Spain, UK: United Kingdom, USA: United States of America) and hsp60 identification. 
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Results
The estimated sensitivity of MALDI-TOF MS for the identification of S. intermedius was 0.95 
(95% CI: 0.68-0.99), of S. pseudintermedius 0.78 (95% CI: 0.60-0.90), and of S. delphini 0.64 (95% 
CI: 0.41-0.83); the estimated specificity was 1.00 for S. intermedius and S. delphini and 0.97 (95% 
CI: 0.86-0.99) for S. pseudintermedius. The efficiency of identification was 0.99 (0.92-0.99) for 
S. intermedius and 0.88 (95% CI: 0.78-0.95) for S. pseudintermedius and S. delphini. The Cohen’s 
kappa was 0.96 (95% CI: 0.87-1.04) for S. intermedius, 0.76 (95% CI: 0.62-0.92) for 
S. pseudintermedius and 0.70 (95% CI: 0.52-0.89) for S. delphini.
Figure 1. Representative spectra of the type strains S. pseudintermedius LMG 22219-T, S. intermedius LMG 
13351-T and S. delphini CCUG 30107-T with relative intensity [%] of the protein profile peaks [m/z] 
ranging between 2000 and 6000 Da. T: type strain. 
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Spectra with specific peaks for the type strains of the three investigated species are shown in Figure 
1. Spectra of strains belonging to the same species displayed a high level of similarity; within the 
same species, however, some variation in the pattern composition and the measured relative 
intensities were observed (e.g. S. intermedius, Figure 2). We created 2 new SuperSpectra for the 
identification of S. intermedius, 3 for S. pseudintermedius and 2 for S. delphini. The selected mass 
to charge ratios ranged from 2002.8 m/z to 19.883.7 m/z (error 0.08 %), with an average of 
21.14±1.46 (SD) different mass to charge ratios used for the creation of each SuperSpectra. Details 
are reported in Table 2.
Figure 2. Spectra of different S. intermedius strains with relative intensity [%] of the protein profile peaks 
[m/z] ranging between 2000 and 6000 Da. 
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Table 2. Mass to charge ratios (m/z) used for the creation of the different SuperSpectra. Error 0.08%. 
Within the strains identified as S. pseudintermedius with the created SuperSpectra 65.6% (21/32) 
strains were correctly identified with a confidence of 99.9%, 12.5% (4/32) with a confidence 
between 99.8% and 90%, and 21.9% (7/32) with a confidence lower than 90%. For S. intermedius
93.3% (14/15) of the strains were correctly identified with a confidence of 99.9% and 6.7% (1/15) 
with a confidence lower than 90%. For S. delphini, 31.8% (7/22) of the strains were correctly 
identified with a confidence of 99.9%, 31.8% (7/22) with a confidence between 99.8% and 90%, 
and 36.4% (8/22) with a confidence lower than 90%. 
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The dendrogram showed two main clusters, one including all S. intermedius and the other 
S. pseudintermedius and S. delphini. The latter two where closer in the dendrogram but all the 
strains identified as S. delphini formed a cluster distinct from all S. pseudintermedius isolates (Fig. 
3). All 7 strains identified as S. pseudintermedius with a confidence lower than 90% were included 
in the cluster of S. pseudintermedius. Isolate P2A, one of the two identified as S. intermedius with a 
confidence lower than 90%, was included in the S. intermedius and isolate P66A in the S. delphini 
cluster. All strains identified as S. delphini with a confidence lower than 90%, with the exception of 
isolate P27B, belonged to the S. delphini cluster (Fig. 3). 
 
Discussion 
MALDI-TOF MS can be used to reliably identify bacterial species belonging to SIG. The estimated 
sensitivity of MALDI-TOF in the identification of the SIG species was higher for S. intermedius 
than for S. pseudintermedius and S. delphini, whereas the estimated specificity was 1 for 
S. intermedius and S. delphini and 0.97 for S. pseudintermedius. The Cohen’s kappa coefficient 
indicated almost perfect agreement between MALDI-TOF MS and hsp60 gene sequencing in the 
identification of S. intermedius and substantial agreement for S. delphini and S. pseudintermedius. 
The overall efficiency of the proteomic identification was quite high and ranged between 88% and 
99% for S. pseudintermedius - S. delphini and S. intermedius respectively. 
We based the choice of the constructed standard used in this study, the hsp60 gene, for the 
calculation of the estimated specificity, sensitivity, efficacy and agreement on the results of the 
work carried out by Sasaki et al. (4). The choice of another constructed standard (e.g. the nuc, gap, 
or sodA genes, (4, 21)) might have led to slightly different agreement values between the two 
identification methods, but overall the identification with MALDI-TOF MS showed to be robust 
enough to allow the creation of reliable SuperSpectra. 
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Figure 3. Dendrogram resulting from single-link clustering analysis (SARAMISTM database software) of 
MALDI-TOF MS on Staphylococcus intermedius Group strains. Error 0.08%; range of m/z from 2000 to 
20,000 Da. T: type strain. 
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Figure 3. Dendrogram resulting from single-l k clustering analysis (SARAMISTM database software) of 
MALDI-TOF MS on taphylococcus intermedius Group strains. Error 0.08%; range of m/z from 2000 to 
20,000 Da. T: type s rain. 
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In the last year new genetic tests have been described for the identification of CPS species. For 
example, the PCR-RFLP method based on pta gene allows accurate differentiation of 
S. pseudintermedius from the other SIG species and also from other important human and animal 
pathogenic staphylococcal species such as S. schleiferi and S. aureus (22). This approach, however, 
does not allow conclusive identification of other SIG species. Recently, Blaiotta et al. have 
described the same methodological approach but based on another housekeeping gene, the kat gene, 
which allows unambiguous identification of CPS, including S. pseudintermedius and S. delphini 
(23). A multiplex-PCR method based on the nuc gene was also shown to reliably identify CPS (24). 
All these methods are based on the analyses of genetic components of the investigated bacteria and 
thus need the classic approach of culture of the organism followed by DNA extraction, PCR 
amplification and gel staining for the detection of amplified fragments. This genetic approach 
allows reliably identification of the investigated species but it is time-consuming if compared with 
the MALDI-TOF MS proteomic approach which shows equivalent efficiency. 
MALDI-TOF MS allows rapid and accurate identification of SIG bacteria within 24h, provided a 
reliable comparison database is available. This means that for each group of microorganisms careful 
phylogenetic characterization of a sufficient number of geographically and genetically diverse 
isolates of the species under consideration is needed before they can be used to construct 
SuperSpectra. In fact, SuperSpectra for S. intermedius previously present in the database led to 
erroneous identification of strains in the present study. This relates most probably to an insufficient 
characterization of the strains used for the creation of these SuperSpectra. It is therefore crucial to 
use only fingerprints of strains well characterized by phylogenetic studies (e.g. by analysis of at 
least two different genes) for the creation of SuperSpectra. The SuperSpectra for 
S. pseudintermedius, S. intermedius and S. delphini described in Table 2 have been constructed 
according to these criteria and have been shown to be highly reliable. 
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The created SuperSpectra were able to identify only 31.8% of the S. delphini strains with a 
confidence greater than 99%. This reflects the high heterogeneity within the S. delphini group 
which has been already described in a molecular study suggesting the presence of a new species 
within the S. delphini group and dividing this species in two groups, A and B (4). In particular the 
strain P27B was identified as S. delphini by partial hsp60 gene sequence and by MALDI-TOF with 
a confidence of 79.5%; in the dendrogram resulting from the MALDI-TOF analysis, however, it 
was not included in the cluster of S. delphini strains but was closer to the S. pseudintermedius 
strains. The position of strain P27B, known to belong to S. delphini group B (24), might be 
explained by the fact that strains of group B are more closely related to those of S. pseudintermedius 
than to S. delphini group A (4).  
This study has provided evidence of the validity and usefulness of MALDI-TOF MS for a rapid, 
comparatively cheap and reliable identification of bacterial isolates belonging to the Staphylococcus 
intermedius Group. Additional work with MALDI-TOF MS, coupled with corresponding 
phylogenetic analyses, may allow better insight in the ongoing speciation within S. delphini as well 
as the geographic validation of the newly created SuperSpectra for S. pseudintermedius and 
S. intermedius with a larger number of collected strains. 
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Abstract 
We investigated the distribution of commensal staphylococcal species and determined the 
prevalence of multi-drug resistance in healthy cats and dogs. Risk factors associated to the carriage 
of multi-drug resistant strains were explored. Isolates from 256 dogs and 277 cats were identified at 
the species level using MALDI-TOF mass spectrometry. Diversity of coagulase-negative 
staphylococci (CNS) was high, with 22 species in dogs and 24 in cats. Multi-drug resistance was 
frequent (17%) and not always associated with the presence of the mecA gene. A stay in a 
veterinary clinic in the last year was associated with an increased risk of colonisation by multi-drug 
resistant staphylococci (OR = 2.4, 95 % CI: 1.1-5.2, p-value LRT = 0.04). In finding new efficient 
control strategies against antibiotic resistance, the presence of mechanisms other than methicillin 
resistance, and the possible role of CNS in the spread of resistance determinants should be 
considered. 
 
Chapter 5 – Research paper 2 - 53 - 
Epidemiology of multi-drug resistant staphylococci in cats, dogs and people in Switzerland 
Background 
Staphylococci resistant against methicillin and other antibiotics have been frequently reported in 
pets worldwide (1, 2). These microorganisms are opportunistic pathogens that may colonise the skin 
and mucosae of humans and other animals. Bacteria belonging to the genus Staphylococcus are 
currently divided into coagulase-positive (S. aureus, S. pseudintermedius, S. hyicus, S. intermedius, 
S. delphini, S. schleiferi subsp. coagulans, S. lutrae) and coagulase-negative species (e.g. 
S. epidermidis, S. hominis, S. warneri, S. felis). For long time the pathogenicity of coagulase-
negative staphylococci (CNS) has been underestimated, because these species were associated with 
more chronic or subacute infections when compared with coagulase-positive staphylococci (CPS) 
(3). Presently, however, the etiological role of CNS in prosthesis and foreign body infections is 
being recognised in human medicine (4-6). In pets, the pathogenic potential of these 
microorganisms has not yet been clearly defined, although we can find some reports of infections 
related to methicillin-resistant CNS in cats and dogs (7, 8). 
Few studies have addressed the composition of staphylococcal populations of the mucosae of 
healthy cats and dogs (9, 10). Previous investigations on the staphylococcal species diversity in 
these animals have focused on clinical isolates (11), mainly CPS (12), or described the distribution 
of well defined antibiotic resistances within a limited number of staphylococcal species (13, 14). 
Moreover these studies were carried out before 2005 when S. pseudintermedius had not yet been 
described: In fact, this species had probably been reported in all previous studies as S. intermedius, 
leading thus to confusion as to its real occurrence in pets (15-19). Recently S. pseudintermedius has 
been suggested to be the most relevant and prevalent CPS colonising dogs, with an increasing 
amount of reports on its pathogenic and methicillin resistance characteristics in this host (20). 
To date, the carriage of CNS strains in pets has been neglected. Recently the development of new 
molecular techniques has allowed accurate identification of CNS (21, 22). This will eventually lead 
to a better understanding and knowledge on these bacteria species. More knowledge on CNS 
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carriage in animals will be of benefit, because these bacteria might represent a genetic pool of 
antibiotic resistance for CPS species; in fact, horizontal gene transfer of staphylococcal 
chromosome cassette mec (SCCmec) has been documented between CPS and CNS species (23). 
In the last decade several authors have suggested that pets may be reservoirs of antibiotic resistant 
bacteria (24-26). This assumption was mainly based on studies reporting antibiotic resistance in 
clinical CPS isolates from dogs and humans being in close contact (27, 28). A clear picture of the 
distribution, diversity and multi-drug resistance (MDR) of both CPS and CNS species in pets, 
however, is lacking and thus the role of cats and dogs as reservoirs of antibiotic resistance hardly 
known. 
The purpose of the present study was to gain insight into the distribution of commensal 
staphylococcal species of healthy cats and dogs of Switzerland and to determine the occurrence of 
MDR in both CNS and CPS. In addition, we explored risk factors associated with the carriage of 
these microorganisms in pets. 
 
Methods 
Study design and settings 
Samples were collected between March 2008 and December 2009 in four different Swiss cantons 
(Berne, Ticino, Vaud and Zurich). Only healthy pets with no overt acute disease at the time of 
sample collection were enrolled in the study. The pets either lived in or visited nursing homes for 
pet-therapy or lived in households. The selection strategy differed between community and nursing 
homes. Pets in the community were included in the study based on a convenience sampling in 
households (n = 196) in four Swiss cantons representing the northern, southern, central and western 
part of Switzerland. Additional pets (n=239) were recruited from cats and dogs visiting a total of 12 
veterinary practices in the same regions for routine vaccinations. Nursing homes were selected by a 
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two-stage random cluster sampling from an exhaustive list of nursing homes located in the four 
Swiss cantons. In randomly selected nursing homes, all pets matching the inclusion criteria and 
present at the time of sample collection (n=98) were enrolled in the study. An informed written 
consent was given by all pet owners. The study received the approval for animal experimentation by 




Nasal and ear swab samples were collected by means of cotton swabs (Amies agar gel 108C and 
110C, Copan, Italy) previously soaked in a physiological 0.9 % NaCl solution. A swab was 
introduced for 1-2 cm in the nostril and a second one as deeply as possible in the ear channel of 
each animal. The collected samples were conserved in the transport medium at room temperature 
and analyzed for the presence of staphylococci within 24-48 h of collection. A questionnaire 
collecting information on the demographic and health status of the pets had to be filled in by the 
owners (available from the corresponding author on request). 
 
Sample analyses 
Both swabs were streaked on Mannitol Salt Agar (Chapman 2 – MSA 2, bioMérieux® SA, France), 
then incubated for 48 h at 37 °C, enriched in MRSA broth supplemented with 6 mg/L of oxacilllin 
(48 h at 37 °C) and cultured on Gelose ChromID S. aureus (SAID, bioMérieux® SA, France) for 
48 h at 37 °C. All morphologically different colonies were isolated and catalase positive, Gram 
positive coccal bacteria were frozen in skimmed milk at -80 °C until further analyses. 
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Isolates were grown on blood agar during 24 h and identified by matrix-assisted laser desorption 
ionisation - time of flight mass spectrometry (MALDI-TOF MS) using an Axima Confidence™ 
spectrometer (Shimadzu-Biotech Corp., Kyoto, Japan) in positive linear mode (m/z = 2,000 to 
20,000) (29). Identity of isolates that could not be identified by MALDI-TOF MS (24%) was 
confirmed by sequencing of the amplified partial rpoB gene (21). 
Phenotypic antibiotic resistance to 24 different drugs was assessed by the Kirby-Bauer method on 
Mueller-Hinton blood agar (MHS2, bioMérieux® SA, France). The following antibiotics were 
tested: penicillin (10 units), ampicillin (10 μg), oxacillin (1 μg), cefazolin (30 μg), gentamicin 
(10 μg), tetracycline (30 μg), erythromycin (15 μg), clindamycin (2 μg), vancomycin (30 μg), 
trimethoprim-sulfamethoxazole (1.25+23.75 μg), ciprofloxacin (5 μg), amoxicillin and clavulanic 
acid (20+10 μg), ceftazidim (30 μg), imipenem (10 μg), tobramycin (10 μg), fusidic acid (10 μg), 
rifampicin (30 μg), chloramphenicol (30 μg), cefoxitin (30 μg), kanamycin (30 μg), doxycyclin 
(30 μg), mupirocin (5 μg), linezolid (30 μg) and quinopristin-dalfopristin (15 μg). Inducible 
clindamycin resistance test (“D-zone” test) was also carried out for all isolates. Results were 
interpreted according to the Clinical and Laboratory Standards Institute (CLSI) guidelines (30, 31); 
for the purpose of this study, intermediate results were classified as resistant. Multi-drug resistance 
(MDR) was defined as resistance to at least 3 drugs belonging to 3 different antibiotic classes. 
Additionally, the presence of the mecA gene, which confers methicillin resistance, was investigated 
by polymerase chain reaction (PCR) on all isolates that showed phenotypic resistance to oxacillin 
(32, 33). 
We considered isolates from the same animal as being different strains if they belonged to different 
staphylococcal species or their phenotypic antibiotic resistance profile differed. 
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Statistical analyses 
Sample size calculation was based on the assumption that 5 % of pets carried at least one MDR 
staphylococcal strain and that the intra-class correlation coefficient (rho) was 0.15. We used the 
cluster sample equation of Bennett et al. (34) for all calculations. Estimating that each nursing home 
with pets owned or was visited by three animals on average; the sample collection in 42 different 
nursing homes would have provided 126 pets. The expected precision for the prevalence estimate of 
MDR in pets would subsequently have a standard error of 2.2 %, and a 95 % confidence interval 
(CI) = 0.68-9.3 %. 
Characteristics of the cats and dogs were compared to check for consistent differences in the 
demographics and health status of the different population sampled. Chi-square test (Fisher’s exact 
test when expected observations < 5) and 95 % CI were used for this comparison. We reported the 
prevalence of staphylococci and MDR staphylococci and the distribution of antibiotic resistance 
among the different staphylococcal species together with the median number of resistances to 
different antibiotic classes. Univariable logistic regression models, with MDR staphylococcal 
carriage status of pet as the outcome variable of interest, were applied to explore risk factors. 
Unadjusted odds ratios (OR with 95% CI) were calculated as a measure of association. Statistical 
significance of each explanatory variable was determined by a likelihood-ratio test (LRT). We 
included in a multivariable model all variables with LRT p-values ≤0.2 from the univariable 
analysis. All statistical analyses were performed with STATA 9.0 (Stata Corporation, College 
Station, TX, USA). 
 
Results 
Demographics and staphylococcal carriage in pets 
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We collected samples from 533 healthy pets (277 cats and 256 dogs). Ninety-eight lived in or 
visited nursing homes at least once a week and 435 lived in the community. The demographics of 
the two population studied are reported in Table 1. Parameters such as sex, age, sterilisation, otitis 
in the last year, and antibiotic treatment showed different distributions between the nursing home 
and community settings, but the 95% CI estimates of these parameters overlapped (Table 1). We 
did not carry out stratified analyses of the samples because the overall frequencies of MDR in 
nursing homes (15/98) and in the community (76/435) did not differ significantly (χ2 = 0.27, 
p = 0.6).  
Staphylococci were detected in 60% (320/533) of pets; 17 % (92/533) of all animals carried at least 
one MDR strain. There were no significant differences in MDR carriage between pet species 
[14.8 % (95 % CI: 11.0-19.5) in cats and 20.0 % (95 % CI:  15.5-25.4) in dogs; χ2 = 2.1, p = 0.14] 
(Table 2). In cats, most CNS were MDR (39/41), whereas the proportion of MDR in CPS was small 
(1/41). In dogs, on the other hand, MDR CPS (20/51) and MDR CNS (28/51) carriage was almost 
equal (Table 2). We observed species-specific differences (χ2 = 63.69, p <0.001) in the proportion 
of S. pseudintermedius carriage, with 27 % (70/256) of dogs and 3 % of cats (8/277) harbouring this 
species. No difference in S. aureus carriage was seen between the two pet species (13/256 dogs and 
14/277 cats, respectively). 
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Table 1. Demographics of investigated cats and dogs with proportions (%) and 95 % confidence intervals 
(95 % CI). 
Characteristics Nursing home(n = 98) Community (n = 435) p-value 1) 
 n % 95% CI n % 95% CI  
Cats 53/98 54 44-63 224/435 51 47-56 0.64 
Female 63/98 64 54-73 226/434 52 47-57 0.03 
Sterilized 80/98 82 73-88 306/433 71 66-75 0.03 
Age       0.006 
 < 3 years 19/98 19 12-27 156/435 36 31-40  
 3-10 years 56/98 57 47-67 189/435 43 39-48  
 > 10 years 23/98 23 15-32 90/435 21 17-24  
Cantons       0.14 
 Berne 32/98 33 23-42 95/435 22 18-26  
 Ticino 26/98 27 18-35 140/435 32 28-37  
 Vaud 20/98 20 12-28 107/435 25 21-29  
 Zurich 20/98 20 12-28 93/435 21 18-25  
Visit to veterinary clinics in the 
last year 
3/97 3 1-9 28/431 7 5-9 0.19 
Stay in animal home in the last 
year 
8/98 8 4-15 22/434 5 3-8 0.23 
Pyoderma in the last year 3/96 3 1-9 22/423 5 3-8 0.60 2) 
Urinary affections in the last year 4/93 4 2-11 17/421 4 3-6 1.00 2) 
Otitis in the last year 3/93 3 1-10 39/425 9 7-12 0.06 
Antibiotic treatment in the last 3 
months 
5/94 5 2-12 59//429 14 11-17 0.02 
Immunosuppressant in the last 3 
months 
3/92 3 1-10 20/423 5 3-7 0.78 2) 
1) χ2 test 
2) Fischer’s exact test applied because expected frequency in at least one cell <5 
 
Table 2. Proportion (%) of staphylococcal and MDR staphylococcal carriage in pets (cats and dogs). 
95 % CI = 95 % confidence interval, CPS = coagulase-positive staphylococci, CNS = coagulase-negative 
staphylococci. 
 Staphylococcal carriage Multi-drug resistance carriage 
    Staphylococci CPS CNS CPS & CNS 
 n % 95%CI n % 95%CI n n n 
Total 320/533 60.0 55.8-64.1 92/533 17.3 14.3-20.7 21/92 67/92 4/92 
Cats 164/277 59.2 53.3-64.8 41/277 14.8 11.0-19.5 1/41 39/41 1/41 
Dogs 156/256 60.9 54.8-66.7 51/256 20.0 15.5-25.4 20/51 28/51 3/51 
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Staphylococcal isolates 
We isolated 284 staphylococcal strains (176 from the nostrils and 108 from the ears)  from dogs 
(Table 3) and 300 (153 from the nostrils and 147 from the ears) from cats (Table 4). We could 
identify 94.5 % (552/584) of all isolates at the species level. Two S. schleiferi isolates from two cats 
were identified only at the species level. CNS species accounted for 60 % (172/284) of all isolates 
in dogs and 86 % (258/300) in cats (Table 3 and Table 4). 
In cats, the total number of CPS strains was lower (22/300) as compared to dogs (98/284). Among 
the CPS strains S. pseudintermedius was more frequently isolated from dogs [(85/98), 87 %] than 
from cats [(8/22), 36 % ], whereas S. aureus was more frequent in cats [(14/22), 63 %] than dogs 
[(13/98), 13 %]. No other CPS were isolated.  
The diversity of CNS was high, with 22 different species in dogs and 24 in cats (Table 3 and Table 
4). S. felis was isolated only from cats, in particular from their nostrils, and it represented 31 % of 
all CNS isolates (41/132). Other CNS recovered in relevant proportions from both pets were 
S. epidermidis, S. warneri, S. hominis, S. xylosus and S. equorum (Table 3 and Table 4). 
 
Antibiotic resistance 
Presence of the mecA gene was observed in 6 % (11/172) of dog and 3 % (7/258) of cat isolates. We 
did not recover any MDR S. aureus (Table 3 and Table 4). MDR, with a few strains showing 
resistance up to eight different antibiotic classes, was detected in bacteria at proportions of 21 % 
(36/172) in dogs and 16 % (42/258) in cats. MDR was observed in S. pseudintermedius isolated 
from both pet species with resistances to up to six different antibiotic classes, but no methicillin 
resistance was seen (Table 3 and 4). 
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About 50% of all isolates in dogs and 30% in cats showed phenotypic resistance to penicillin and 
ampicillin (Table 5). Fusidic acid and erythromycin resistance were detected in 31% and 25% of 
dog and 28% and 19% of cat isolates, respectively. 15% of all strains isolated from dogs were 
resistant to tetracycline and 11% to kanamycin. Clindamycin resistance was reported from 16% of 
dog and 15% of cat isolates (Table 5).  
 
Exploratory analysis of risk factors 
Univariable analysis revealed that the stay in a veterinary clinic in the last year was associated with 
an increased risk of colonisation by MDR staphylococci in pets (unadjusted OR = 2.4, 
95 % CI: 1.1-5.2, p-value LRT = 0.04) (Table 6). We included following variables in the 
multivariable analysis according to criteria mentioned in the method section: species, canton, stay in 
veterinary clinic in last year and antibiotic treatment in last 3 months. A total of 465 records had no 
missing data for these variables. When accounting for other variables, we could see an influence of 
the investigated cantons on the carriage of MDR staphylococci (p-value LRT = 0.02). Cats had a 
lower risk of being carriers of MDR staphylococci, whereas staying in veterinary clinic in the last 
year and antibiotic treatment in the last 3 months showed higher risk, although none of them were 
statistically significant (Table 6). 
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Table 3. Staphylococcal strains isolated from the nostril and the ear of 256 dogs and distribution of antibiotic 
resistance among the different species. Q1 = 1st quartile, Q3 = 3rd quartile, Max. = maximum, mecA = gene 
encoding methicillin resistance, MDR = multi-drug resistance. 
Isolates No. different resistant antibiotic classes mecA MDR isolates Identified isolates 
Nose Ear Nose Ear Nose Ear Nose Ear 




Max n n n n 
Coagulase positive 69 29 1 (1; 2) 6 2 (1; 5) 6 0/69 0/29 15/69 9/29 
S. aureus 10 3 1 (0; 2) 2 1 (1; 2) 2 0/10 0/3 0/10 0/3 
S. pseudintermedius 59 26 1 (0; 3) 6 2 (1; 5) 6 0/59 0/26 15/59 9/26 
Coagulase negative 97 75 1 (0; 2) 8 1 (0; 2) 8 8/97 3/75 22/97 14/75 
S. arlettae 1 - 3 (3; 3) 3 - - 0/1 - 1/1 - 
S. auricularis 1 1 0 (0; 0) 0 0 (0; 0) 0 0/1 0/1 0/1 0/1 
S. capitis 3 1 0 (0; 0) 0 0 (0; 0) 0 0/3 0/1 0/3 0/1 
S. caprae/capitis 5 3 2 (1; 2) 2 1 (0; 1) 1 0/5 0/3 0/5 0/3 
S. cohnii 4 1 2.5 (1; 4) 5 1 (1; 1) 1 0/4 0/1 2/4 0/1 
S. devriesei - 3 - - 0 (0; 0) 0 - 0/3 - 0/3 
S. epidermidis 15 12 1 (0; 2) 7 0.5 (0; 2) 3 2/15 1/12 2/15 1/12 
S. equorum 9 3 1 (0; 1) 4 0 (0; 0) 0 1/9 0/3 2/9 0/3 
S. haemolyticus 8 5 1 (0.5; 2.5) 8 2 (0; 3) 8 2/8 0/5 2/8 2/5 
S. hominis 9 11 2 (0; 2) 3 2 (1; 2) 3 2/9 1/11 2/9 1/11 
S. kloosi - 1 - - 1 (1; 1) 1 - 0/1 - 0/1 
S. lentus - 1 - - 3 (3; 3) 3 - 0/1 - 1/1 
S. lugdunensis - 1 - - 0 (0; 0) 0 - 0/1 - 0/1 
S. pasteuri 2 1 0.5 (0; 1) 1 1 (1; 1) 1 0/2 0/1 0/2 0/1 
S. pettenkoferi 2 - 0 (0; 0) 0 - - 0/2 - 0/2 - 
S. saprophyticus 4 5 1 (1; 1.5) 2 2 (2; 3) 3 0/4 0/5 0/4 1/5 
S. sciuri 6 1 3 (3; 3) 4 4 (4; 4) 4 1/6 0/1 6/6 1/1 
S. simulans 1 - 1 (1; 1) 1 - - 0/1 - 0/1 - 
S. succinus 3 1 0 (0; 2) 2 0 (0; 0) 0 0/3 0/1 0/3 0/1 
S. vitulinus 6 2 1 (1; 1) 1 1 (1; 1) 1 0/6 0/2 0/6 0/2 
S. warneri 9 13 1 (0; 2) 3 1 (1; 3) 5 0/9 1/13 2/9 5/13 
S. xylosus 9 9 2 (2; 3) 4 2 (2; 2) 4 0/9 0/9 3/9 2/9 
Other staphylococci 10 4         
Staphylococcus spp. 10 4 0 (0; 2) 3 0.5 (0; 1) 1 0/10 0/4 2/10 0/4 
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Table 4. Staphylococcal strains isolated from the nostril and the ear of 277 cats and the distribution of 
antibiotic resistance among the different species. Q1 = 1st quartile, Q3 = 3rd quartile, Max. = maximum, 
mecA = gene encoding methicillin resistance, MDR = multi-drug resistance. 
Isolates No. different resistant antibiotic classes mecA MDR isolates Identified isolates 
Nose Ear Nose Ear Nose Ear Nose Ear 




Max n n n n 
Coagulase positive 17 5 0 (0; 1) 1 1 (1; 3) 5 0/17 0/5 0/17 2/5 
S. aureus 11 3 1 (0; 1) 1 1 (0; 1) 1 0/11 0/3 0/17 0/3 
S. pseudintermedius 6 2 0 (0; 0) 0 4 (3; 5) 5 0/6 0/2 0/7 2/2 
Coagulase negative 132 126 1 (0; 2) 7 1 (0; 2) 7 3/132 4/126 23/132 19/126 
S. arlettae 1 - 6 (6; 6) 6 - - 0/1 - 1/1 - 
S. auricularis 4 10 0 (0; 0) 0 0 (0; 1) 4 0/4 0/10 0/4 1/10 
S. capitis 1 6 3 (3; 3) 3 1 (0; 2) 3 0/1 0/6 1/1 1/6 
S. caprae - 1 - - 1 (1; 1) 1 - 0/1 - 0/1 
S. caprae/capitis 4 5 1.5 (1; 2) 2 1 (1; 1) 1 0/4 0/5 0/4 0/5 
S. cohnii 2 3 0.5 (0; 1) 1 1 (1; 4) 4 0/2 0/3 0/2 1/3 
S. epidermidis 16 20 1 (0.5; 3) 4 1 (1; 2) 7 1/16 4/20 5/16 4/20 
S. equorum 11 10 0 (0; 1) 7 0 (0; 1) 2 0/11 0/10 1/11 0/10 
S. felis 41 28 0 (0; 0) 3 0 (0; 0) 3 0/41 0/28 4/41 2/28 
S. haemolyticus 5 1 1 (1; 3) 3 1 (1; 1) 1 0/5 0/1 2/5 0/1 
S. hominis 5 4 1 (0; 2) 5 0 (0; 0.5) 1 1/5 0/4 1/5 0/4 
S. lentus 3 1 2 (2; 4) 4 3 (3; 3) 3 0/3 0/1 1/3 1/1 
S. lugdunensis - 2 - - 2.5 (2; 3) 3 - 0/2 - 1/2 
S. nepalensis 2 - 2.5 (1; 4) 4 - - 0/2 - 1/2 - 
S. pasteuri - 1 - - 2 (2; 2) 2 - 0/1 - 0/1 
S. pettenkoferi 4 4 0 (0; 0) 0 0 (0; 0) 0 0/4 0/4 0/4 0/4 
S. saprophyticus 2 4 1.5 (1; 2) 2 1.5 (1; 2.5) 3 0/2 0/4 0/2 1/4 
S. sciuri 5 3 2 (1; 3) 3 2 (1; 3) 3 1/5 0/3 2/5 1/3 
S. simulans 3 8 1 (1; 1) 2 1 (1; 1) 3 0/3 0/8 0/3 1/8 
S. succinus - 1 - - 0 (0; 0) 0 - 0/1 - 0/1 
S. vitulinus 1 - 1 (1; 1) 1 - - 0/1 - 0/1 - 
S. warneri 12 6 1 (0.5; 1.5) 4 1.5 (1; 3) 4 0/12 0/6 1/12 2/6 
S. xylosus 10 8 2 (2; 3) 4 1.5 (1; 3) 3 0/10 0/8 3/10 3/8 
Coagulase n.d. 4 16         
S. schleiferi sp. 1 1 0 (0; 0) 0 0 (0; 0) 0 0/1 0/1 0/1 0/1 
Staphylococcus spp. 3 15 0 (0; 2) 2 0 (0; 1) 4 0/3 0/15 0/3 1/15 
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Table 5. In vitro antibiotic resistance. Proportion (%) on all staphylococcal isolates of the in vitro antibiotic 
resistance against tested drugs. 
 Resistance in dogs isolates 
(n = 284) 
Resistance in cat isolates 
(n = 300) 
 n % n % 
Beta-lactams 
Penicillin 140 49 90 30 
Ampicillin 131 46 77 26 
Cefazolin 1 0.3 0 0 
Cefoxitin 9 3 7 2 
Ceftazidim 13 5 8 3 
Co-amoxicillin 1 0.3 1 0.3 
Imipenem 0 0 0 0 
Oxacillin 13 5 7 2 
Aminoglycosides 
Gentamicin 5 2 1 0.3 
Kanamycin 31 11 4 1 
Tobramycin 1 0.3 0 0 
Tetracyclines 
Doxycyclin 35 12 12 4 
Tetracycline 44 15 17 6 
Macrolides 
Erythromycin 72 25 58 19 
Lincosamides 
Clindamycin 45 16 39 15 
Glycopeptides 
Vancomycin 0 0 0 0 
Fluoroquinolones 
Ciprofloxacin 4 1 5 2 
Folate pathway inhibitors 
Trimethoprim-sulfamethoxazole 10 3 4 1 
Ansamycin 
Rifampicin 0 0 0 0 
Phenicols 
Chloramphenicol 22 8 4 1 
Oxazolidinones 
Linezolid 0 0 0 0 
Streptogramins 
Quinopristin-dalfopristin 8 3 10 3 
Other classes 
Fusidic acid 87 31 85 28 
Mupirocin 0 0 1 0.3 
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Table 6. Risk factors. Univariable logistic regressions with odds ratio (OR) and 95 % confidence interval 
(95 % CI) as measure of possible association with the carriage of multi-drug resistant (MDR) staphylococci 
and multivariable logistic regression with adjusted odds ratio (AOR); p-value of the likelihood-ratio test 
(LRT) was considered statistically significant if ≤0.05. 
   Univariable analysis Multivariable model 
Variable level  MDR OR  LRT AOR  LRT 
 N n (%)              95 % CI p-value              95 % CI p-value 
Origin         
 Nursing homes 98 15 (15) baseline     
 Community setting 434 76 (18) 1.1 0.6-2.0 0.6 not included 
Species         
 Dog 255 50 (20) baseline  baseline 
 Cat 277 41 (15) 0.7 0.4-1.1 0.1 0.7 0.4-1.1 0.1 
Sex         
 Male 243 42 (17) baseline     
 Female 288 49 (17) 1.0 0.6-1.5 0.9 not included 
Age          
 0-3 years 175 36 (21) baseline     
 3-10 years 245 40 (16) 0.8 0.5-1.2     
 10-20 years 112 15 (13) 0.6 0.3-1.2 0.3 not included 
Sterilised         
 No 145 27 (19) baseline     
 Yes 385 64 (17) 0.9 0.5-1.4 0.6 not included 
Canton         
 Bern 126 20 (16) baseline  baseline 
 Ticino 166 20 (12) 0.7 0.4-1.4  0.6 0.3-1.2  
 Vaud 127 27 (21) 1.4 0.8-2.7  1.5 0.8-3.0  
 Zurich 113 24 (21) 1.4 0.7-2.8 0.1 1.5 0.8-3.0 0.02 
Stay in veterinary clinic in last year        
 No 496 81 (16) baseline  baseline 
 Yes 31 10 (32) 2.4 1.1-5.4 0.04 1.3 0.4-3.8 0.6 
Stay in animal home in last year        
 No 501 84 (17) baseline     
 Yes 30 7 (23) 1.5 0.6-3.6 0.4 not included 
Pyoderma in last year         
 No 493 85 (17) baseline     
 Yes 25 5 (20) 1.2 0.4-3.3 0.7 not included 
Urinary infection in last year         
 No 492 88 (18) baseline     
 Yes 21 2 (10) 0.5 0.1-2.1 0.3 not included 
Otitis in last year         
 No 475 84 (18) baseline     
 Yes 42 7 (17) 0.9 0.4-2.2 0.9 not included 
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   Univariable analysis Multivariable model 
Variable level  MDR OR  LRT AOR  LRT 
 N n (%)              95 % CI p-value              95 % CI p-value 
Antibiotic treatment in last 3 months        
 No 458 73 (16) baseline  baseline 
 Yes 64 15 (23) 1.6 0.9-3.0 0.1 1.3 0.6-2.8 0.4 
Immunosuppressant in last 3 months        
 No 491 79 (16) baseline     




This study provides, for the first time since the description of S. pseudintermedius, detailed 
information on staphylococcal carriage in healthy cats and dogs and on drug resistance of these 
bacteria to different antibiotic classes. We showed that S. pseudintermedius was recovered from the 
mucosae of healthy dogs more frequently than from those of healthy cats. Previous hospitalisation 
(at least one night in a veterinary clinic) was a risk factor for the carriage of MDR staphylococci in 
pets using the univariable approach. The multivariable model showed that the Swiss Cantons in 
which the animals lived had an influence on the carriage of MDR staphylococci. This finding most 
likely reflects different prescription practices of veterinarians in different regions of Switzerland. 
Identification of the staphylococci was carried out by MALDI-TOF MS, which provides a reliable 
and rapid identification of the taxa in the S. intermedius group (S. delphini, S. intermedius and 
S. pseudintermedius) (29). Previous studies on the staphylococcal population of the mucosae of cats 
and dogs were based on phenotypic characterisation of the isolates, which may have led to 
misidentification of some closely related staphylococcal species (17, 35).  
We have isolated MDR staphylococcal strains from healthy cats and dogs: MDR, however, was not 
always associated with the presence of the mecA gene. In this study, resistance of strains to different 
antibiotic classes ranged from very low proportions, as for resistance to ciprofloxacin (1-2%) in cats 
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and dogs, to high values as for kanamycin resistance in dogs (11%). Methicillin resistance is of 
particular interest, because it confers resistance to all beta-lactams and is also often linked to 
resistance to other antibiotic classes, but in clinical settings other resistances are also relevant; in 
fact, infections resulting from MDR opportunistic pathogens are a critical problem to clinicians 
because they limit the choice of active antibiotic treatments (36). 
Our study has some limitations. The exploratory analysis of risk factors was carried out by 
combining all staphylococcal species and information on pet-therapy animals as well as household 
pets, although the risk associated to the carriage of MDR staphylococci belonging to several species 
might differ between the two groups. This approach was necessary  because the numbers for given 
combinations of investigated risk factors and animals carrying different MDR staphylococcal 
species were small. Pet management factors in the three months preceding the study were reported 
by the owners: therefore, a recall bias might be present, but we do not think it important because 
one can reasonably expect pet owners to recall whether or not a pet had visited a veterinary clinic 
during the preceding three months. We did not collect data on the number of different antibiotic 
treatment and the length of treatment: analysis of these data could have revealed other risk factors. 
Despite the limitations of an exploratory univariable approach, our results confirm findings from 
published studies on factors associated with the carriage of MDR staphylococci in pets, and in 
particular the importance of previous hospitalisation, which was already reported as a risk factor for 
acquisition of both MRSA and MRSP in pets (37, 38).  
 
Conclusions 
Our study has shown that carriage of multi-drug resistant staphylococci in healthy cats and dogs is 
common. Thus, clinical therapy guidelines would benefit from an approach that is not only focused 
on methicillin resistance, neglecting the presence of other resistances. The monitoring of antibiotics 
use in veterinary clinics could provide an overview on the possible future trends of antibiotic 
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resistance in pets. In veterinary medicine, further studies investigating the dissemination of 
antibiotic resistance determinants would benefit from considering the possible role of reservoir of 
CNS for their spread. 
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Abstract 
Background: Pets, often used as companionship and for psychological support in the therapy of 
nursing home residents, have been implicated as reservoirs for antibiotic-resistant bacteria. We 
investigated the importance of pets as reservoirs of multidrug-resistant (MDR) staphylococci in 
nursing homes. 
Methods: We assessed the carriage of MDR staphylococci in pets and in 2 groups of residents, 
those living in nursing homes with pets and those living without pet contacts. We collected 
demographic, health status, and human–pet contact data by means of questionnaires. We assessed 
potential bacteria transmission pathways by investigating physical resident-to-pet contact. 
Results: The observed prevalence of MDR staphylococci carriage was 84/229 (37%) in residents 
living with pets and 99/216 (46%) in those not living with pets (adjusted odds ratio [AOR], 0.6; 
95% confidence interval [CI], 0.4-0.9). Active pet contact was associated with lower carriage of 
MDR staphylococci (AOR, 0.5; 95% CI, 0.4-0.8). Antibiotic treatment during the previous 3 
months was associated with significantly increased risk for MDR carriage in residents (AOR, 3.1; 
95% CI, 1.8-5.7). 
Conclusions: We found no evidence that the previously reported benefits of pet contact are 
compromised by the increased risk of carriage of MDR staphylococci in residents associated with 
interaction with these animals in nursing homes. Thus, contact with pets, always under good 
hygiene standards, should be encouraged in these settings. 
Key Words: Companion animals; antibiotics; social network analyses; exchange of strains; ‘‘One 
Health’’. 
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Background 
Multidrug resistance (MDR) in microorganisms poses a serious public health challenge. In nursing 
homes, MDR in opportunistic pathogens is of concern because people often suffer from infections 
or are immunocompromised and thus at increased risk for disease after infection by MDR 
microorganisms (1, 2). Methicillin resistant Staphylococcus aureus (MRSA) is a major problem in 
human medicine (3, 4), and coagulase-negative staphylococci (CNS) also have emerged as a major 
cause of nosocomial infections (5). Patients with foreign bodies such as catheters or prostheses are 
usually at risk for CNS infections (6). Unlike MRSA, the clinical manifestations of MDR CNS, are 
subtle, with a subacute or even chronic clinical course and no immediate signs of infection (7, 8). 
Nonetheless, the role of these pathogens and their increasing importance and incidence have been 
recognized (6). 
Pets have been described as potential reservoirs for drug-resistant bacteria (9-11). Companion 
animals represent potential sources of spread of antimicrobial resistance due to the extensive use of 
antimicrobial agents in veterinary practices that treat small animals (12, 13). Staphylococci, which 
are part of the normal skin and mucosal bacterial community of cats and dogs, have developed 
resistance to antibiotics (14). The transmission of MDR staphylococci between pets and humans has 
been documented in different settings (15-17), and MRSA has been reported in a pet therapy dog 
that visits aged-care wards in the United Kingdom (18). 
Pets are increasingly used as companions and for psychological support in the therapy of 
chronically diseased or elderly patients, but their zoonotic potential is a matter of debate (19, 20). 
Studies of elderly persons residing in institutional settings have reported a general health benefit 
from pet-assisted therapy, along with reduced feelings of loneliness and isolation (21, 22). People 
who interact with animals may have improved physical health and psychological and social well 
being; moreover, actively caring for a pet also might serve as an incentive to maintain at least a 
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moderate level of physical activity in elderly people, thereby reducing the risk of being overweight 
(23). 
The present study aimed to quantify the importance of pets as reservoirs of MDR staphylococci in 
nursing homes by assessing the carriage of these microorganisms in residents and in pets living in 




Study design and setting 
This was a retrospective study of the carriage of MDR staphylococci in pets and in 2 groups of 
residents: those living in nursing homes in which pets were present and those in nursing homes 
without pets. Sample collection was performed between March 2008 and September 2009. The 
nursing homes were located in 4 different Swiss cantons (Berne, Ticino, Vaud, and Zurich). Nasal 
and ear swabs from pets and nasal swabs from residents in the same home were collected. A 
questionnaire eliciting information on demographic data, health status, and human–pet contact was 
completed by each participant and for each animal investigated. A nursing home was classified as 
hosting pets if at least 1 cat or dog was owned by the nursing home or by a resident, or a pet 
therapist was active in the home at least once a week. The study received ethical clearance by the 4 
responsible cantonal Ethical Committees and authorization for animal experimentation from the 
cantonal and federal veterinary offices. 
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Selection of participants 
This study included adult residents who either provided informed consent or had informed consent 
provided by relatives. For pets, consent had to be given by the owner. Residents and pets with any 
acute disease or currently already participating in another clinical trial were excluded. We randomly 
selected 315 nursing homes from an exhaustive list of 827 eligible homes provided by canton health 
authorities. Among these, 195 nursing homes reported keeping pets and 120 nursing homes reported 
having no pets. We then selected 68 nursing homes from each group and invited them to participate. 
A total of 59 homes declined to participate; thus, we enrolled 39 nursing homes with pets and 38 
without pets in the study. Within each nursing home, we randomly selected 6 residents from an 
alphabetical list of residents provided by management. Residents who declined to participate were 
replaced by another randomly selected resident living in the same home. 
 
Sample collection and laboratory analyses 
Samples were collected with swabs (Amies Agar Gel 108C and 110C; Copan, Murrieta, CA), 
conserved in the transport medium at room temperature, and analyzed for the presence of 
staphylococci within 24-48 hours of collection. Swabs were first streaked on Mannitol Salt Agar 
(Chapman 2–MSA 2; bioMérieux® SA, Craponne, France) and incubated for 48 hours at 37°C, and 
then enriched in MRSA broth, supplied with 6 mg/L of oxacilllin (48 hours at 37°C), followed by 
culture on Gelose ChromID S aureus (SAID bioMérieux® SA) for 48 hours at 37°C. Colonies were 
isolated, and catalase-positive, gram-positive coccal bacteria isolates were frozen in skimmed milk 
at -80°C until further analyses. 
Identification of pure colonies grown on blood agar at 37 °C for 24 h was carried out with a matrix 
assisted laser desorption ionization - time of flight mass spectrometry (MALDI-TOF MS) using an 
Axima Confidence™ spectrometer (Shimadzu-Biotech Corp., Kyoto, Japan) in positive linear mode 
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(m/z = 2,000 to 20,000) as described by Decristophoris et al. (24). Cultures not identifiable by 
MALDI-TOF MS were identified by sequencing of the amplified rpoB gene fragments (25). 
Phenotypic antibiotic resistance was assessed using the Kirby-Bauer method on Mueller-Hinton 
blood agar (MHS2, bioMérieux® SA, France). Antibiotics tested included penicillin (10 units), 
ampicillin (10 µg), oxacillin (1 µg), cefazolin (30 µg), gentamicin (10 µg), tetracycline (30 µg), 
erythromycin (15 µg), clindamycin (2 µg), vancomycin (30 µg), trimethoprim-sulfamethoxazole 
(1.25+23.75 µg), ciprofloxacin (5 µg), amoxicillin and clavulanic acid (20+10 µg), ceftazidim 
(30 µg), imipenem (10 µg), tobramycin (10 µg), fusidic acid (10 µg), rifampicin (30 µg), 
chloramphenicol (30 µg), cefoxitin (30 µg), kanamycin (30 µg), doxycyclin (30 µg), mupirocin 
(5 µg), linezolid (30 µg) and quinopristin-dalfopristin (15 µg). Strains were classified as susceptible, 
intermediately resistant, or resistant to the drug according to Clinical and Laboratory Standards 
Institute (CLSI) guidelines (26, 27). A strain was defined as MDR if it was resistant to at least 3 
antibiotics of different classes. Polymerase chain reaction analysis was used to investigate for the 
presence of the mecA gene, which confers methicillin resistance (28). 
 
Analysis of physical contact and typing of strains 
We investigated the arrangement and the intensity of physical contact between pets and residents 
(time spent with pets), and thus the potential zoonotic bacteria transmission pathways, by means of 
questionnaires. Resident–pet contacts were described graphically using Pajek version 1.28. (29). To 
reveal potential transmission scenarios of MDR staphylococci in residents and pets, molecular 
typing was carried out when the same bacterial species that was MDR and harbored the mecA gene 
was identified contemporaneously in at least 1 pet and 1 resident in contact within the same nursing 
home. Strains were typed by multilocus sequence typing following Thomas et al. (30) and by pulsed 
field gel electrophoresis following MacKenzie et al. (31), using Salmonella serotype Braenderup 
H9812 as a universal standard for the analysis. The staphylococcal cassette chromosome mec 
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(SCCmec) harbouring the mecA gene was typed by polymerase chain reaction following Milheirico 
et al. and Zhang et al. (32, 33).  
 
Statistical analysis 
Sample size. The intra-class correlation coefficient (rho) was estimated to be 0.15, with an 
estimated prevalence of about 10 % of people and 5 % of pets carrying at least one MDR 
staphylococcal strain. For estimating prevalence with a precision of a standard error of 2.5 % (upper 
95 % CI = 14.9 %), 252 people clustered in 42 different nursing homes of each category were 
needed. We estimated that each nursing home with pets owned or was visited by three animals on 
average; thus, a total of 126 pets could have been sampled in 42 different nursing homes. The 
expected precision for the prevalence in pets would have been within a standard error of 2.2 % 
(upper 95 % CI = 9.3 %). 
Univariable and multivariable analyses. We used generalized estimating equation (GEE) models 
with correlated binomial outcome, a logit link function, an exchangeable correlation matrix, and 
robust standard errors to account for clustering at the nursing home level. Subsequent models were 
adjusted for age, sex, and antibiotic treatment within 3 months before the study. The model used to 
explore possible risk factors was adjusted for age, sex, and contact with pets. All statistical analyses 
were performed with Stata 9.0 (StataCorp, College Station, TX). 
 
Results 
We collected samples from 216 residents living in 38 nursing homes where pets were not allowed, 
as well as from 229 residents and 98 pets in 39 nursing homes in which cats and dogs were present. 
Thirtyfour residents declined to participate and were replaced by randomly selected alternatives; 17 
others also declined to participate, but no alternatives were available. A total of 135 animals were 
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present in 39 nursing homes; exclusions included 2 that did not meet the inclusion criteria, 2 in 
which it was not possible to collect nasal and ear swabs, and 33 that were not present at the time of 
sample collection. The median age of the residents living with pets was 86.6 years and that of those 
without pets was 85.2 years; the proportion of women in the 2 groups was 75% and 69%, 
respectively. Approximately 60% of the residents of nursing homes with pets and 9% of those in 
homes without pets had contact with cats and dogs at least once a week. Cats represented 54% of all 
investigated pets; dogs, 46%. Demographic data for residents and pets are summarized in Tables 1 
and 2. In terms of the sociopsychological component of the human–pet relationship, 63% (281/445) 
of all investigated residents reported considering contact with pets of great importance to quality of 
life. 
Table 1. Demographic characteristics of residents living with and without pets. 
who had been in physical contact. In this home, 1 cat
and 1 resident, linked by a low-frequency contact
(1 visit per week), carried MDR S epidermidis strains
with the mecA gene (Fig 1). The 2 strains belonged to
the same multilocus sequence type ST5, harbored the
same type of SCCmec IVa, and had identical pulsed field
gel electrophoresis profiles, indicating a clonal ori-
gin.34 Both strains were phenotypically resistant to
penicillin, ampicillin, oxacillin, gentamicin, tetracy-
cline, erythromycin, ciprofloxacin, fusidic acid, cefoxi-
tin, and kanamycin. In addition, strain p1 was resistant
to cefazolin, and strain r1 was resistant to clindamycin.
Additional univariable exploratory analysis of risk
factors related to the carriage of MDR staphylococci
in residents showed that antibiotic treatment within
3 months before the start of the investigation (OR,
3.5; 95% CI, 2.2-5.5), presence of a catheter (OR, 2.3;
95% CI, 1.3-4.1), urinary tract infection (OR, 2.6;
95% CI, 1.6-4.2), and hospitalization in the previous
year (OR, 1.7; 95% CI, 1.1-2.6) all increased the risk
of carrying MDR staphylococci in residents (Table 5).
However, in the multivariate analysis, only antibiotic
treatment within 3 months before the investigation re-
mained a significant factor in increasing the risk of
MDR carriage (aOR, 3.1; 95% CI, 1.8-5.7).
DISCUSSION
In this study, living in a nursing home in which pets
were present or residents had regular contact with pets
at least once a week did not increase the risk for MDR
staphylococci carriage. In fact, residents living in nurs-
ing homes with pets and with regular pet contact had a
lower prevalence of MDR staphylococci carriage. This
might not indicate a causal protective effect of pets,
however; rather, compared with residents without con-
tact with pets, residents with contact might be more ac-
tive and healthier, and thus more immunocompetent
and less likely to be colonized by MDR staphylococci.
The only risk factor identified in the multivariate
analysis as associated with MDR staphylococci carriage
was antibiotic treatment within 3 months before the
investigation. Factors reported to increase the risk of
colonization or infection by MDR staphylococci in-
clude age .60 years, previous colonization, hospitali-
zation in the previous year, antibiotic use in the
previous 3 months, the presence of wounds, and recent
skin infection.1,35-37
Previous reports have suggested that pets may be
reservoirs of MDR microorganisms, and cases of possi-
ble exchange of staphylococcal strains between ani-
mals and humans have been described.15-17,38,39 In
this study, we found a lower risk of MDR staphylococci
carriage in residents living with pets, suggesting that
strain transmission is rather limited. We identified
only 1 case in which an exchange of strains most likely
had occurred. Whether the carriage of these microor-
ganisms originatea from a common source of coloniza-
tion (eg, surrounding environment) or from direct
exchange between humans and animals remains to
be clarified, however. Our findings seem to indicate
that for most residents, the previously reported bene-
fits of pet contact might outweigh the potential risk
of infection.
Limitations of this study include a potential recall
bias in elderly persons who had to self-report their
contact with pets and the time that they regularly
spent with the animals. The study focused on the
role of pets in nursing homes and did not generate
information on person-to-person contacts, which
would have completed the contact network. Thus,
we could not fully explore the relative importance
of resident-to-resident versus resident-to-pet con-
tacts for the MDR staphylococci carriage. Ideally, to
uncover potential transmission scenarios, the total-
ity of human and pet bacterial isolates should be
typed to reveal molecular epidemiologic patterns
and their congruence with physical contact patterns.
But strain molecular typing is expensive and time-
consuming, and social network analyses can be a
useful approach that may help keep the focus only
Table 1. Demographic characteristics of residents living
with and without pets
With pets Without pets
Age, years, median 6 interquartile
range
86.6 6 10.8 85.2 6 11.4
Female 75% (172/229) 69% (148/216)
History of MRSA 5% (12/229) 3% (7/216)
Catheter in the last year 16% (36/229) 14% (30/216)
Urinary infection in the last year 22% (50/226) 26% (55/212)
Surgical intervention in the last year 14% (32/227) 6% (14/216)
Stay in another care center in
the last year
23% (53/228) 22% (47/215)
Antibiotic treatment the last
3 months
23% (52/228) 21% (45/214)
Contact with pets at least
once a week
60% (137/229) 9% (20/216)
Table 2. Demographic characteristics of pets living in or
regularly visiting nursing homes
Owner
Cats
(n 5 53), n (%)
Dogs
(n 5 45), n (%)
Nursing homes 43 (81) 0
Residents 9 (17) 5 (11)
Pet-assisted therapy 0 11 (24)
Visitors 0 11 (24)
Care staff 0 14 (31)
Others 1 (2) 4 (9)
4 Gandolfi-Decristophoris et al. American Journal of Infection Control
n 2011
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Table 2. Demographic characteristics of pets living in or regularly visiting nursing homes. 
The adjusted prevalence of MDR staphylococci carriage was 36 % (95 % CI: 29-44) in the 229 
residents living with pets, 46 % (95 % CI: 39-53) in the 216 residents living without pets, and 16 %
(95 % CI: 10-25) in the 98 pets. A total of 815 staphylococcal strains were isolated from the nostrils 
of the residents, and 109 strains were isolated from the nostrils and ears of the animals. MDR 
strains (n=127 in residents without pets; n=108 in residents with pets; n=28 in pets) belonged to 
various staphylococcal species, including S. aureus, S. pseudintermedius, S. epidermidis, 
S. hominis, S. haemolyticus, S. xylosus, S. warneri, S. capitis, S. simulans, S. pettenkoferi, 
S. fleuretti, S. saprophyticus, S. pasteuri, S. cohnii, S. auricularis, and S. croceolyticus, in different 
proportions. S. epidermidis represented > 50% of the MDR strains recovered from residents and 
about 30% of those recovered from pets. The mecA gene was harbored by 17% (140/815) of all 
staphylococcal strains from residents and 7% (8/109) of those strains from pets. We isolated 9 
MRSA strains from 8 residents, but found no methicillin-resistant S. pseudintermedius. No MRSA 
or methicillin-resistant S. pseudintermedius was isolated from pets. 
Living in nursing homes in which pets were present was associated with a decreased prevalence of 
MDR staphylococci carriage (AOR = 0.6; 95 % CI: 0.4-0.9; Table 3). We also analyzed the 
exposure to pets by defining it as active contact at least once a week, and found a negative 
who had been in physical contact. In this home, 1 cat
and 1 resident, linked by a low-frequency contact
(1 visit per week), carried MDR S epidermidis strains
with the mecA gene (Fig 1). The 2 strains belonged to
the same multilocus sequence type ST5, harbored the
same type of SCCmec IVa, and had identical pulsed field
gel electrophoresis profiles, indicating a clonal ori-
gin.34 Both strains were phenotypically resistant to
penicillin, ampicillin, oxacillin, gentamicin, tetracy-
cline, erythromycin, ciprofloxacin, fusidic acid, cefoxi-
tin, and kanamycin. In addition, strain p1 was resistant
to cefazolin, and strain r1 was resistant to clindamycin.
Additional univariable exploratory analysis of risk
factors related to the carriage of MDR staphylococci
in residents showed that antibiotic treatment within
3 months before the start of the investigation (OR,
3.5; 95% CI, 2.2-5.5), presence of a catheter (OR, 2.3;
95% CI, 1.3-4.1), urinary tract infection (OR, 2.6;
95% CI, 1.6-4.2), and hospitalization in the previous
year (OR, 1.7; 95% CI, 1.1-2.6) all increased the risk
of carrying MDR staphylococci in residents (Table 5).
However, in the multivariate analysis, only antibiotic
treatment within 3 months before the investigation re-
mained a significant factor in increasing the risk of
MDR carriage (aOR, 3.1; 95% CI, 1.8-5.7).
DISCUSSION
In this study, living in a nursing home in which pets
were present or residents had regular contact with pets
at least once a week did not increase the risk for MDR
staphylococci carriage. In fact, residents living in nurs-
ing homes with pets and with regular pet contact had a
lower prevalence of MDR staphylococci carriage. This
might not indicate a causal protective effect of pets,
however; rather, compared with residents without con-
tact with pets, residents with contact might be more ac-
tive and healthier, and thus more immunocompetent
and less likely to be colonized by MDR staphylococci.
The only risk factor identified in the multivariate
analysis as associated with MDR staphylococci carriage
was antibiotic treatment within 3 months before the
investigation. Factors reported to increase the risk of
colonization or infection by MDR staphylococci in-
clu e age .60 year , previous colonizatio , ospitali-
zation in the previous year, antibiotic use in the
previous 3 months, the presence of wounds, and recent
skin infection.1,35-37
Previous reports have suggested that pets may be
reservoirs of MDR microorganisms, and cases of possi-
ble exchange of staphylococcal strains between ani-
mals and humans have b en described.15-17,38,39 In
this study, we found a lower risk of MDR staphylococci
carriage in residents living with pets, suggesting that
strain transmission is rather limited. We identified
only 1 case in which an exchange of strains most likely
had occurred. Whether the carriage of these microor-
ganisms originatea from a common source of coloniza-
tion (eg, surrounding environment) or from direct
exchange between humans and animals remains to
be clarified, however. Our fi dings seem to indicate
that for most residents, the previously reported bene-
fits of pet contact might outweigh the potential risk
of infection.
Limitations of this study include a potential recall
bias in elderly persons who had to self-report their
contact with pets and t e time that th y regularly
spent with the animals. The study focused on the
role of ets in nursing homes and did not generate
information on person-to-person contacts, which
would have completed the contact network. Thus,
we could not fully explore the relative importance
of resident-to-resident versus resident-to-pet con-
tacts for the MDR staphylococci carriage. Ideally, to
uncover potential transmission scenarios, the total-
ity of human and pet bacterial isolates should be
typed to reveal molecular epidemiologic patterns
and their congruence with physical contact patterns.
But strain molecular typing is expensive and time-
consuming, and social network analyses can be a
useful approach that may help keep the focus only
Table 1. Demographic characteristics of residents living
with and without pets
With pets Without pets
Age, years, median 6 interquartile
range
86.6 6 10.8 85.2 6 11.4
Female 75% (172/229) 69% (148/216)
History of MRSA 5% (12/229) 3% (7/216)
Catheter in the last year 16% (36/229) 14% (30/216)
Urinary infection in the last year 22% (50/226) 26% (55/212)
Surgical intervention in the last year 14% (32/227) 6% (14/216)
Stay in another care center in
the last year
23% (53/228) 22% (47/215)
Antibiotic treatment the last
3 months
23% (52/228) 21% (45/214)
Contact with pets at least
once a week
60% (137/229) 9% (20/216)
Table 2. Demographic characteristics of pets living in or
regularly visiting nursing homes
Owner
Cats
(n 5 53), n (%)
Dogs
(n 5 45), n (%)
Nursing homes 43 (81) 0
Residents 9 (17) 5 (11)
Pet-assisted therapy 0 11 (24)
Visitors 0 11 (24)
Care staff 0 14 (31)
Others 1 (2) 4 (9)
4 Gandolfi-Decristophoris et al. American Journal of Infection Control
n 2011
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association here as well (AOR = 0.5; 95 % CI: 0.4-0.8) (Table 3). The frequency of the contact with 
pets was not associated with an increased risk of MDR staphylococci carriage (Table 4). 
Table 3. Stay in a nursing home with pets and active contact of nursing home residents with pets as risk 
factors for staphylococcal carriage using GEE models to account for within-home clustering. 
on situations that are of interest and determinant for
an exchange of microorganisms. We investigated the
carriage of staphylococci because MDR in these mi-
croorganism is of concern in health care settings,
but we did not explore the potential for pets to act
as reservoirs of other MDR microorganisms, such as
extended-spectrum b-lactamase–producing entero-
bacteriaceae.40 In addition, we defined MDR as resis-
tance of a strain to at least 3 antibiotics of different
classes. Unfortunately, official guidelines (eg, Clini-
cal and Laboratory Standards Institute and EUCAST;
European Committee on Antimicrobial Susceptibility
Testing) lack a clear and standard definition of the
criteria needed to define a staphylococcal strain as
MDR. This reduces the possibility of carrying out
meaningful comparisons with published data.
To the best of our knowledge, this is the first study
that has investigated pets as potential reservoirs of
MDR staphylococci in the nursing home setting. The
study’s limitations notwithstanding, we have shown
how the complementary analysis of epidemiologic
links via physical contacts and molecular typing are
useful for targeting the investigation of the complexity
of possible exchange of MDR microorganisms. We re-
ported a case of possible exchange of methicillin-
resistant S epidermidis strains between a resident and
a cat. In addition, we explored possible risk factors
for the carriage of MDR staphylococci in nursing
Table 3. Stay in a nursing home with pets and active contact of nursing home residents with pets as risk factors for









pets (n 5 229),
n (%)
Homes without
pets (n 5 216),
n (%)
Residents
Staphylococcus spp 216 (94) 208 (96) 1.0 (0.9-1.0) 0.6 (0.3-1.5) 0.7 (0.3-1.6)
MDR Staphylococcus spp 84 (37) 99 (46) 0.8 (.6-1.0) 0.7 (0.5-1.0) 0.6 (0.4-0.9)
Staphylococci with mecA 55 (24) 64 (30) 0.8 (.6-1.1) 0.8 (0.5-1.2) 0.7 (0.4-1.1)
MRSA 2 (1) 6 (3) 0.3 (.1-1.5) 0.3 (0.1-1.6) ND
Pets (n 5 98)
Staphylococcus spp 56 (57) NA NA NA NA
MDR Staphylococcus spp 16 (16) NA NA NA NA
Staphylococci with mecA 6 (6) NA NA NA NA








Staphylococcus spp 146 (93) 278 (97) 1.0 (0.9-1.0) 0.5 (0.2-1.2) 0.5 (0.2-1.2)
MDR Staphylococcus spp 54 (34) 129 (45) 0.8 (0.6-1.0) 0.7 (0.4-1.0) 0.5 (0.4-0.8)
Staphylococci with mecA 32 (20) 87 (30) 0.7 (0.5-1.0) 0.6 (0.4-1.0) 0.5 (0.3-0.9)
MRSA 2 (1) 6 (2) 0.6 (0.1-3.0) 0.6 (0.1-2.9) ND
NOTE. Active contact was defined as self-reported physical contact to a pet at least once a week.
aOR, OR adjusted for age, sex, and antibiotic treatment in the last 3 months; GEE, generalized estimating equation; NA, not applicable; ND, not determined; RR, relative risk.
Table 4. Association between carriage of MDR staphylococci in residents and contact intensity with pets (time spent with
pets) using GEE models to account for within-home clustering
Time spent with pets MDR yes (n 5 84), n (%) MDR no (n 5 145), n (%) Crude OR (95% CI) aOR (95% CI)
No contact 39 (46) 62 (43) Reference Reference
.12 hours/day 3 (4) 9 (6) 0.6 (0.2-2.3) 0.5 (0.1-2.0)
1-12 hours/day 9 (11) 5 (3) 3.3 (0.9-12.8) 3.6 (1.1-12.1)
,1 hour/day 12 (14) 16 (11) 1.2 (0.6-2.3) 0.9 (0.4-2.0)
1 visit per week 21 (25) 53 (37) 0.6 (0.3-1.2) 0.5 (0.2-1.1)
NOTE. Reference group, no contact.
aOR, OR adjusted for age, sex, and antibiotic treatment in the last 3 months; GEE, generalized estimating equation.
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Table 4. Association between carriage of MDR staphylococci in residents and contact intensity with pets 
(time spent with pets) using GEE models to account for within-home clustering. 
In only 1 nursing home was the same MDR staphylococcal species carried by 1 pet and at least 1 
resident who had been in physical contact. In this home, 1 cat and 1 resident, linked by a low-
frequency contact (1 visit per week), carried MDR S. epidermidis strains with the mecA gene 
(Figure 1). The 2 strains belonged to the same multilocus sequence type ST5, harbored the same 
type of SCCmec IVa, and had identical pulsed field gel electrophoresis profiles, indicating a clonal 
origin (34). Both strains were phenotypically resistant to penicillin, ampicillin, oxacillin, 
gentamicin, tetracycline, erythromycin, ciprofloxacin, fusidic acid, cefoxitin, and kanamycin. In 
addition, strain p1 was resistant to cefazolin, and strain r1 was resistant to clindamycin. 
Figure 1. Weighted graph illustrating the network of contacts in a nursing home setting, with pets (p) 
represented by boxes and residents (r) represented by circles. Edges represent physical contacts between pets 
and persons, with line thickness increasing with higher reported contact frequency. Individuals carrying 
S. epidermidis [1] are depicted as gray vertices, those not carrying this staphylococcal species [-] in white. 
mecA is the gene encoding for methicillin resistance in staphylococci. 
on situations that are of interest and determinant for
an exchange of microorganisms. We investigated the
carriage of staphylococci because MDR in these mi-
croorganism is of concern in health care settings,
but we did not explore the potential for pets to act
as reservoirs of other MDR microorganisms, such as
extended-spectrum b-lactamase–producing entero-
bacteriaceae.40 In addition, we defined MDR as resis-
tance of a strain to at least 3 antibiotics of different
classes. Unfortunately, official guidelines (eg, Clini-
cal and Laboratory Standards Institute and EUCAST;
European Committee on Antimicrobial Susceptibility
Testing) lack a clear and standard definition of the
criteria needed to define a staphylococcal strain as
MDR. This reduces the possibility of carrying out
meaningful comparisons with published data.
To the best of our knowledge, this is the first study
that has investigated pets as potential reservoirs of
MDR staphylococci in the nursing home setting. The
study’s limit tions notwithstanding, we have shown
how the complementary analysis of epidemiologic
links via physical contacts and molecular typing are
useful for targeting the investigation of the complexity
of possible exchange of MDR microorganisms. We re-
ported a case of possible exchange of methicillin-
resistant S epidermidis strains between a resident and
a cat. In addition, we explored possible risk factors
for the carriage of MDR staphylococci in nursing
Table 3. Stay in a nursing home with pets and active contact of nursing home residents with pets as risk factors for









pets (n 5 229),
n (%)
Homes without
pets (n 5 216),
n (%)
Residents
Staphylococcus spp 216 (94) 208 (96) 1.0 (0.9-1.0) 0.6 (0.3-1.5) 0.7 (0.3-1.6)
MDR Staphylococcus spp 84 (37) 99 (46) 0.8 (.6-1.0) 0.7 (0.5-1.0) 0.6 (0.4-0.9)
Staphylococci with mecA 55 (24) 64 (30) 0.8 (.6-1.1) 0.8 (0.5-1.2) 0.7 (0.4-1.1)
MRSA 2 (1) 6 (3) 0.3 (.1-1.5) 0.3 (0.1-1.6) ND
Pets (n 5 98)
Staphylococcus spp 56 (57) NA NA NA NA
MDR Staphylococcus spp 16 (16) NA NA NA NA
Staphylococci with mecA 6 (6) NA NA NA NA








Staphylococcus spp 146 (93) 278 (97) 1.0 (0.9-1.0) 0.5 (0.2-1.2) 0.5 (0.2-1.2)
MDR Staphylococcus spp 54 (34) 129 (45) 0.8 (0.6-1.0) 0.7 (0.4-1.0) 0.5 (0.4-0.8)
Staphylococci with mecA 32 (20) 87 (30) 0.7 (0.5-1.0) 0.6 (0.4-1.0) 0.5 (0.3-0.9)
MRSA 2 (1) 6 (2) 0.6 (0.1-3.0) 0.6 (0.1-2.9) ND
NOTE. Active contact was defined as self-reported physical contact to a pet at least once a week.
aOR, OR adjusted for age, sex, and antibiotic treatment in the last 3 months; GEE, generalized estimating equation; NA, not applicable; ND, not determined; RR, relative risk.
Table 4. Association between carriage of MDR staphylococci in residents and contact intensity with pets (time spent with
pets) using GEE models to account for within-home clustering
Time spent with pets MDR yes (n 5 84), n (%) MDR no (n 5 145), n (%) Crude OR (95% CI) aOR (95% CI)
No contact 39 (46) 62 (43) Reference Reference
.12 hours/day 3 (4) 9 (6) 0.6 (0.2-2.3) 0.5 (0.1-2.0)
1-12 hours/day 9 (11) 5 (3) 3.3 (0.9-12.8) 3.6 (1.1-12.1)
,1 hour/day 12 (14) 16 (11) 1.2 (0.6-2.3) 0.9 (0.4-2.0)
1 visit per week 21 (25) 53 (37) 0.6 (0.3-1.2) 0.5 (0.2-1.1)
NOTE. Reference group, no contact.
aOR, OR adjusted for age, sex, and antibiotic treatment in the last 3 months; GEE, generalized estimating equation.
www.ajicjournal.org
Vol. n No. n
Gandolfi-Decristophoris et al. 5
Chapter 6 – Research paper 3 - 86 - 
Epidemiology of multi-drug resistant staphylococci in cats, dogs and people in Switzerland 
Additional univariable exploratory analysis of risk factors related to the carriage of MDR 
staphylococci in residents showed that antibiotic treatment within 3 months before the start of the 
investigation (OR = 3.5; 95 % CI: 2.2-5.5), presence of a catheter (OR = 2.3; 95 % CI: 1.3-4.1),
urinary infections (OR = 2.6; 95 % CI: 1.6-4.2) and hospitalization in the last year (OR = 1.7;
95 % CI: 1.1-2.6) all increased the risk of carrying MDR staphylococci in residents (Table 5). 
However, in the multivariate analysis, only antibiotic treatment within 3 months before the 
investigation remained a significant factor in increasing the risk of MDR carriage (AOR = 3.1;
95 % CI: 1.8-5.7).
Table 5. Exploratory analysis of potential risk factors for the carriage of MDR staphylococci in residents 
using GEE models to account for within-home clustering. 
Discussion
In this study, living in a nursing home in which pets were present or residents had regular contact 
with pets at least once a week did not increase the risk for MDR staphylococci carriage. In fact, 
residents living in nursing homes with pets and with regular pet contact had a lower prevalence of 
MDR staphylococci carriage. This might not indicate a causal protective effect of pets, however; 
rather, compared with residents without contact with pets, residents with contact might be more 
active and healthier, and thus more immunocompetent and less likely to be colonized by MDR 
staphylococci.
home residents. Future studies are needed to assess
risk factors for the carriage of these microorganisms
in pets.
Public health investigations may benefit from an in-
creased awareness of the potential for cooperation
among different sectors (eg, human medicine, veteri-
nary medicine, social science). Investigations under
the ‘‘One Health’’ paradigm are important to under-
standing the complexity of public health chal-
lenges.41,42 Evaluating the presence of pets in nursing
homes must take into account various social, emo-
tional, and psychological components and factors.
More than 60% of the residents surveyed reported
that they considered contact with pets of great impor-
tance to their quality of life. We found no evidence
that the previously reported benefits of pet contact
are compromised by the increased risk of MDR staph-
ylococci carriage in residents with pet contact. Thus,
we suggest that contact with pets be encouraged in
nursing home settings: Published guidelines for
animal-assisted interventions in health care facilities
may be important for defining applicable hygiene
standards.43,44
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tacting nursing homes; Dr Jalil Darkan and Elodie Papin for their help in sample collec-
tion; Federica Mauri, Joyce Rigozzi, Nadia Ruggeri-Bernardi, and Monia Sobrio for help
with laboratory analyses; and Dr Helen Thornton for the English revisions to the
manuscript.
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The only risk factor identified in the multivariate analysis as associated with MDR staphylococci 
carriage was antibiotic treatment within 3 months before the investigation. Factors reported to 
increase the risk of colonization or infection by MDR staphylococci include age >60 years, previous 
colonization, hospitalization in the previous year, antibiotic use in the previous 3 months, the 
presence of wounds, and recent skin infection (1, 35-37). 
Previous reports have suggested that pets may be reservoirs of MDR microorganisms, and cases of 
possible exchange of staphylococcal strains between animals and humans have been described (15-
17, 38, 39). In this study, we found a lower risk of MDR staphylococci carriage in residents living 
with pets, suggesting that strain transmission is rather limited. We identified only 1 case in which 
an exchange of strains most likely had occurred. Whether the carriage of these microorganisms 
originated from a common source of colonization (e.g., surrounding environment) or from direct 
exchange between humans and animals remains to be clarified, however. Our findings seem to 
indicate that for most residents, the previously reported benefits of pet contact might outweigh the 
potential risk of infection. 
Limitations of this study include a potential recall bias in elderly persons who had to self-report 
their contact with pets and the time that they regularly spent with the animals. The study focused on 
the role of pets in nursing homes and did not generate information on person-to-person contacts, 
which would have completed the contact network. Thus, we could not fully explore the relative 
importance of resident-to-resident versus resident-to-pet contacts for the MDR staphylococci 
carriage. Ideally, to uncover potential transmission scenarios, the totality of human and pet bacterial 
isolates should be typed to reveal molecular epidemiologic patterns and their congruence with 
physical contact patterns. But strain molecular typing is expensive and time-consuming, and social 
network analyses can be a useful approach that may help keep the focus only on situations that are 
of interest and determinant for an exchange of microorganisms. We investigated the carriage of 
staphylococci because MDR in these microorganism is of concern in health care settings, but we did 
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not explore the potential for pets to act as reservoirs of other MDR microorganisms, such as 
extended-spectrum b-lactamase–producing enterobacteriaceae (40). In addition, we defined MDR 
as resistance of a strain to at least 3 antibiotics of different classes. Unfortunately, official 
guidelines (eg, Clinical and Laboratory Standards Institute and EUCAST; European Committee on 
Antimicrobial Susceptibility Testing) lack a clear and standard definition of the criteria needed to 
define a staphylococcal strain as MDR. This reduces the possibility of carrying out meaningful 
comparisons with published data. 
To the best of our knowledge, this is the first study that has investigated pets as potential reservoirs 
of MDR staphylococci in the nursing home setting. The study’s limitations notwithstanding, we 
have shown how the complementary analysis of epidemiologic links via physical contacts and 
molecular typing are useful for targeting the investigation of the complexity of possible exchange of 
MDR microorganisms. We reported a case of possible exchange of methicillin-resistant 
S. epidermidis strains between a resident and a cat. In addition, we explored possible risk factors for 
the carriage of MDR staphylococci in nursing home residents. Future studies are needed to assess 
risk factors for the carriage of these microorganisms in pets. 
Public health investigations may benefit from an increased awareness of the potential for 
cooperation among different sectors (eg, human medicine, veterinary medicine, social science). 
Investigations under the ‘‘One Health’’ paradigm are important to understanding the complexity of 
public health challenges (41, 42). Evaluating the presence of pets in nursing homes must take into 
account various social, emotional, and psychological components and factors. More than 60% of the 
residents surveyed reported that they considered contact with pets of great importance to their 
quality of life. We found no evidence that the previously reported benefits of pet contact are 
compromised by the increased risk of MDR staphylococci carriage in residents with pet contact. 
Thus, we suggest that contact with pets be encouraged in nursing home settings: Published 
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guidelines for animal-assisted interventions in health care facilities may be important for defining 
applicable hygiene standards (43, 44). 
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Relationship between pets and people in Swiss households: implications for the 
carriage of staphylococci in pet owners 
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Abstract 
Background: In the modern society the relationship between pets and their owners has become 
very close, with cats and dogs being integrated in the family network. On one hand the relationship 
with pets positively influences human physical and mental health, on the other this interaction may 
raise some concerns due to the possible role of pets as reservoir of antibiotic resistant 
microorganisms. In this study we aimed at investigating the relationship between cats, dogs and 
their owners in Swiss households and to evaluate the importance of these contacts for the carriage 
of staphylococci in people. 
Results: We investigated 356 pet owners and 177 people not owning any cat or dog since at least 
one year. Among the owners, 114 held only dogs and 141 only cats; the remaining 101 had both. 
70 % allowed their pets to touch their faces. 34.5 % affirmed that their pet slept regularly on the 
bed. Contacts with animals other than cats and dogs were recorded for 33 % of owners and 30 % of 
people not owning any cat or dog. The same proportion of multi-drug resistant staphylococcal 
carriage (20 %) was found in pet owners and in the control group. S. pseudintermedius was carried 
by eight owners but by none of the non-owners. 
Conclusions: Although we did not find any evident impact of pets on multi-drug resistance carriage 
in the staphylococci isolated from their owners, the intensity of the contact between pets and 
humans deserve to be considered when investigating the exchange of multi-drug resistant strains 
under an interdisciplinary “One Health” approach. 
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Background 
Human and pets are living together since ancient times. The evolution of cooperation with dogs led 
to their domestication (1). Earliest archaeological evidence of a “true” domestic dog is dated to 
14,000 years ago and the emergence of dog keeping seems to coincide with the evolutionary 
appearance of altruism and empathy among humans (2). Domestication of cats has a more recent 
history. It suggested that cats were fully domesticated only during the last 150 years, although the 
history of Felis catus is characterised by the animal drifting unpredictably in and out of various 
states of domestication, semi-domestication and feralness (3). First archaeological evidence of cat 
keeping stems from Cyprus where, in human settlements dating from 6,000 years ago, remains of 
cat’s jawbone were found (3). 
In modern societies pets have taken up an important companion role as they probably never 
previously had in the human history. The relationship between pets and their owners has become 
closer with time: cats and dogs can now be considered regular members of the family network. 
Statistics from 2008 show that 500,000 dogs and 1,4 million of cats live in 385,000 respectively 
780,000 Swiss households. According to the Society for the food of domestic animals, in the last 
years the number of Swiss households keeping cats and dogs is increasing, reaching 12 % for dogs 
and 25 % for cats in 2008 (4).  
The World Health Organisation (WHO) defined health as a state of complete physical, mental and 
social well-being and not merely as the absence of disease or infirmity. In this context, the 
relationship with pets is an important component of human health. It has been shown that people 
interacting with animals may benefit from improved physical health and psychological and social 
well-being (5). Pets can help people by providing them much needed companionship, thus giving 
them a feeling of security (6). Serpell (7) showed long term befits of pet ownership on people’s 
health, behaviour and general well-being. A positive short term influence of the presence and 
interaction with pets on the indicators of stress (e.g. blood pressure and anxiety) were also 
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demonstrated (8). Additionally, actively looking after pets might be an incentive to keep a moderate 
level of physical activity (9). 
In the last decade the relationship with cats and dogs has been suggested to be of potential concern 
to public health due to the possible role of pets as reservoir of antibiotic resistant microorganisms 
(10-13). In fact, studies reported probable exchange of multi-drug resistant (MDR) microorganisms 
between pets and humans (14-17). Meanwhile there is raising awareness of the added value that an 
interdisciplinary approach would have in the investigation of the spread of antibiotic resistance (18). 
To this aim, not only knowledge on bacterial resistance processes, but also a better understanding of 
the emotional and physical relationship between human and their pets is of great interest. 
This study aimed at investigating the relationship between cats, dogs and their owners in the Swiss 




Study design and setting 
Samples were collected between November 2008 and December 2009 in four different Swiss 
cantons (Berne, Ticino, Vaud and Zurich). Only healthy people older than 18 years old, with no 
overt acute disease at the time of sample collection, were enrolled in the study. We investigated 
Swiss cat and dog owners, including people not owning these pets since at least one year as control 
group. People were sampled based on random selection as well as on convenience. Pet owners were 
enrolled both by selecting them from a list of dog owners provided by the Cantonal Veterinary 
Offices and by recruitment at veterinary clinics that they visited for routine vaccination of their 
animals. People not owning pets were mainly contacted in their household as well as in travel 
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medicine centres. An informed written consent had to be given by each participant. The study 
received ethical clearance from the corresponding Cantonal Ethical Committees. 
 
Data collection 
A questionnaire with demographic, health status information and description of emotional and 
physical relationship with cats and dogs was filled in by each participant. People were asked to 
answer closed questions. Relevance and intensity of the relationship the owners had with their pets 
was self-reported by the participants. 
 
Sample collection 
Nasal swabs were collected by means of a cotton swab (Amies agar gel 108C, Copan, Italy) 
previously soaked in a physiological 0.9 % NaCl solution. The swab was introduced for 1-2 cm in 
the nostril. The collected samples were conserved in the transport medium at room temperature and 
analysed for the presence of staphylococci within 24-48 h of collection.  
 
Sample analyses 
Swabs were both streaked on Mannitol Salt Agar (Chapman 2 – MSA 2, bioMérieux® SA, France), 
incubated for 48 h at 37 °C, and enriched in MRSA broth supplied with 6 mg/L of oxacilllin (48 h 
at 37 °C) and cultured on Gelose ChromID S. aureus (SAID, bioMérieux® SA, France) for 48 h at 
37 °C. Colonies were isolated and catalase positive, Gram positive coccal bacteria isolates were 
frozen in skimmed milk at -80 °C until further analyses. 
Strains were grown on blood agar during 24 h and identified by mass assisted laser desorption 
ionisation - time of flight (MALDI-TOF MS) using an Axima Confidence™ spectrometer 
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(Shimadzu-Biotech Corp., Kyoto, Japan) in positive linear mode (m/z = 2,000 to 20,000) (19). 
Sequencing of the amplified partial rpoB gene was carried out on isolates that could not be 
identified by MALDI-TOF MS (20). 
Phenotypic antibiotic resistance to 24 different drugs was assessed by the Kirby-Bauer method on 
Mueller-Hinton blood agar (MHS2, bioMérieux® SA, France). Results were interpreted according 
to Clinical and Laboratory Standards Institute (CLSI) guidelines (21, 22); for the purpose of this 
work, intermediate results were considered resistant. In this investigation MDR was defined as 
resistance to at least 3 drugs belonging to different antibiotic classes. Additionally, the presence of 
the mecA gene which confers methicillin resistance was investigated by polymerase chain reaction 
(PCR) (23, 24). 
 
Statistical analysis 
Medians were reported with interquartile range (IQR) and with 1st quartile (Q1) and 3rd quartile 
(Q3); proportions (%) with 95 % confidence interval (95 % CI). Statistical analyses were performed 
with STATA 9.0 (Stata Corporation, College Station, TX, USA). 
 
Results 
Demographic of investigated people 
533 people living in the Swiss community of the Cantons of Bern (n=132), Ticino (n=135), Vaud 
(n=131) and Zürich (n=135) were included in this study; 356 were pet owners and 177 did not own 
any cat or dog since at least one year. Median age of the pet owners was 46, of people without pets 
45. Demographic characteristics of the two groups were similar; details are reported in Table 1. 
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Table 1. Demographics of investigated people with median age and proportions (%) of the different 
characteristics. IQR = interquartile range, 95 % CI = 95 % confidence intervals. 
Characteristics Pet owners (n = 356) No pet owners (n = 177) 
 
n Median IQR n Median IQR 
Age 353 45 20 176 45 26 
 n % 95% CI n % 95% CI 
Women 263/354 74 70-79 67/177 62 57-67 
MRSA history 7/355 2 0.9-4 4/176 2 0.8-6 
Antibiotic treatment in the last 3 months 13/350 13 10-17 17/176 10 6-15 
Immunosuppressant in the last 3 months 7/349 2 1-4 3/174 2 0.5-5 
Surgical intervention in the last year 43/355 12 9-16 14/177 8 5-13 
Stay in an hospital in the last year 25/355 7 5-10 13/177 7 4-12 
Diabetes 3/355 0.8 0.3-3 1/177 0.6 0.8-4 
Catheter 16/355 5 3-8 6/177 3 2-7 
Urinary affections in the last year 32/354 9 6-12 9/176 5 3-9 
 
 
Relationship with cats, dogs and other animals 
On average the relationship between owners and their pets lasted since 6 years, with a minimum of 
5 days and a maximum of 18 years. About 96 % (343/356) of the owners rated pets to have a 
positive influence on their quality of life (QoL) whereas 54 % (95/177) of people not owning a pet 
acknowledged that the presence of a cat or a dog could possibly have a positive impact on their QoL 
(Table 2). Among the 356 owners, 114 held only dogs and 141 only cats; the remaining 101 kept 
both species within their household. The median number of dogs per household was 1 (IQR = 1) 
dog, with 10 households reporting 5 or more of these animals. For cats, the median value was 1 
(IQR = 2), with 21 households where 5 or more cats were present. Two owners reported that more 
than 5 cats and more than 5 dogs where present within the same household. Contact with animals 
other than cats and dogs was reported in 33 % (95 % CI: 28-38) of owners and 30 % (95 % CI: 23-
37) of control people. 
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Table 2. Influence of pets on the QoL (quality of life), self-evaluated by the investigate people. 
95 % CI = 95 % confidence interval; N.D.  = not determined. 
 Pet owners (n = 356) Controls (n = 177) 
Influence of pets on QoL n  % 95%CI n  % 95%CI 
Positive 343 96 94-98 95 54 46-61 
Indifferent 9 2.5 0.9-4 39 22 16-28 
Negative 3 1 0-2 42 24 17-30 
Do not know - - - 1 0.5 0-1.6 
N.D. 1 0.5 0-0.8 - - - 
 
 
Intensity of the contact between cats, dogs and their owners in the household 
About 29 % (104/356) of the respondents declared to have only hand contact with their pets, 
whereas 70 % (248/356) allowed their animals to touch also their face. In one case the holder 
declared not having any physical contact with the dog and the cat present at home (Table 3). In 
49 % (173/355) of the household, pets slept regularly (minimum of 4 nights per week) in the room 
of the owner. Additionally, 34.5 % (122/354) of the respondents declared that their pet slept 
regularly on their bed (Table 3). In at least 31 of the 122 documented situations [9 % (31/354) of all 
households] the pet sleeping regularly on the bed was a dog. 
 
Table 3. Descriptive statistic of the physical contact between owners and their pets in the households. 
95 % CI = 95 % confidence interval. 
 n % 95%CI 
Type of Contact 
 No contact 1/356 0.3 0-0.8 
 Only hands 104/356 29 24-34 
 Hands and face 248/356 70 65-74 
 Other 3/356 0.8 0-1.7 
Pet sleep in the room 173/355 49 44-54 
Pet sleep on the bed 122/354 34.5 30-40 
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Staphylococcal carriage in healthy people in the household 
Staphylococci were recovered from 92 % (326/356) of the owner and 97 % (172/177) of the non-
owner nostrils. S. epidermidis was isolated at highest frequency, with 54 % (488/905) of all 
recovered strains belonging to this species. S. pseudintermedius was carried by eight owners but by 
none of the people in the control group (Table 4). The same proportion of MDR staphylococcal 
carriage (20 %: 71/356 and 35/177 respectively) was observed in owners and in control group. The 
mecA gene encoding for methicillin resistance was identified in 6 % (95 % CI: 4-8; 20/356) of the 
owners and 11 % (95 % CI: 7-17; 20/177) of the other people; with 93 % (38/41) of all mecA 
positive strains belonging to the species S. epidermidis. No methicillin-resistant S. aureus (MRSA) 
or methicillin-resistant S. pseudintermedius (MRSP) were isolated (Table 4). About 28 % (147/533) 
of the investigated people carried S. aureus in their nostril. Some strains belonging to the species 
S. epidermidis (n = 7) and S. pseudintermedius (n = 1) were found to be phenotypically resistant to 
six or more different antibiotic classes, with this latter species present only in pet owners (Table 4). 
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Table 4. Staphylococcal strains (n = 905) isolated from the nostril of 533 people (356 pet owners and 177 
controls) and the distribution of antibiotic resistance among the different species. Q1 = 1st quartile, Q3 = 3rd 
quartile, Max. = maximum, mecA = gene encoding methicillin resistance, MDR = multi-drug resistance. 
Identified isolates Pet owners (n = 607) Controls (n = 298) 
 Isolates Median 
(Q1; Q3; 
Max.) 




 n  n (%) n (%) n  n (%) n (%) 
Coagulase positive 112 1 (1; 1; 6) 0 (0) 8 (7) 48 1 (1; 2; 4) 0 (0) 4 (8) 
S. aureus 102 1 (0; 1; 4) 0 (0) 5 (5) 48 1 (1; 2; 4) 0 (0) 4 (8) 
S. delphini 1 0 (0; 0; 0) 0 (0) 0 (0) - - - - 
S. intermedius 1 1 (1; 1; 1) 0 (0) 0 (0) - - - - 
S. pseudintermedius 8 2 (2; 5; 6) 0 (0) 3 (38) - - - - 
Coagulase negative 494 1 (0; 2; 8) 20 (4) 78 (16) 250 1 (0; 2; 7) 21 (8) 32 (13) 
S. arlettae 1 4 (4; 4; 4) 0 (0) 1 (100) - - - - 
S. capitis 21 0 (0; 1; 3) 0 (0) 1 (5) 8 0.5 (0; 1; 1) 0 (0) 0 (0) 
S. caprae 1 0 (0; 0; 0) 0 (0) 0 (0) - - - - 
S. caprae/capitis 4 0 (0; 1; 2) 0 (0) 0 (0) 5 0 (0; 0; 2) 0 (0) 0 (0) 
S. cohnii 6 2.5 (2; 4; 4) 0 (0) 3 (50) 2 0.5 (0; 1; 1) 0 (0) 0 (0) 
S. devriesei - - - - 1 3 (3; 3; 3) 0 (0) 1 (100) 
S. epidermidis 325 1 (1; 2; 8) 18 (6) 57 (17) 163 1 (0; 2; 7) 20 (12) 26 (16) 
S. equorum 4 1 (0; 2; 2) 0 (0) 0 (0) 3 1 (0; 1; 1) 0 (0) 0 (0) 
S. fleuretti 1 2 (2; 2; 2) 0 (0) 0 (0) - - - - 
S. haemolyticus 16 1 (1; 2; 5) 1 (6) 2 (13) 10 2 (1; 3; 4) 1 (10) 3 (30) 
S. hominis 7 2 (1; 2; 3) 0 (0) 1 (14) 5 1 (1; 1; 2) 0 (0) 0 (0) 
S. kloosii 1 2 (2; 2; 2) 0 (0) 0 (0) - - - - 
S. lugdunensis 13 0 (0; 0; 2) 0 (0) 0 (0) 4 0 (0; 0.5; 1) 0 (0) 0 (0) 
S. pasteuri 13 0 (0; 1; 3) 0 (0) 1 (8) 2 0.5 (0; 1; 1) 0 (0) 0 (0) 
S. pettenkoferi 2 2.5 (1; 4; 4) 0 (0) 1 (50) - - - - 
S. saprophyticus 14 2 (1; 2; 4) 0 (0) 3 (21) 6 2 (2; 2; 2) 0 (0) 0 (0) 
S. sciuri 3 3 (1; 4; 4) 1 (33) 2 (67) 1 2 (2; 2; 2) 0 (0) 0 (0) 
S. simulans 1 1 (1; 1; 1) 0 (0) 0 (0) 1 0 (0; 0; 0) 0 (0) 0 (0) 
S. succinus 2 0.5 (0; 1; 1) 0 (0) 0 (0) 4 0.5 (0;1.5; 2) 0 (0) 0 (0) 
S. vitulinus 2 1 (1; 1; 1) 0 (0) 0 (0)  - - - 
S. warneri 43 0 (0; 1; 4) 0 (0) 4 (9) 25 1 (0; 1; 2) 0 (0) 0 (0) 
S. warneri/pasteuri 2 0 (0; 0; 0) 0 (0) 0 (0) 3 1 (1; 2; 2) 0 (0) 0 (0) 
S. xylosus 11 2 (2; 2; 3) 0 (0) 2 (18) 7 2 (1; 3; 3) 0 (0) 2 (29) 
Staphylococcus spp. 1 1 (1; 1; 1)  0 (0) - - - - 
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Discussion 
This study has demonstrated the physical closeness of pets with people and the emotional 
importance of this relationship. The majority of the owners reported pets to positively influence 
their QoL. No impact of the animals on the MDR carriage in owners was evident. MDR and 
methicillin resistance were identified in staphylococci recovered from both people in contact and 
people not owning any cat or dog. No MRSA or MRSP were detected. S. pseudintermedius was 
isolated only from people belonging to the owner’s group. 
We observed a very close contact between owners and their pets, with a large number of owners 
allowing their pets a direct contact with their face. The number of pets sleeping on the bed of their 
owners is also quite large. It could be expected that cats can hardly be forbidden this sleeping 
practice, but we can reasonably assume that dogs reported to sleep on the owner’s bed were 
consciously allowed to do so by their owners. This suggests that a large number of people are 
actively seeking a very close contact with their pets. 
In a previous study, where 30 % of healthy dogs were found to be carriers of S. pseudintermedius, 
we suggested host specificity of this staphylococcal species for dogs (25). Results of the present 
study, however, suggest that carriage of this microorganism only in pet owners may imply 
transmission of strains from animals to owners. An additional investigation in nursing homes, 
where people had contacts with cats and dogs did not allow to recover any S. pseudintermedius 
isolate (26). This might be explained by the fact that in institutionalised settings people usually have 
no such intense and close contact with pets as we could document it in the households.  
There is increasing awareness on the importance of the interactions between the different hosts (e.g. 
human and animals) when evaluating spreading dynamics of microorganisms. For example Alvarez 
et al. (27) proposed the use of network analysis as a valuable approach for the modelling of bovine 
S. aureus spread between farms. However the analysis of contact networks using cattle-tracing data 
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alone did not adequately capture the disease dynamics and it was suggested that consideration also 
of human contacts (i.e. farmers and farm visitors) might allow a better evaluation of strain spread 
(27). In our investigation we did not explore the relationship between different pets within the same 
household. This information, together with human contacts would eventually present a more 
exhaustive picture of the potential spreading dynamics of MDR staphylococci within household. 
 
Conclusion 
We did not find any evident impact of the close relationship between pet and owners on MDR 
carriage in people. Nevertheless, we suggest considering the intensity of the contact between pets 
and humans as an important component when investigating the possible exchange of MDR 
staphylococci between different hosts under the interdisciplinary “One Health” approach. 
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Summary 
We report the antibiotic treatments administered to a female dog with mastitis and successive 
pyoderma. Microbiological investigations allowed the identification of Staphylococcus 
pseudintermedius after 54 days of various antibiotic treatments. The isolate carried the mecA gene 
and was resistant to 9 out of 15 tested antibiotics. Consistent antibiotic treatment of the infection 
was possible only after an accurate microbiological diagnosis. 
 
Key words: pyoderma, microbiological investigation, Staphylococcus pseudintermedius, 
antibiogram, antibiotic treatment 
 
 
Antibiotische Behandlungen einer Methicillin-resistenten Staphylococcus pseudintermedius 
Infektion bei einem Hund: eine Fallvorstellung 
Wir berichten über die antibiotischen Behandlungen einer Hündin mit Mastitis und folgender 
Pyodermie. Die mikrobiologische Untersuchung erlaubte die Identifizierung von Staphylococcus 
pseudintermedius nach 54 Tagen mit verschiedenen antibiotischen Behandlungen. Der isolierte 
Stamm beinhaltete das mecA-Gen und war gegen 9 der 15 getesteten Antibiotika resistent. Eine 
angemessene antibiotische Behandlung der Infektion war erst nach einer genauen 
mikrobiologischen Diagnose möglich. 
 
Schlüsselwörter: Pyodermie, mikrobiologische Untersuchung, Staphylococcus pseudintermedius, 
Antibiogramm, antibiotische Behandlung 
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Introduction 
Staphylococcus pseudintermedius is an opportunistic pathogen of various animal species, 
particularly dogs and cats, and causes skin and soft tissue infections (1). This pathogen was first 
described in 2005 from four clinical specimens from a cat, a dog, a horse and a parrot (2). 
Phylogenetic analyses showed that this was not a new emerging species among dogs, but rather a 
misidentified biotype of Staphylococcus intermedius (3). Phenotypic identification methods can 
lead to incorrect identification of S. pseudintermedius, whereas molecular methods (e.g. sequencing 
of the partial hsp60 gene, MALDI-TOF MS) allow reliable identification of this species (3, 4). 
Methicillin resistance, encoded by the mecA gene, was described in S. pseudintermedius and 
multidrug resistance has been reported with increasing frequency in veterinary settings (5, 6). This 
is of concern for the treatment of animal diseases and may carry potential public health 
consequences (7). To effectively manage antibiotic resistant bacteria and subsequent infections, it is 
mandatory to prevent inappropriate use of drugs and to improve the rapid prescription of 
appropriate antibiotics to a patient (8). We report the antibiotic treatments administered to a female 
dog before an infection by S. pseudintermedius had been diagnosed and a consistent antibiotic 
therapy was administered to the dog. 
 
Case history 
A 5-year-old, mixed breed, female dog with an ongoing mastitis was brought to an Italian 
veterinary practice. The dog had an ovariectomy 3 months before the visit because of recurrent 
pseudopregnancies. For treatment of mastitis the antibiotic first choosen consisted of Synulox 
(amoxicillin-clavulanic acid, 14.3 mg/kg bw and 3.6 mg/kg bw respectively, bid for 7 days) 
together with Stomorgyl (spiramycin-metronidazole, 17.9 mg/kg bw, sid for 7 days). Due to the 
lack of efficacy, treatment with these antibiotics was stopped and the dog was given Baytril 
(enrofloxacin, 10.7 mg/kg bw, sid orally for 2 days) and Rocefin (ceftriaxone, sc, 35.7 mg/kg bw, 
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sid for 31 days). At that stage the dog weighed 14 kg, was anaemic with a haematocrit of 31.9 % 
(37-55 %), had raised liver values (AP = 472 U/L; 23-212 U/L) and was febrile (40.8°C). A 
complete blood cell count (CBC) revealed a leukocytosis of 23.47 K/μL (5.50-16.90 K/μL) 




Figure 1. Pyoderma with exudates and blood appearing around the occipital bone. 
 
Enrofloxacin was stopped after 2 days and treatment was continued with ceftriaxone (sc, 35.7 
mg/kg bw, sid) alone. Skin lesions with purulent and sanguineous exudates appeared on the back 
and around the occipital bone (Fig. 1). An Elizabethan collar was used to hinder scratching, because 
the dog was very pruritic. Diagnosis of deep pyoderma was made on the basis of the clinical 
appearance of the skin, but no skin tests were carried out. Due to the lack of efficacy of ceftriaxone 
alone, Antirobe (clindamycin; 10.7 mg/kg bw, bid for 5 days) was added to the ongoing treatment 
together with methylprednisolone tablets (0.3 mg/kg bw, bid for 30 days) to control the pruritus. 
The mastitis resolved but the pyoderma persisted and the owner decided to bring the dog to another 
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veterinary clinic, where clindamycin treatment was stopped and the antifungal Sporanox 
(itraconazole, 7.1 mg/kg bw, sid for 5 days) was added to the ongoing ceftriaxone and corticosteroid 
treatment; also in this case no skin scraping or other cytological tests were performed. Pyoderma 
persisted and blood analysis revealed anaemia with a haematocrit of 24.5% and Hb = 9.8 g/dL 
(12.0-18.0 g/dL) and eosinophilia (2.51 K/μL; 0.10-1.49 K/μL), together with elevated liver enzyme 
values (ALT = 187 U/L, 10-100 UL; AP value = 2400 U/L). Ceftriaxone treatment resulted in no 
skin improvement, therefore after 31 days of treatment the owner went to a third veterinary clinic 
where the drug was replaced by doxycycline (7.1 mg/kg bw, sid for 9 days). Progressive decreasing 
methylprednisolone doses and treatment with doxycycline were continued with no significant 
improvement of the skin, leading to the decision to carry out a microbiological analysis. A sterile 
swab (Amies agar gel 108C; Copan, Italy) was taken directly from the eyebrow arch lesion, plated 
out on blood agar with nalidixic acid within 24h after collection, and incubated during 24h at 35°C. 
 
Bacteriology 
Heavy growth of Gram positive haemolytic, catalase positive cocci was observed. The strain was 
identified as Staphylococcus aureus by RapiDEC Staph biochemical tests (bioMérieux® SA, 
France), but this result was not confirmed by latex agglutination test (Pastorex®; Bio-Rad, France). 
The strain was eventually identified as S. pseudintermedius by MALDI-TOF MS analysis (matrix 
assisted laser desorption ionisation – time of flight mass spectrometry) with a confidence of 99.9% 
(4). MALDI-TOF MS produces a fingerprint spectrum of peptides and proteins of the analyzed 
microorganism. The diagnosis was later confirmed by sequencing of the partial hsp60 gene (9). 
According to the disk diffusion method (Clinical and Laboratory Standards Institute, previously 
NCCLS guidelines) (10), the isolated methicillin-resistant S. pseudintermedius (MRSP) was 
phenotypically resistant to 9 antibiotics of 15 tested, but sensitive to minocycline, a long acting 
tetracycline (minimal inhibitory concentration assessed by E-test method: 0.19 μg/mL) (Tab. 1). 
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Possible therapeutic options 
after (8, 11) 
   S R Lyold 2010 and Weese 2006 
Oxacillin R 1 6 ≥18 ≤17 No 
Tobramycin  R 11 ≥15 ≤12 No 
Doxycycline R 8.5 ≥16 ≤12 No 
Chloramphenicol  R 6 ≥18 ≤12 No 
Ciprofloxacin  R 6 ≥21 ≤15 No 
Clindamycin  R 6 ≥21 ≤14 No 
Erythromycin  R 6 ≥23 ≤13 No 
Fusidic acid R 18 ≥20 ≤19 No 
Trimethoprim-
sulfamethoxazole 
R 6 ≥16 ≤10 No 
      
Minocycline S 0.19 * ≤4 ** ≥16 ** First line 
Rifampicin S 31.5 ≥20 ≤16 restricted 
Linezolid S 26.5 ≥21 - restricted 
Quinupristin-dalfopristin S 21 ≥19 ≤15 restricted 
Mupirocin S 22 ≥14 ≤13 restricted 
Vancomycin S 16 ≥15 ≤14 restricted 
 
1
 when resistant to oxacillin and presenting the mecA gene, the strain is considered resistant also to all other 
beta-lactams (i.e. penicillins, cephalosporins and carbapenems). Cefoxitin breakpoints are not predictive of 
mecA-mediated resistance to methicillin/oxacillin in Staphylococcus pseudintermedius (12). R = resistant,  
S = susceptible 
*
 in µg/mL 
**
 human interpretative criteria of the E-test for the assessment of the minimal inhibitory concentration 
(MIC) measured in µg/mL 
 
Oxacillin susceptibility test, used to predict mecA-mediated resistance in S. pseudintermedius, was 
evaluated according to Bemis and co-workers (13). The mecA gene responsible for methicillin 
resistance was detected by PCR (14). Minocycline (14.29 mg/kg bw, bid orally for 7 days) was 
administered based on dosage recommendation of CliniPharm/Clinitox-Datenbanken from the 
Institute of Veterinary Pharmacology and Toxicology, Zürich (www.vetpharm.uzh.ch). The dog’s 
general clinical condition improved, the areas of pyoderma decreased in size and the sanguineous 
secretions diminished. Leukocytosis disappeared (11.18 k/µL). Topical treatment with a cream 
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containing allicin, a garlic extract, was administered to help healing of the lesions. Despite of their 
improvement, two weeks later, the dog had a febrile attack which was clinically traced back to the 
S. pseudintermedius and the dog was therefore given rifampicin (21.4 mg/kg bw, sid orally for 7 
days). After the administration of this antibiotic the pyoderma continued to improve, the liver 
values returned to the normal range (ALT = 33 U/L) and the fever disappeared. Since the treatment, 
the animal has been suffering from an undiagnosed articular pain. 
 
Discussion 
Infections due to S. pseudintermedius and MRSP have been reported with increased frequency in 
dogs since the species was described in 2005. S. pseudintermedius was isolated as colonising agent 
from the ear, perineum and nasal mucosae of both healthy dogs and dogs with atopic dermatitis 
(15). Moreover, MRSP was isolated as urinary tract infection agent also in cats (5), and 
S. pseudintermedius infections in humans were documented (16, 17). Lack of the use of molecular 
identification methods might lead to incorrect characterisation of S. pseudintermedius. The 
RapiDEC Staph is a test based on biochemical reactions for the identification of the main 
staphylococci isolated from human specimens (S. aureus, S. epidermidis and S. saprophyticus) but 
also for the presumptive identification of S. intermedius, a staphylococcal species of animal origin. 
The use of RapiDEC Staph for the diagnosis of the dog isolate led to incorrect identification of the 
recovered microorganism. This observation suggest that the use of this phenotypic test can entail 
misidentification of S. pseudintermedius, because this species shares many phenotypic 
characteristics and mechanisms of antibiotic resistance with S. aureus (2, 6).  
The described clinical manifestations due to S. pseudintermedius in pets mainly consist of 
pyoderma and skin infections (18). Here we report a MRSP strain isolated from a pyoderma lesion 
in a female dog previously affected by mastitis. The origin of the infection is unclear. The dog 
might have contracted the MRSP infection during the ovariectomy. Correspondingly, cases of 
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nosocomial wound infections are reported for methicillin-resistant S. aureus (MRSA) in humans 
after surgery (19). On the other hand, it is also possible that the dog carried the S. pseudintermedius 
strain as part of its normal skin bacterial community, so that the multi-drug resistant strain was 
selected by the antibiotics. Humans and other in-contact pets could also have been a source of 
MRSP transmission to the dog, but this possibility was not further explored.  
The eosinophilia present in the blood could have been an indicator for an allergic or parasitic origin 
particularly because of the pruritus observed. Skin scraping for parasites can be easily carried out in 
any practice together with a Fungassay to rule out any fungal infections, as well as an impression 
smears to confirm diagnosis by showing intracytoplasmic bacteria on cytological examination. If 
underling systemic disease is suspected, a full blood workup has to be done taking care to include 
also differential count of the WBC and eventually also a skin biopsy. These clinical diagnostic 
methods should have been applied also in the described case before the administration of different 
antibiotics. In any case bacterial culture and sensitivity test should be carried out if antibiotic 
treatment does not yield the expected results. 
Treatment of MRSP is critical because of its resistance to all beta-lactams and, often, other classes 
of antibiotics. As for the antibiotic therapy of other bacterial infections, the administration of 
antibiotics until completion of full treatment is of primary importance. An effective antimicrobial 
therapy depends on several parameters such as bacterial susceptibility, pharmacokinetic 
characteristics of the drug, and dosage regime. Lack of treatment completion or prolonged 
antibiotics use may result in selection for resistant strains (20). Delayed or inadequate prescriptions 
can reduce the efficacy of treatment and favour the spread of the infection, both in human and in 
veterinary medicine (21). As in human medicine, treatment of animal infections should rely on a 
stepwise approach that includes successive use of first, second and third line antibiotics (8). In this 
case, the first therapy consisted of amoxicillin-clavulanic acid and spiramycin-metronidazole. Due 
to lack of efficacy of this empiric approach, enrofloxacin was administered together with 
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ceftriaxone. These drugs, however, belong to antibiotic classes that are usually employed as third 
line treatment in human medicine: thus, they should be used in animals only for a limited number of 
cases, i.e. where all other antibiotics fail (22). Minocycline is a semi-synthetic, long acting 
tetracycline which has been suggested to be effective against staphylococci resistant to 
semisynthetic penicillins and cephalosporins (23). In Japan, minocycline is commonly used in 
veterinary dermatological practices (24), whereas in other countries, such as Switzerland, drugs 
containing this antimicrobial principle are not approved for use in animals (www.vetpharm.uzh.ch). 
If the infection persists after a first line empiric treatment, the choice of a more specific, active drug 
to be administered should rely on an accurate microbiological analysis and antibiogram, which 
allow to evaluate the susceptibility of the pathogen against different drugs (8). In the described case, 
the antibiotic treatment of pyoderma included the administration of six different antibiotics, one 
corticosteroid and one antifungal agent, during a total of 54 days, before a microbiological 
investigation was eventually carried out. The microbiological analysis allowed determination of the 
antibiotic susceptibility profile of the MRSP strain within 48 h. 
Possible therapeutic options after failure of the treatment with minocycline and successive relapse 
were limited (Tab. 1). These consisted of antibiotic agents for which the use in veterinary medicine 
should be restricted to life-threatening infections, when culture and susceptibility testing indicate no 
other options (8). The dog was treated with rifampicin, even if this drug is rarely used in dogs, at the 
recommended doses of 10-15 mg/kg orally sid. This is a bactericidal staphylococcal agent which 
inhibits the bacterial RNA polymerase activity resulting in a block of the protein synthesis. 
Normally, with deep pyoderma antibiotic treatment is given for at least six weeks, extended to no 
less than two weeks after clinical resolution. However as rifampicin is very hepatotoxic and plasma 
liver enzymes should be monitored weekly, the veterinary surgeon preferred to give a higher dose 
for only seven days. Topical treatment was hardly used in this case; only an ointment containing 
allicin was applied toward to the end of the treatment, although it is very useful in the treatment of 
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pyoderma. It helps removing debris and bacteria and favours drainage of exudative and deep 
lesions. There are many products on the market, such as soaks with chlorhexidine or iodine and 
special shampoos containing benzoyl peroxide or ethyl lactate. Creams tend to be used for localised 
lesions. In this case the frequent change of veterinary practices did not permit a continuity of the 
dog follow up and this had a deleterious effect on the outcome. 
 
Conclusion 
This clinical case emphasizes the importance of a rapid and accurate microbiological diagnosis, 
based on the identification of the pathogen and an antibiogram for an effective treatment of severe 
cutaneous infections in dogs, especially when an empiric first line treatment is not successful. This 
is particularly important in the case of infections that might result from microorganisms such as 
S. pseudintermedius, known to develop multidrug resistance (7). 
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9. Discussion and conclusion 
9.1. The inter- and multidisciplinary approach 
Resistance to antibiotics is a multifactorial, complex problem, with the occurrence of several factors 
(e.g. antibiotic administration, the success in the transmission of specific resistant clones and the 
fitness cost related to resistance mechanisms) affecting its evolution in time and space. Multi-drug 
resistance affects human, animal and environmental health, thus asking for a multi-faceted approach 
towards understanding and management of resistance evolution. 
I believe that the “One Health” interdisciplinary approach, with investigations at the interface 
between veterinary and human medicine, will be helpful to understand the role of pets in the spread 
of antibiotic resistance, considering the socio-emotional context of the human-pet relationship. I 
tried, therefore, to use a multidisciplinary approach in my work and I explored the complexity of the 
problem at several levels. I first examined the diagnostic and microbiological perspective, studying 
then the risk factors for epidemiological spread of multi-drug resistant (MDR) bacteria and the 
behavioural characteristics of the relationship between human and pets, to finish with a study on the 
clinical implications of antibiotic resistance. 
 
9.2. Overview of findings 
Matrix assisted laser desorption ionisation – time of flight mass spectrometry (MALDI-TOF MS) 
allowed rapid and reliable identification of staphylococcal species also for phylogenetically close 
related taxa such as S. delphini, S. intermedius, S. pseudintermedius (REARCH PAPER 1). The 
analysis of the staphylococcal population composition of healthy cats and dogs revealed that 
S. pseudintermedius was present in 27 % of healthy dogs and 3 % of healthy cats, whereas S. felis 
was isolated only from cats and represented 31 % of their CNS isolates. About 17 % of the pets 
carried at least one MDR Staphylococcus spp. strain. Previous hospitalisation (stay in a veterinary 
Chapter 9 – Discussion and conclusion - 130 - 
Epidemiology of multi-drug resistant staphylococci in cats, dogs and people in Switzerland 
clinic during at least one night) was identified as a risk factor for the carriage of MDR 
staphylococci in nostrils and ears of cats and dogs (RESEARCH PAPER 2). Although a relevant 
proportion of pets and nursing home residents carried MDR staphylococci, people had no increased 
risk of being carriers of MDR strains when living in homes with pets or having contact with them at 
least once a week compared to people living in homes without pets (RESEARCH PAPER 3). Our 
findings on MDR staphylococcal carriage in residents living with pets suggested that strain 
transmission between pets and humans within nursing homes is limited. Two genetically identical 
strains of methicillin-resistant S. epidermidis were isolated from a nostril of a nursing resident and a 
cat with which the resident had contact once a week; however it was not possible to infer the origin 
and direction of the possible strain exchange (RESEARCH PAPER 3). Physical closeness of pets 
with their owners was very frequent in the household, also indicating the emotional importance of 
this relationship, but we did not find any evident impact of pets on carriage of MDR staphylococci 
in their owners (WORKING PAPER 1). Clinical implications of methicillin-resistant 
S. pseudintermedius (MRSP) infection were then discussed in RESEARCH PEPER 4, using as an 
example the isolation of S. pseudintermedius from a pyoderma lesion in a dog that underwent 
various antibiotic treatments before the correct diagnosis was made and an appropriate antibiotic 
treatment was administered.  
 
9.3. Contact to pets and risk of transmission of staphylococci 
The emotional importance of pets for Swiss people was evident during the whole investigation. 
People and pets had a close and intense interaction within their household; in nursing homes the 
physical closeness between residents and pets was, as a general rule, less strong. This suggests 
different probabilities of microorganism transmission between the two settings.  
I did not observe any increased carriage of MDR staphylococci in people due to pet contact in 
nursing homes or in the households. This might stem from the fact that nursing home residents, 
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basically more susceptible to get MDR staphylococci because often immunosuppressed, had less 
intense physical contact to pet and thus a low probability to acquire staphylococci from the animals. 
People in the community, on the average, had intense physical contact with their pets, but, being 
immunocompetent, their chances of acquisition of MDR staphylococci from their companions are 
presumably not very high.  
 
9.4. Identification of staphylococci 
My work benefited from the use of rapid, accurate and relatively inexpensive microorganism 
identification by MALDI-TOF MS. The correct and exhaustive identification of both coagulase-
positive and coagulase-negative staphylococci was a pre-requisite to understand the distribution of 
Staphylococcus spp. in people and pets. Our results suggested the presence of host-specific 
staphylococcal species, with S. pseudintermedius being the most prevalent species in dogs, S. felis 
in cats and S. epidermidis in humans. This information, coupled with typing methods (e.g. pulsed 
field gel electrophoresis, multilocus sequence typing) might be of value also in future works dealing 
with the direction of possible exchange of strains among the different hosts. 
 
9.5. Antibiotic administration and surveillance 
The correct identification of isolates is also of primary importance for the assessment of antibiotic 
resistance and subsequent correct antibiotic administration, as highlighted in the MRSP case report. 
Antibiotic treatment is known to be one of the factors influencing the acquisition of resistance in 
microorganisms (1). Thus, antibiotic stewardship is important to reduce the rapidity at which 
microorganisms develop resistance and to control the occurrence of co-selection between drugs 
used in different sectors (e.g. veterinary and human medicine) (2). In this context there is a need to 
increase the awareness of veterinarians and medical doctors on the challenge deriving from 
antibiotic resistance; this global challenge cannot be dealt with a sectorial approach. Joined 
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antibiotic surveillance programs such as the Canadian Integrated Program for Antimicrobial 
Resistance Surveillance (CIPARS) (3) should be promoted everywhere. In Switzerland, a recent 
investigation highlighted the potential for synergic actions between veterinary and human medicine 
(4). Also in this context antibiotic resistance management would benefit from a joint surveillance 
program. 
 
9.6. Fitness cost of antibiotic resistance 
Fitness cost is one of the key parameters influencing establishment of antibiotic resistance (5). I 
reported MDR in staphylococci carried by healthy cats, dogs and people. The absence of risk 
related to the contact with pets for the carriage of these microorganisms in nursing home residents 
indicated a relatively low rate of strain exchange between different hosts. This, together with the 
presence of host-specific staphylococcal species, suggests different fitness costs associated to the 
colonisation of different hosts. There is therefore a need to investigate the fitness costs of antibiotic 
resistance associated to the different staphylococcal species in different hosts. This would 
eventually allow evaluating the epidemic potential of antibiotic resistant staphylococci of different 
origins and understanding their real impact on human and animal health. 
 
9.7. Management of pets in nursing homes 
I did not observe any increased risk of MDR staphylococcal carriage in nursing home residents in 
contact with cats and dogs; nevertheless, guidelines for a correct keeping of pets would be of 
importance. During sample collection, I had the impression that the decision to allow the presence 
of pets in nursing homes was left to the initiative of individuals, with each nursing home taking up 
independent decisions. To my knowledge, so far no official guidelines have been developed at the 
Federal or Cantonal level. Better awareness of benefits and risks linked to the presence of pets in 
nursing home is pivotal to help administrations in taking informed decisions on the opportunity and 
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methods to keep pets in the institutions. Allergy to pets should also be taken into account, for 
example by leaving “pet-free” areas for allergic residents. 
 
9.8. Conclusions 
MDR staphylococci were recovered in relevant proportions from healthy pets and people in nursing 
homes and in the community. I documented the potential for exchange of strains as a consequence 
of close physical contact between the different hosts. My results, however, indicated negligible rates 
of MDR staphylococcal transmission between human and pets. I also document the importance of 
considering different antibiotic resistances (not merely methicillin resistance), all staphylococcal 
species (not just coagulase-positive) and the socio-cultural context of the study when investigating 
the possible exchange of staphylococcal strains between different hosts. 
Future studies are now needed to assess the public health impact of MDR in people and in pets in 
other contexts by combining, under the “One Health” approach, investigations on fitness costs of 
antibiotic resistance in different staphylococcal species recovered from different hosts and 
modelling of multi-drug resistance carriage data within contact networks. 
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10.1. Posters 
During the 3-years of my PhD thesis I had the opportunity to attend national and international 
meetings and conferences were I could present posters on the progresses of my work and to 
exchange opinions on my PhD project with researchers in the field of microbiology, antimicrobial 
resistance and public health. 
 
In particular I attended and I presented posters at the following conferences: 
 
- Sympo Staph, Lyon, France, 13th-15th of October 2008 (POSTER 1) 
- ASM (American Society of Microbiology) Conference – Antimicrobial resistance in zoonotic 
bacteria and foodborne pathogens in animals, humans and the environment, Toronto, Canada, 8th-
11th of June 2010 (POSTER 2 and POSTER 3) 
- Annual Congress of the SSM (Swiss Society of Microbiology), Zürich, Switzerland, 24th-25th of 
June 2010 (POSTER 4) 
- EcoHealth 2010 – Global Ecohealth Challenges; Multiple Perspectives, London, United 
Kingdom, 18th-20th of August 2010 (POSTER 5) 
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10.1.1. POSTER 1 - Portage de staphylocoque antibiorésistants chez les chiens et chats 
présents dans des établissements de long séjour – étude pilote 
 
Presented at the:  Sympo Staph, Lyon, France, 13th-15th of October 2008 
By:  P. Decristophoris, E. Papin, G. Regula, O. Petrini 
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10.1.2.  POSTER 2 - Carriage of multidrug resistant staphylococci in healthy cats and dogs in 
Swiss nursing homes 
 
Presented at the:  ASM (American Society of Microbiology) Conference – Antimicrobial 
resistance in zoonotic bacteria and foodborne pathogens in animals, 
humans and the environment, Toronto, Canada, 8th-11th of June 2010 
By:  P. Decristophoris, G. Regula, E. Schelling, J. Zinsstag, O. Petrini 
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10.1.3.  POSTER 3 - Effective antibiotic treatment in a dog with methicillin resistant 
Staphylococcus pseudintermedius infection: A case report 
 
Presented at the:  ASM (American Society of Microbiology) Conference – Antimicrobial 
resistance in zoonotic bacteria and foodborne pathogens in animals, 
humans and the environment, Toronto, Canada, 8th-11th of June 2010 
By:  P. Decristophoris, F. Mauri, A. Carnelli, T. Vanzetti, J. Zinsstag, O. 
Petrini 
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10.1.4. POSTER 4 - Carriage of multidrug resistant staphylococci in cats, dogs and nursing 
home residents of the Canton Ticino 
 
Presented at the:  Annual Congress of the SSM (Swiss Society of Microbiology), Zürich, 
Switzerland, 24th-25th of June 2010 
By:  P. Decristophoris, V. Francini, A. De Benedetti, E. Schelling, J. 
Zinsstag, O. Petrini 
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10.1.5.  POSTER 5 - Antibiotic resistance: a challenge to human-pet relationship 
 
Presented at the:  EcoHealth 2010 – Global Ecohealth Challenges; Multiple Perspectives, 
London, United Kingdom, 18th-20th of August 2010 
By:  P. Decristophoris, O. Petrini, E. Schelling, J. Zinsstag 
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10.2. Report to the nursing homes 
This report was written and translated in the three main Swiss languages (German, French and 
Italian) and was mailed to all 77 nursing homes that participated into the study in the four different 
Swiss Cantons (Bern, Ticino, Vaud and Zürich). 
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10.2.1. German version 
- ERGEBNISBERICHT - 
Die Epidemiologie der Antibiotika-resistenten Staphylokokken bei Katzen, Hunden 
und Bewohnern in Alters- und Pflegeheimen in der Schweiz 
 
Paola Decristophoris, Anna De Benedetti, Giovanni Marvin, Jan Guillaume, Christiane Petignat, 
Monica Attinger, Orlando Petrini 
 
Aus dem Französischen von Lena Fiebig 
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 Hintergrund der Studie 
Antibiotika-resistente Mikroorganismen stellen weltweit eine Gefahr für die öffentliche Gesundheit 
dar. Bakterien der Gattung Staphylococcus, welche bei Mensch und Tier zur natürlichen Mikroflora 
der Haut und der Schleimhäute gehören, können über verschiedene Mechanismen Resistenzen 
gegenüber ein oder mehrere Antibiotika entwickeln.  
Diese Bakterien können ein Gen (mecA) tragen, über welches eine Resistenz gegen Methicillin und 
alle andere Betalaktame vermittelt wird. Durch eine solche Resistenz wird die Behandlung von 
Infektionen durch diese Mikroorganismen erschwert. Aktuellen Studien zufolge, welche in Alters- 
und Pflegeheimen von vier Schweizer Kantonen durchgeführt wurden, sind etwa 6-10% der 
Bewohner symptomlose Träger von MRSA (Methicillin-resistenter Staphylococcus aureus) (1, 2). 
Auch koagulasenegative Staphylokokken, wie S. epidermidis, können zu nosokomialen (in 
medizinischen Einrichtungen erworbenen) Infektionen führen, die subakut oder ohne deutliche 
Krankheitsanzeichen verlaufen können. Diese Staphylokokken spielen auch eine wichtige Rolle als 
opportunistische Erreger. Im Laufe der vergangenen Jahre wurde ein Anstieg an durch diese Erreger 
bedingte Infektionen verzeichnet, und zwar vor allem bei Personen mit Prothesen oder bei welchen 
ein Intravenös - oder ein Harnkatheter gelegt wurde (3). 
Bei Haustieren (vor allem bei Katzen und Hunden) werden am häufigsten Staphylokokken 
gefunden, welche zur Art S. pseudintermedius gehören. Auch diese Staphylokokken können 
Antibiotikaresistenzen entwickeln, unter anderem gegenüber Methicillin (MRSP: Methicillin-
resistenter Staphylococcus pseudintermedius). Es sind Fälle beschrieben, in welchen diese Erreger 
zwischen Haustieren und Mitarbeitern von Tierkliniken übertragen wurden. Haustiere wurden 
hierbei als mögliches Reservoir Antibiotika-resistenter Bakterien vermutet (4). 
Katzen und Hunde spielen eine immer wichtigere Rolle bei therapeutischen Massnahmen für ältere 
und chronisch erkrankte Menschen. In Alters- und Pflegeheimen durchgeführte Studien zeigen, dass 
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sich der therapeutische Einsatz von Tieren günstig auf das psychische und physische Wohl der 
Bewohner auswirkt (5). Allerdings sind Bewohner von Alters- und Pflegeheimen häufig 
immungeschwächt und können daher einem besonders hohen Risiko einer Infektion mit 
multiresistenten Staphylokokken ausgesetzt sein. Bislang ist wenig darüber bekannt, in welchem 
Ausmass Haustiere mit Staphylokokken kolonisiert sind und welche Rolle eine 
Bakterienübertragung zwischen Mensch und Tier in Alters- und Pflegeheimen spielt. 
 
Zielstellung 
Die Ziele der Studie umfassten 
- die Bestimmung der Prävalenz, mit welcher multiresistente Staphylokokken bei Katzen, Hunden 
und Bewohnern in Alters- und Pflegeheimen in den Kantonen Bern, Tessin, Waadt und Zürich 
vorkommen; 
- die Beschreibung der epidemiologischen Zusammenhänge zwischen Staphylokokken, welche bei 
Tieren isoliert wurden und jenen, welche bei Personen isoliert wurden, die Kontakt zu den Tieren 
hatten; sowie 
- eine Einschätzung der möglichen Bedeutung von Haustieren als Reservoir für Antibiotika-
resistente Bakterien. 
 
Studienablauf und Auswahl der Studienteilnehmer 
Die Studie wurde von den Ethikkommissionen der Kantone Bern, Tessin, Waadt und Zürich, durch 
die Veterinärämter dieser Kantone, sowie durch das Bundesamt für Veterinärwesen (BVET) 
bewilligt. 
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Die Alters- und Pflegeheime der Kantone Bern, Tessin, Waadt und Zürich wurden in zwei Gruppen 
eingeteilt: eine Gruppe bestand aus Einrichtungen, bei welchen Katzen und Hunde als Haustiere 
zugelassen waren, und die andere Gruppe bestand aus Einrichtungen ohne Haustiere. Aus beiden 
Gruppen wurden Alters- und Pflegeheime nach dem Zufallsprinzip ausgewählt und zu einer 
freiwilligen Teilnahme an dieser Studie eingeladen. Als Einrichtungen mit Tieren wurden jene 
Alters- und Pflegeheime eingestuft, in welchen 
- mindestens eine Katze oder ein Hund von der Einrichtung oder von einem der Bewohner gehalten 
wurde oder 
- mindestens einmal wöchentlich eine Katze oder ein Hund zu Therapiezwecken einbezogen wurde. 
Innerhalb jeder teilnehmenden Einrichtung wurden dann zufällig ausgewählte Bewohner gefragt, ob 
sie bereit wären, an der Studie teilzunehmen. Anhand einer Pilotstudie ergab sich, dass für die 
Durchführung der Studie je fünf bis sieben Teilnehmer pro Alters- und Pflegeheim nötig wären. 
Nach Einverständnis der Besitzer wurden ausserdem alle Katzen und Hunde der teilnehmenden 
Einrichtungen in die Probenentnahme einbezogen. Alle Studienteilnehmer hatten das 18. 
Lebensjahr vollendet und gaben ihr schriftliches Einverständnis zur Studienteilnahme. 
Ausgeschlossen von der Studie wurden alle Personen, welche bereits an anderen klinischen Studien 
teilnahmen, oder zum Zeitpunkt der Nasentupferentnahme akut erkrankt waren. 
 
Probennahme und Laboranalysen 
Jedem Tier, welches in die Studie einbezogenen war, wurde je ein Nasen- und ein Ohrabstrich, den 
teilnehmenden Personen jeweils ein Nasenabstrich entnommen. Für alle Teilnehmer (Tiere und 
Personen) wurde ausserdem ein Datenformular ausgefüllt, um auch demographische Angaben, 
sowie Informationen zum Gesundheitszustand und über Kontakte der Bewohner zu den Tieren zu 
erfassen. 
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Die Proben wurden innerhalb von 24 bis 48 Stunden nach Probenentnahme im Labor auf 
Staphylokokken untersucht. Bei positivem Befund wurden die Bakterien selektiv in Fest- und 
Flüssigmedien angereichert, und eine Speziesbestimmung mittels molekularer Methoden wurde 
durchgeführt.  
Die isolierten Staphylokokken wurden dann auf Resistenzen gegenüber 24 verschiedenen 
Antibiotika getestet. Anhand der Testergebnisse wurden Bakterienstämme nach standardisierten 
Verfahren (6, 7) als “resistent” (bei fehlenden Medikamentensensibilität) oder als “sensibel” 
gegenüber den jeweiligen Antibiotika eingestuft. Als “multiresistent” wurden in dieser Studie 
diejenigen Bakterienstämme bezeichnet, welche gegenüber mindestens drei Wirkstoffe 
verschiedener Antibiotikaklassen resistent waren. Mittels molekularbiologischer Methoden wurde 
untersucht, ob die Bakterien das mecA-Gen trugen. Dieses Gen kommt bei Staphylokokken vor, 
welche ähnliche Antibiotikaresistenzen wie MRSA aufweisen und ist für die Resistenz gegenüber 
Methicillin und andere Betalaktame verantwortlich. Es ist leicht von einem auf einen anderen 
Bakterienstamm übertragbar (8). 
 
Statistische Auswertung 
Die für die Studie benötigte Teilnehmerzahl wurde über eine Pilotstudie ermittelt. Aus dieser 
ergaben sich Schätzwerte, dass bei 10% der Bewohner und bei 5% der Tiere mindestens ein 
multiresistenter Staphylokokkenstamm vorkommt. Alle erhobenen (Labor- und Befragungs-) Daten 
wurden deskriptiv und vergleichend statistisch ausgewertet. 
 
Ergebnisse und Diskussion 
Bei insgesamt 445 Bewohnern und 98 Haustieren (53 Katzen und 45 Hunden) aus 77 Alters- und 
Pflegeheimen wurden Proben entnommen (Tabelle 1). Die durchschnittliche Teilnahmequote der 
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Alters- und Pflegeheime aus vier Kantonen betrug 53,2%. Die demographischen Angaben zu den 
Studienteilnehmern sind in den Tabellen 2A und 2B dargestellt. 
 
Tabelle 1. Anzahl der Studienteilnehmer (Bewohner und Tiere) nach Kanton und nach der Gruppe des 
Alters- und Pflegeheims (mit oder ohne Tiere). 
 Alters- und Pflegeheime mit Tiere  
(n = 39) 
Alters- und Pflegeheime ohne Tiere 
(n = 38) 
Anzahl Bewohner (insgesamt) 229 216 
Im Kanton Bern 59 58 
Im Kanton Tessin 58 58 
Im Kanton Waadt 60 60 
Im Kanton Zürich 52 40 
Anzahl Tiere (insgesamt) 98 - 
Im Kanton Bern  32 - 
Im Kanton Tessin 26 - 
Im Kanton Waadt 20 - 
Im Kanton Zürich 20 - 
 
 
Tabelle 2: A. Demographische Angaben zu den Bewohnern der Alters- und Pflegeheime mit und ohne Tiere. 
B. Angaben zu den Tieren. 
A. Alters- und Pflegeheime 
mit Tiere 
Alters- und Pflegeheime 
ohne Tiere 
Alter (Median) 86.6 ± 10.8 85.2 ± 11.4 
 % n % n 
Anteil Frauen 75 (172/229) 69 (148/216) 
Früherer Befund von MRSA 5 (12/229) 3 (7/216) 
Katheter innerhalb des vergangenen Jahres gelegt 16 (36/229) 14 (30/216) 
Harnwegsinfektionen (vergangenen Jahr) 22 (50/226) 26 (55/212) 
Chirurgischer Eingriff (vergangenen Jahr) 14 (32/227) 6 (14/216) 
Aufenthalt in anderen Alters- / Pflegeheim (verg. Jahr) 23 (53/228) 22 (47/215) 
Behandlung mit Antibiotika (innerhalb letzten 3 Monate) 23 (52/228) 21 (45/214) 
Wöchentlicher Kontakt zu einer Katze oder einem Hund 60 (137/229) 9 (20/216) 
B. Katzen (n=53) Hunde (n=45) 
 % n % n 
Besitzer des Tieres ist      
 das Alters- und Pflegeheim 81 43 0 0 
 ein Bewohner 17 9 11 5 
 ein Therapeut 0 0 24 11 
 ein Besucher 0 0 24 11 
 ein Mitglied des Pflegepersonals 0 0 31 14 
 Andere 2 1 9 4 
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Bewohner 
Bei den 445 untersuchten Personen wurden insgesamt 815 Staphylokokkenstämme gefunden. In 
Alters- und Pflegeheimen mit Tieren wurden bei 36,7% (84/229) der Bewohner multiresistente 
Staphylokokken festgestellt und bei 24% (55/229) Methicillin-resistente Staphylokokken (mit 
mecA-Gen). In Alters- und Pflegeheimen ohne Tiere wurden bei 45,8% (99/226) der untersuchten 
Bewohner multiresistente Staphylokokken festgestellt, und bei 29,6% (64/216) Methicillin-
resistente Staphylokokken.  
Darüber hinaus wurden 9 MRSA-Stämme aus Nasentupfern von 8 Personen isoliert. Von diesen 
Personen wohnten zwei Personen in Alters- und Pflegeheimen mit Tieren und sechs Personen in 
Einrichtungen ohne Tiere. In keiner der Proben wurde ein MRSP (Methicillin-resistenter 
Staphylococcus pseudintermedius) gefunden, welcher hauptsächlich bei Haustieren vorkommen 
kann. 
 
Katzen und Hunde 
Aus den Nasen- und Ohrtupferproben der 98 untersuchten Tiere wurden insgesamt 109 
Staphylokokkenstämme isoliert. Von den Tieren trugen 16,3% (16/98) multiresistente 
Staphylokokken und 6,1% (6/98) Methicillin-resistente Staphylokokken.  
Weder MRSA noch MRSP wurden bei den untersuchten Tieren gefunden.  
 
Kontakt der Bewohner zu den Katzen und Hunden 
Insgesamt 63,1% (281/445) der Studienteilnehmer gaben an, dass ein Kontakt zu Haustieren sehr 
wichtig für ihre Lebensqualität sei. Jedoch hatten nicht alle Personen, welche in Alters- und 
Pflegeheimen mit Tieren wohnten, tatsächlich direkten Kontakt zu einem Tier: nur 55,9% (128/229) 
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der befragten Bewohner von Alters- und Pflegeheimen mit Tieren gaben an, mindestens einmal 
wöchentlich ein oder mehrere Tiere der Einrichtung berührt zu haben. 
In einem Fall wurde derselbe Stamm eines multiresistenten S. epidermidis in der Nasentupferprobe 
eines Bewohners und in der Nasentupferprobe von einer Katze gefunden. Gemäss den erhobenen 
Kontaktdaten hatte dieser Bewohner die Katze etwa einmal wöchentlich berührt. Anhand dieses 
Ergebnisses kann jedoch nicht gesagt werden, ob eine direkte Übertragung des Bakterienstammes 
zwischen Mensch und Tier stattgefunden hat, oder ob es eine gemeinsame Expositionsquelle in der 
Umgebung gab, von welcher sowohl die Katze als auch der Bewohner die Bakterien unabhängig 
voneinander erworben hatten.  
Es stellte sich heraus, dass für die Bewohner von Alters- und Pflegeheimen kein erhöhtes Risiko 
bestand, multiresistente Staphylokokken zu tragen (relatives Risiko = 0,80; CI: 0,64-1,00), wenn 
Katzen und Hunde in der Einrichtung gehalten wurden (bzw. Zugang hatten) und berührt wurden. 
Wurde jedoch innerhalb der drei Monate vor Befragung eine Antibiotikabehandlung durchgeführt, 
war das Risiko dreimal so hoch, dass multiresistente Staphylokokken vorkamen. 
 
Schlussfolgerungen 
Die Ergebnisse dieser Studie zeigen, dass Bewohner in Alters- und Pflegeheimen durch den 
Kontakt zu Katzen und Hunden keinem erhöhten Risiko ausgesetzt sind, multiresistente 
Staphylokokken zu tragen. Bedenkt man die günstigen Auswirkungen, welche die Anwesenheit von 
Tieren insbesondere auf das psychische Wohlbefinden der Bewohner hat, kann man zu einer 
Zulassung von Katzen und Hunden in Alters- und Pflegeheime ermutigen. Es sollte aber darauf 
geachtet werden, dass im Umgang mit den Tieren Hygieneregeln strikt eingehalten werden und der 
Gesundheitszustand der Haustiere regelmässig untersucht wird, um eine Übertragung von 
Infektionskrankheiten zu vermeiden. Dazu sollten Tiere mit akuten infektiösen Erkrankungen nicht 
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in direkten Kontakt mit den Bewohnern kommen. Daher ist es wichtig, auch eine Möglichkeit 
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10.2.2. Italian version 
- RAPPORTO DELLO STUDIO - 
Epidemiologia degli stafilococchi multiresistenti agli antibiotici nei gatti, nei cani e nei 
residenti di istituti di lunga degenza in Svizzera 
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Monica Attinger, Orlando Petrini 
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Contesto dello studio 
I microrganismi multiresistenti agli antibiotici sono una preoccupazione per la salute pubblica a 
livello mondiale. Anche batteri del genere Staphylococcus, appartenenti alla comunità batterica 
naturale della cute e delle mucose di uomini e animali, hanno sviluppato vari meccanismi che 
conferiscono resistenze a diversi tipi di antibiotici. In particolare, questi germi, possono avere un 
gene (mecA) che conferisce loro la capacità di essere resistenti alla meticillina e a tutti i beta-
lattamici. Possono quindi insorgere difficoltà nel trattamento di eventuali infezioni derivanti da 
questi microrganismi. Secondo studi recenti condotti negli istituti di lunga degenza di alcuni 
Cantoni svizzeri, circa il 6% di residenti è portatore sano di MRSA (Staphylococcus aureus 
meticillino resistente) (1, 2). Pure gli stafilococchi coagulasi negativa (ad es. S. epidermidis) 
causano infezioni nosocomiali, con manifestazioni cliniche subacute e dei decorsi cronici, senza 
segni fulminanti d’infezioni, e rivestono un ruolo importante quali patogeni opportunisti. Negli 
ultimi anni vi è stato un aumento d’infezioni riconducibili a questi microorganismi, in particolare 
nei pazienti con cateteri e protesi (3). 
Negli animali domestici, in particolare nei cani e nei gatti, gli stafilococchi più frequentemente 
isolati appartengono alla specie Staphylococcus pseudintermedius. Anche questi stafilococchi 
possono sviluppare resistenze a vari tipi di antibiotici, tra i quali pure la meticillina (MRSP: 
Staphylococcus pseudintermedius meticillino resistente). Sono stati documentati anche dei casi di 
trasmissione di questi microorganismi tra animali domestici e personale di cliniche veterinarie. 
Questi animali sono quindi stati descritti come potenziale serbatoio per batteri resistenti agli 
antibiotici (4). 
Gli animali, in particolare cani e gatti, sono impiegati sempre più spesso quale parte integrante della 
terapia alle persone anziane o malati cronici. Studi condotti in istituti di lunga degenza hanno 
mostrato come l’impiego di animali nella terapia porti a dei benefici sia a livello psichico sia fisico 
nei residenti (5). Tuttavia, gli ospiti presenti negli istituti di lunga degenza sono, frequentemente, 
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delle persone immunodepresse esposte quindi a un potenziale rischio d’infezioni da stafilococchi 
multiresistenti agli antibiotici. Abbiamo a disposizione poche informazioni riguardanti la 
colonizzazione degli animali domestici da parte degli stafilococchi e l’eventuale trasmissione di 
questi batteri all’ambiente di un istituto di lunga degenza.  
 
Scopi dello studio 
- Conoscere la prevalenza di colonizzazione da stafilococchi multiresistenti agli antibiotici in gatti, 
cani e nelle persone residenti in istituti di lunga degenza nei Cantoni Ticino, Berna, Vaud e Zurigo; 
- Descrivere le relazioni epidemiologiche tra gli stafilococchi isolati negli animali e quelli isolati 
nelle persone in contatto con questi ultimi;  
- Chiarire il ruolo degli animali domestici quali serbatoi di resistenze batteriche. 
 
Disegno dello studio e scelta dei soggetti 
Tutti gli istituti di lunga degenza dei Cantoni Berna, Ticino, Vaud e Zurigo sono stati classificati in 
due categorie, in base alla presenza o meno di animali da compagnia quali cani e gatti. All’interno 
di ogni categoria è stata eseguita una scelta casuale degli istituti cui richiedere, su base volontaria, la 
partecipazione allo studio. Gli istituti classificati come istituti con animali da compagnia 
presentavano almeno una delle seguenti caratteristiche: 
- presenza di un gatto o di un cane appartenente all’istituto o ad un residente, oppure 
- svolgimento di un’attività di pet-therapy con gatto o cane almeno una volta a settimana. 
I residenti ai quali è stata richiesta la partecipazione sono stati scelti in modo casuale all’interno di 
ogni singolo istituto. Il numero di partecipanti necessario allo studio è stato calcolato sulla base di 
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uno studio pilota svolto in precedenza. All’interno di ogni istituto hanno quindi partecipato tra le 
cinque e le sette persone. Tutti gli animali presenti al momento dello svolgimento dello studio sono 
stati inclusi nel campionamento, previo consenso del proprietario. Tutti i partecipanti erano 
maggiorenni e hanno fornito il loro consenso scritto allo studio. Sono stati esclusi dallo studio i 
soggetti già partecipanti ad altri studi clinici e quelli affetti da una patologia acuta al momento dello 
striscio di una narice. Lo studio è stato autorizzato dai Comitati Etici dei Cantoni Berna, Ticino, 
Vaud e Zurigo e dai rispettivi Uffici cantonali e federale di veterinaria. 
 
Raccolta dei campioni e analisi di laboratorio 
Per ogni animale sono stati raccolti uno striscio dal naso e uno dall’orecchio, mentre ai residenti è 
stato eseguito un solo striscio nasale. Per ogni soggetto incluso nello studio, è stato inoltre 
compilato un questionario per la raccolta di dati demografici e d’informazioni sullo stato di salute e 
sul contatto residente-animale.  
Gli strisci raccolti sono stati analizzati in laboratorio per la ricerca di stafilococchi entro le 24-48 
ore dalla raccolta. Questi microorganismi sono stati isolati da piastre e arricchimenti selettivi e sono 
stati identificati a livello di specie per mezzo di tecniche molecolari. 
Sono state pure testate le reazioni degli stafilococchi nei confronti di 24 diversi antibiotici. I ceppi 
sono poi stati classificati come “resistenti”, con sensibilità ridotta o “sensibili” ai diversi antibiotici 
secondo specifiche linee guida (6, 7). In questo studio abbiamo definito quale “multiresistente” ogni 
ceppo che presentava resistenze ad almeno tre principi attivi appartenenti a diverse classi di 
antibiotici. Abbiamo inoltre investigato con metodi molecolari la presenza del gene mecA. Questo 
gene è presente negli stafilococchi che hanno caratteristiche di resistenza antibiotica paragonabili a 
quelle dell’MRSA, conferisce la resistenza alla meticillina e agli altri beta-lattamici ed è facilmente 
trasmesso da un ceppo di stafilococco all’altro (8). 
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Analisi statistiche 
Il numero di soggetti da investigare in questo studio é calcolato sulla base dei risultati di uno studio 
pilota che stima la presenza di almeno un ceppo di stafilococco multiresistente agli antibiotici nel 
10% dei residenti e nel 5% degli animali. 
 
Risultati e discussione 
Sono stati raccolti campioni da 445 residenti e da 98 animali domestici (53 gatti e 45 cani) in 77 
diversi istituti di lunga degenza (Tabella 1). Il tasso di partecipazione allo studio degli istituti dei 
quattro Cantoni investigati é stato del 53.2%. Il dettaglio delle caratteristiche demografiche dei 
soggetti investigati è presentato nelle Tabella 2A e 2B. 
 
Tabella 1. Numero di soggetti partecipanti allo studio suddivisi per Cantone e per tipologia di istituto a 
lunga degenza (con o senza animali). 
 
Istituti con animali  
(n = 39) 
Istituti senza animali 
(n = 38) 
Totale persone 229 216 
 Canton Berna 59 58 
 Canton Ticino 58 58 
 Canton Vaud 60 60 
 Canton Zurigo 52 40 
Totale animali 98 - 
 Canton Berna 32 - 
 Canton Ticino 26 - 
 Canton Vaud 20 - 
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Tabella 2: A. Caratteristiche demografiche dei residenti investigati negli istituti a lunga degenza con e senza 
animali. B. Caratteristiche demografiche degli animali investigati. 
A. Istituti con animali Istituti senza animali 
Età (mediana) 86.6 ± 10.8 85.2 ± 11.4 
 % n % n 
Sesso femminile 75 (172/229) 69 (148/216) 
Precedente storia di MRSA 5 (12/229) 3 (7/216) 
Portatori di catetere (ultimo anno) 16 (36/229) 14 (30/216) 
Infezioni urinarie (ultimo anno) 22 (50/226) 26 (55/212) 
Intervento chirurgico (ultimo anno) 14 (32/227) 6 (14/216) 
Permanenza in un altro istituto (ultimo anno) 23 (53/228) 22 (47/215) 
Trattamento antibiotico (ultimi 3 mesi) 23 (52/228) 21 (45/214) 
Contatto con cane/gatto ogni settimana 60 (137/229) 9 (20/216) 
     
     
B. Gatti (n=53) Cani (n=45) 
 % n % n 
Proprietari     
 Istituti a lunga degenza 81 43 0 0 
 Residenti 17 9 11 5 
 Personale di pet-therapy 0 0 24 11 
 Visitatori 0 0 24 11 
 Personale curante 0 0 31 14 




Sono stati isolati 815 ceppi di stafilococco dalle narici dei 445 residenti. Negli istituti di lunga 
degenza con animali la proporzione di residenti portatori di stafilococchi multiresistenti agli 
antibiotici è del 36.7% (84/229) e quella dei residenti portatori di stafilococchi resistenti alla 
meticillina (presenza del gene mecA) è del 24% (55/229). Negli istituti di lunga degenza senza 
animali il 45.8% (99/216) dei residenti è portatore di stafilococchi multiresistenti agli antibiotici, e 
il 29.6% (64/216) è portatore di stafilococchi resistenti alla meticillina. 
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Dalle narici di 8 residenti (2 residenti in istituti con e 6 residenti in istituti senza animali) sono stati 
isolati 9 ceppi di MRSA, con un residente portatore di due ceppi diversi. Non è stato isolato nessun 
MRSP (stafilococco resistente alla meticillina riscontrato di solito negli animali domestici). 
 
Cani e gatti 
Sono stati isolati 109 ceppi dalle narici e dalle orecchie dei 98 animali. Il 16.3% (16/98) degli 
animali è portatore di stafilococchi multiresistenti agli antibiotici, e il 6.1% (6/98) è portatore di 
stafilococchi resistenti alla meticillina. 
Non è stato isolato nessun MRSA dai cani e dai gatti investigati in questo studio, né nessun MRSP. 
 
Contatti dei residenti con cani e gatti 
Il 63.1% (281/445) dei residenti inclusi nello studio ha dichiarato di considerare il contatto con un 
animale domestico di primaria importanza per la propria qualità di vita. Non tutti residenti in istituti 
dove cani e gatti sono presenti hanno però un contatto con questi animali, infatti, solo il 55.9% 
(128/229) ha dichiarato d’avere un contatto fisico diretto con gli animali dell’istituto almeno una 
volta a settimana. 
In un solo caso si é riscontrato lo stesso ceppo di stafilococco meticillino resistente, appartenente 
alla specie S. epidermidis, nelle narici di un residente e in quelle di un gatto con cui il residente 
dichiarava di avere contatto una volta a settimana. Non è tuttavia chiaro se i due soggetti si siano 
scambiati il ceppo tramite contatto fisico diretto o se i due abbiano acquisito questo ceppo da una 
fonte comune di colonizzazione (ad es. ambiente circostante). 
In base al nostro studio, la presenza di cani e gatti negli istituti di lunga degenza e il contatto dei 
residenti con questi animali non è un fattore che aumenta nei residenti il rischio di essere portatori 
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di stafilococchi multiresistenti agli antibiotici (rischio relativo = 0.80; 95% CI: 0.64-1.00). È invece 
chiaro che un trattamento antibiotico nei tre mesi precedenti lo studio è un fattore che aumenta di 
tre volte il rischio di essere portatore di stafilococchi multiresistenti agli antibiotici. 
 
Conclusioni 
I risultati di questo studio mostrano che il contatto con cani e gatti all’interno di istituti di lunga 
degenza non aumenta il rischio nei residenti di essere portatori di stafilococchi multiresistenti agli 
antibiotici. La presenza di cani e gatti nel rispetto delle regole d’igiene di base dovrebbe quindi 
essere promossa considerando i benefici, in particolare a livello psichico, per le persone che hanno 
un contatto con questi animali. Per il benessere di residenti e animali sarebbe tuttavia auspicabile 
evitare la presenza di animali affetti da patologie acute o prevederne l’isolamento temporaneo 
all’interno degli istituti. 
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chiens et les personnes dans les EMS en Suisse 
 
Paola Decristophoris, Anna De Benedetti, Giovanni Marvin, Jan Guillaume, Christiane Petignat, 
Monica Attinger, Orlando Petrini 
 
Traduction allemande par Lena Fiebig 
 
Chapter 10 – Appendices - 172 - 
Epidemiology of multi-drug resistant staphylococci in cats, dogs and people in Switzerland 
 Contexte de l’étude 
Les microorganismes multirésistants aux antibiotiques sont un souci pour la santé publique au 
niveau mondial. Les bactéries du genre Staphylococcus, qui font partie de la communauté 
bactérienne naturelle de la peau et des muqueuses chez l’homme et chez les animaux, ont développé 
divers mécanismes qui les rendent résistants à plusieurs types d’antibiotiques. Ces germes peuvent 
en particulier être porteurs d’un gène (mecA) qui leur confère la capacité d’être résistants à la 
méticilline et à tous les autres bêta-lactames. Des difficultés peuvent donc se présenter lors du 
traitement d’infections provoquées par ces microorganismes. Selon des études récentes conduites 
dans les EMS de quatre cantons suisses, environ 6-10% des résidants sont porteurs sains du MRSA 
(Staphylococcus aureus résistant à la méticilline) (1, 2). Les staphylocoques coagulase-négative 
(par ex. S. epidermidis) peuvent également causer des infections nosocomiales avec manifestations 
subaiguës et décours sans signe d’infection fulminante, et jouent un rôle important en tant qu’agents 
pathogènes opportunistes. Au cours des dernières années, on a relevé une hausse des infections 
causées par ces microorganismes, surtout chez les patients avec prothèse ou porteurs de cathéter 
intraveineux ou de sonde urinaire (3). 
Chez les animaux domestiques, en particulier les chats et les chiens, les staphylocoques les plus 
fréquemment isolés appartiennent à l’espèce Staphylococcus pseudintermedius et peuvent 
développer également des résistances à divers types d’antibiotiques, dont la méticilline (MRSP: 
Staphylococcus pseudintermedius résistant à la méticilline). Des cas de transmission de ces 
microorganismes entre animaux domestiques et personnel de clinique vétérinaire ont été 
documentés. Ces animaux ont donc été décrits comme réservoirs potentiels de bactéries résistantes 
aux antibiotiques (4). 
Les chats et les chiens font de plus en plus partie intégrante des thérapies appliquées aux personnes 
âgées ou aux malades chroniques. Des études conduites dans des EMS ont montré que le recours à 
des animaux apporte des bénéfices psychiques et physiques aux résidants (5). Ces derniers sont 
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cependant souvent immunodéprimés et, partant, exposés à un risque potentiel d’infection à des 
staphylocoques multirésistants aux antibiotiques. On dispose actuellement de peu d’éléments quant 
à la colonisation des animaux de compagnie par les staphylocoques et la possible transmission de 
ces bactéries dans les EMS. 
 
Buts de l’étude 
- Connaître le taux de prévalence de la colonisation par les staphylocoques multirésistants aux 
antibiotiques chez les chats, les chiens et les résidants d’EMS dans les cantons de Berne, du Tessin, 
de Vaud et de Zurich. 
- Décrire les relations épidémiologiques entre les staphylocoques isolés chez les animaux d’une 
part, et chez les personnes en contact avec ces derniers d’autre part. 
- Evaluer le rôle potentiel des animaux domestiques comme réservoirs de bactéries résistantes aux 
antibiotiques. 
 
Dessin de l’étude et choix des sujets 
L’étude a été autorisée par les commissions d’éthique des cantons de Berne, du Tessin, de Vaud et 
de Zurich ainsi que par les offices cantonaux concernés et par l’Office vétérinaire fédéral. 
Les EMS des cantons de Berne, du Tessin, de Vaud et de Zurich ont été classés en deux catégories, 
en fonction de la présence ou non de chats ou de chiens comme animaux de compagnie. Nous avons 
ensuite sélectionné de manière aléatoire les institutions de chaque catégorie appelées à participer à 
l’étude sur une base volontaire. Les EMS étaient catalogués comme institutions avec animaux de 
compagnie s’ils présentaient au moins une des caractéristiques suivantes: 
- présence d’un chat ou d’un chien appartenant à l’EMS ou à un résidant,  
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- activité de thérapie animale avec un chat ou un chien au moins une fois par semaine. 
Nous avons également choisi de façon aléatoire, au sein de chaque institution, les résidants dont 
nous avons sollicité la participation. Calculé sur la base d’une étude pilote préalable, le nombre de 
participants nécessaire au déroulement de l’étude a été fixé entre cinq et sept résidants par EMS. 
Tous les chats et les chiens présents dans l’institution ont été inclus dans l’échantillonnage, avec le 
consentement de leur propriétaire. Les participant étaient âgés de plus de 18 ans et ont donné leur 
accord écrit. Ont été exclus de l’étude les sujets qui participaient déjà à d’autres études cliniques ou 
qui souffraient d’une ou de plusieurs maladies aiguës au moment du prélèvement nasal. 
 
Prélèvement d’échantillons et analyses de laboratoire 
Un frottis de nez et d’oreille a été effectué chez tous les animaux et un frottis de nez chez tous les 
résidents inclus dans l’étude. Nous avons en outre rempli un questionnaire pour chaque sujet inclus 
dans l’étude afin de disposer de données démographiques et d’informations sur l’état de santé ainsi 
que sur le contact résidant-animal. 
Les prélèvements microbiologiques ont été analysés en laboratoire dans les 24 à 48 heures suivant 
leur prélèvement afin d’y déceler la présence éventuelle de staphylocoques. Ceux-ci ont été isolés 
au moyen de plaques et de bouillons d’enrichissement sélectifs et les espèces identifiées par 
technique moléculaire. 
Nous avons aussi testé les réactions des staphylocoques à 24 antibiotiques, puis classé les souches 
isolées comme “résistantes” avec sensibilité réduite ou “sensibles” aux différents antibiotiques 
selon des lignes directrices spécifiques (6, 7). Dans cette étude, les souches ont été définies comme 
“multirésistantes” en présence de résistances à au moins trois principes actifs appartenant à diverses 
classes d’antibiotiques. Nous avons par ailleurs recouru à des méthodes moléculaires pour détecter 
le gène mecA, que l’on trouve dans les staphylocoques présentant des résistances aux antibiotiques 
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comparables à celles observées pour le MRSA. Responsable de la résistance à la méticilline et aux 




Le nombre de participants a été déterminé sur la base des résultats obtenus lors d’une étude pilote 
préalable, qui estimait la présence d’au moins une souche de staphylocoques multirésistants aux 
antibiotiques chez 10% des résidants et 5% des animaux. 
 
Résultats et discussion 
Au total, nous avons prélevé des échantillons sur 445 résidants et 98 animaux domestiques (53 chats 
et 45 chiens) dans 77 EMS (Tableau 1). Le taux de participation des EMS à l’étude menée dans les 
quatre cantons susmentionnés a été de 53,2%. Le détail des caractéristiques démographiques des 
sujets est présenté aux Tableaux 2A et 2B. 
 
Tableau 1 Nombre de sujets ayant participé à l’étude, par canton et par typologie d’EMS (avec ou sans 
animaux). 
 
EMS avec animaux  
(n = 39) 
EMS sans animaux 
(n = 38) 
Total résidants 229 216 
 Canton de Berne 59 58 
 Canton du Tessin 58 58 
 Canton de Vaud 60 60 
 Canton de Zurich 52 40 
Total animaux 98 - 
 Canton de Berne 32 - 
 Canton du Tessin 26 - 
 Canton de Vaud 20 - 
 Canton de Zurich 20 - 
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Tableau 2: A. Caractéristiques démographiques des résidants dans les EMS avec et sans animaux. B. 
Caractéristiques démographiques des animaux. 
A. EMS avec animaux EMS sans animaux 
Age (médiane) 86.6 ± 10.8 85.2 ± 11.4 
 % n % n 
Sexe féminin 75 (172/229) 69 (148/216) 
Historique du MRSA 5 (12/229) 3 (7/216) 
Porteurs de cathéter/sonde (dernière année) 16 (36/229) 14 (30/216) 
Infections urinaires (dernière année) 22 (50/226) 26 (55/212) 
Intervention chirurgicale (dernière année) 14 (32/227) 6 (14/216) 
Séjour dans un autre EMS (dernière année) 23 (53/228) 22 (47/215) 
Traitement antibiotique (3 derniers mois) 23 (52/228) 21 (45/214) 
Contact avec chat/chien chaque semaine 60 (137/229) 9 (20/216) 
     
     
B. Chats (n=53) Chiens (n=45) 
 % n % n 
Propriétaires     
 EMS 81 43 0 0 
 Résidants 17 9 11 5 
 Animateur de thérapie animale 0 0 24 11 
 Visiteurs 0 0 24 11 
 Personnel de soins 0 0 31 14 




Nous avons isolé 815 souches de staphylocoques chez les 445 résidants inclus dans l’étude. Dans 
les EMS avec animaux, la proportion de résidants porteurs de staphylocoques multirésistants aux 
antibiotiques était de 36,7% (84/229) et celle des résidants porteurs de staphylocoques résistants à la 
méticilline (présence du gène mecA) de 24% (55/229). Dans les EMS sans animaux, 45,8% 
(99/216) des résidants étaient porteurs de staphylocoques multirésistants aux antibiotiques et 29,6% 
(64/216) de staphylocoques résistants à la méticilline. 
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Par ailleurs, 9 souches de MRSA ont été isolées dans les frottis nasaux de 8 résidants 
(respectivement 2 résidants dans des EMS avec et 6 dans des EMS sans animaux). Un résident était 
porteur de deux souches différentes de MRSA. Nous n’avons en revanche isolé aucun MRSP 
(staphylocoque résistant à la méticilline habituellement présent chez les animaux domestiques). 
 
Chats et chiens 
Les écouvillons nasaux et auriculaires prélevés sur les 98 animaux ont révélé la présence de 
109 souches de staphylocoques. Au total, 16,3% (16/98) des animaux étaient porteurs de 
staphylocoques multirésistants aux antibiotiques et 6,1% (6/98) de staphylocoques résistants à la 
méticilline. 
Nous n’avons pas isolé de MRSA ni de MRSP. 
 
Contacts des résidants avec des chats et des chiens 
Sur la totalité des sujets ayant participé à l’étude, 63,1% (281/445) ont déclaré que le contact avec 
un animal domestique était très important pour leur qualité de vie. Les résidants d’EMS avec 
animaux n’avaient cependant pas tous un contact réel avec ces animaux: seuls 55,9% (128/229) 
d’entre eux ont indiqué avoir un contact physique direct avec les animaux de l’EMS au moins une 
fois par semaine. 
Dans un cas, nous avons retrouvé la même souche de staphylocoque résistant à la méticilline 
appartenant à l’espèce S. epidermidis dans le frottis nasal d’un résidant et dans l’écouvillon nasal 
d’un chat avec qui le résidant a dit avoir un contact hebdomadaire régulier. Il n’est toutefois pas 
possible de déterminer si les deux sujets ont échangé cette souche par contact physique direct ou 
s’ils ont été contaminés par une source commune de colonisation (par ex. environnement voisin). 
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Selon notre étude, la présence de chats et de chiens dans les EMS et le contact des résidants avec 
ces animaux n’augmentent pas le risque pour les résidants d’être porteurs de staphylocoques 
multirésistants aux antibiotiques (risque relatif = 0,80; 95% CI: 0,64-1,00). En revanche, il ressort 
de façon manifeste qu’un traitement antibiotique dans les trois mois précédant l’étude accroît de 
trois fois le risque d’être porteur de staphylocoques multirésistants aux antibiotiques. 
 
Conclusions 
Les résultats de cette étude montrent que le contact avec des chats et des chiens dans les EMS 
n’augmente pas le risque chez les résidants d’être porteurs de staphylocoques multirésistants aux 
antibiotiques. Vu les bénéfices apportés par ces animaux aux personnes avec qui ils entrent en 
contact, en particulier au niveau psychique, la présence de chats et de chiens dans les EMS peut 
donc être encouragée. Cette pratique nécessite tout de même le strict respect des règles d’hygiène et 
un contrôle régulier de la santé des animaux de compagnie, ceci afin d’éviter la transmission de 
pathologies infectieuses. Pour le bien-être des résidants et des animaux, il conviendrait cependant 
d’éviter la présence d’animaux atteints de pathologies aiguës ou de prévoir leur isolement 
temporaire au sein des EMS. 
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